- Conditions: Type 1 Diabetes; Type 2 Diabetes
Intervention:
Sponsors: Metabolic Fitness Association, Italy; Metabolic Fitness Association, Italy; University of Roma La Sapienza
Recruiting - verified May 2012 - Condition: Type 1 Diabetes
Interventions: Behavioral: Interactive computer game; Behavioral: Convertible PC
Sponsors: Rabin Medical Center; Rabin Medical Center; Intel
Not yet recruiting - verified April 2012 - Condition: Type 2 Diabetes
Intervention: Behavioral: Theoretical & practical exercise counseling
Sponsors: Metabolic Fitness Association, Italy; Metabolic Fitness Association, Italy; University of Roma La Sapienza
Not yet recruiting - verified May 2012 - A Study to Compare LY2963016 to Lantus After a Single Dose to Subjects With Type 1 Diabetes MellitusCondition: Diabetes Mellitus, Type 1
Interventions: Drug: LY2963016; Drug: Lantus
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Not yet recruiting - verified May 2012 - Conditions: Gestational Diabetes Mellitus; Pregnancy
Intervention: Behavioral: lifestyle counseling
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill
Not yet recruiting - verified May 2012 - Conditions: Type 2 Diabetes Mellitus; Atherosclerosis; Dyslipidemia
Intervention: Other: Statin withdrawal
Sponsors: University of Padova; University of Padova
Recruiting - verified May 2012 - Conditions: Type 2 Diabetes Mellitus; Diabetic Foot Syndrome; Critical Limb Ischemia
Intervention:
Sponsors: GWT-TUD GmbH; GWT-TUD GmbH
Recruiting - verified May 2012 - Conditions: Type 2 Diabetes; Gastric Banding
Interventions: Drug: Liraglutide; Drug: Orlistat; Drug: Liraglutide + Orlistat
Sponsors: East Carolina University; East Carolina University
Not yet recruiting - verified May 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 2; Healthy
Interventions: Drug: NNC 0148-0000-0362; Drug: insulin glargine; Drug: placebo; Drug: NNC 0148-0000-0362; Drug: NNC 0148-0000-0362; Drug: NNC 0148-0000-0362
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Intervention: Behavioral: Lifestyle Counselling
Sponsors: University of Manitoba; University of Manitoba; Manitoba Institute of Child Health
Not yet recruiting - verified May 2012 - Conditions: Hypertension; Hyperlipidemia; Coronary Artery Disease; Diabetes Mellitus
Intervention: Other: Education
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; The American Legion, Department of Wisconsin
Not yet recruiting - verified May 2012 - Conditions: Coronary Artery Disease; Diabetes Mellitus, Type 2
Interventions: Drug: Liraglutide; Drug: Placebo
Sponsors: Haugaard, Steen Bendix, M.D., DMSc; Haugaard, Steen Bendix, M.D., DMSc
Recruiting - verified May 2012 - Conditions: Multiple Conditions; Coronary Heart Disease; Diabetes; Hypertension; Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: University of Southampton; University of Southampton
Not yet recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: lixisenatide (AVE0010); Drug: liraglutide
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Diabetes Mellitus Type 2
Interventions: Drug: regular insulin; Drug: Insulin glulisine, Insulin glargine
Sponsors: HaEmek Medical Center, Israel; HaEmek Medical Center, Israel
Not yet recruiting - verified May 2012 - Conditions: Diabetics Mellitus Type 1; Diabetes Mellitus Type 2
Intervention: Device: InsuPad
Sponsors: Insuline Medical Ltd.; Insuline Medical Ltd.
Not yet recruiting - verified May 2012 - Condition: Type 2 Diabetes
Intervention: Drug: Yohimbine
Sponsors: Region Skane; Anders Rosengren, MD PhD; Region Skane; Lund University
Not yet recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Liraglutide + metformin; Drug: Glimepiride + metformin
Sponsors: Fundación Fernández-Cruz; Fundación Fernández-Cruz
Not yet recruiting - verified May 2012 - Conditions: Type II Diabetes; Diabetes Mellitus
Interventions: Behavioral: Education on risk factors for Type II Diabetes; Behavioral: Education on Type II Diabetes; Behavioral: Education on regular visits to a Primary Care Provider
Sponsors: Ethnicity and Disease Community Empowerment Center; Ethnicity and Disease Community Empowerment Center; Steward Carney Hospital; Boston Public Housing Authority
Not yet recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Placebo
Sponsors: Merck; Merck
Not yet recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Placebo
Sponsors: Merck; Merck
Not yet recruiting - verified May 2012 - Condition: Impaired Glucose Tolerance
Interventions: Dietary Supplement: Resveratrol; Dietary Supplement: resveratrol /HMB; Other: Placebo treatment
Sponsors: Vanderbilt University; Vanderbilt University; Nutraceutical Discoveries, Inc.
Recruiting - verified May 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 1
Interventions: Drug: insulin degludec; Drug: insulin degludec/insulin aspart
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified May 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 2
Interventions: Drug: biphasic insulin aspart 30; Drug: biphasic insulin aspart 30
Sponsors: Novo Nordisk; Novo Nordisk
Not yet recruiting - verified April 2012 - Condition: Type 1 Diabetes
Intervention: Device: Pump suspension
Sponsors: In Home Closed Loop Study Group; In Home Closed Loop Study Group; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified May 2012 - Condition: Prediabetes
Intervention: Behavioral: Lifestyle changes
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified April 2012 - Conditions: Diabetic Retinopathy; HIV
Interventions: Drug: Tesamorelin; Drug: Placebo-Control
Sponsors: EMD Serono; EMD Serono
Not yet recruiting - verified May 2012 - Conditions: Type 2 Diabetes; Overweight; Obesity
Interventions: Behavioral: Weight Watchers modified program; Other: Standard Care group
Sponsors: Medical University of South Carolina; Medical University of South Carolina; Weight Watchers International
Recruiting - verified March 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: 60 mg LY2409021; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin (Scilin N, BAY81-9924); Drug: Insulin (Scilin R _BAY81-9924; Drug: Insulin(Scilin M30_BAY81-9924)
Sponsors: Bayer; Bayer
Not yet recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Alogliptin; Drug: Vildagliptin
Sponsors: Nagaoka Red Cross Hospital; Nagaoka Red Cross Hospital; Kurume University
Not yet recruiting - verified April 2012 - Condition: Cardiovascular Disease
Interventions: Drug: Methotrexate; Drug: Placebo
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified May 2012 - Condition: Type 1 Diabetes
Interventions: Device: Continuous Glucose Monitor (CGM); Other: Fingerstick BGs only
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic
Recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Other: Low Glycemic Index (LGI) intervention arm; Other: Standard Diet Intervention
Sponsors: National University Hospital, Singapore; National University Hospital, Singapore; National Medical Research Council (NMRC), Singapore
Recruiting - verified September 2011 - Condition: Diabetes Mellitus Type 2
Intervention:
Sponsors: GWT-TUD GmbH; GWT-TUD GmbH; Bayer
Not yet recruiting - verified May 2012 - Conditions: Heart Failure; Type 2 Diabetes; Glucose Intolerance
Interventions: Drug: Eplerenone; Drug: Spironolactone
Sponsors: Montreal Heart Institute; Montreal Heart Institute; Pfizer
Recruiting - verified April 2012 - Conditions: Diabetes Mellitus; Diabetic Neuropathic Foot Ulcer
Interventions: Device: SANIDIAB; Device: BAROUK
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; MAYZAUD
Recruiting - verified April 2012 - Conditions: Hperglycemia; Diabetes Mellitus; Weight Gain
Intervention: Behavioral: Weight Control
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Dulaglutide; Drug: Insulin glargine; Drug: Sulfonylureas (SU); Drug: Biguanide
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2605541; Drug: Insulin glargine
Sponsors: Eli Lilly and Company; Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Saxagliptin; Drug: Vildagliptin; Drug: Placebo
Sponsors: Merck; Merck
Not yet recruiting - verified May 2012 - Condition: Gestational Diabetes Mellitus
Interventions: Other: Low GI diet; Other: Standard Care
Sponsors: University of Toronto; University of Toronto; Canadian Diabetes Association; Canadian Institutes of Health Research (CIHR); Canadian Foundation for Dietetic Research (CFDR)
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Vildagliptin
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Vildagliptin; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Type 1 Diabetes
Intervention: Other: Observational study
Sponsors: Institution of Mother and Child, Warsaw, Poland; Institution of Mother and Child, Warsaw, Poland
Recruiting - verified April 2012 - Condition: Type 1 Diabetes Mellitus
Intervention: Device: Heart rate informed SSM+HMM
Sponsors: University of Virginia; University of Virginia; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom, Inc.; Insulet Corporation; Abbott Diabetes Care
Not yet recruiting - verified April 2012 - Conditions: Diabetic Nephropathy; Persistent Proteinuria With Type II Diabetes
Interventions: Procedure: Percutaneous renal denervation and TMNS; Drug: Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified March 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI10773; Drug: BI10773; Drug: BI10773; Drug: BI10773
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Diabetes Mellitus Type 2
Interventions: Other: Treatment as usual; Other: Self-monitoring for patients with Diabetes mellitus type 2; Other: Nurse-monitoring for patients with Diabetes mellitus type 2
Sponsors: Landeskrankenanstalten-Betriebsgesellschaft; Landeskrankenanstalten-Betriebsgesellschaft; European Commission
Recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Procedure: Dead Sea water; Procedure: Pool water
Sponsors: Soroka University Medical Center; Idit F Liberty
Not yet recruiting - verified April 2012 - Conditions: Diabetes Mellitus; Metabolic Syndrome; Obesity; Atherosclerosis
Intervention:
Sponsors: University of Sao Paulo; University of Sao Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Not yet recruiting - verified April 2012 - Condition: Type 2 Diabetes
Intervention: Other: Exendin 9-39 (Bachem, Germany)
Sponsors: Hvidovre University Hospital; Hvidovre University Hospital
Recruiting - verified April 2012 - Conditions: Chronic Kidney Disease; Diabetes
Interventions: Drug: darbepoetin alfa; Drug: darbepoetin alfa
Sponsors: Translational Research Informatics Center, Kobe, Hyogo, Japan; Translational Research Informatics Center, Kobe, Hyogo, Japan; Showa University School of Medicine
Recruiting - verified April 2012 - Condition: Type 1 Diabetes
Interventions: Drug: Statin; Drug: Ace Inhibitor; Drug: Placebo; Drug: Combination therapy
Sponsors: Cambridge University Hospitals NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Juvenile Diabetes Research Foundation; Diabetes UK; British Heart Foundation; Pfizer; The University of Western Australia; The Hospital for Sick Children; University of Oxford; St Thomas' Hospital, London
Recruiting - verified April 2012 - Conditions: Sedentary Lifestyle; Physical Activity; Pre-Diabetic
Interventions: Behavioral: Mobile phone based physical activity with intervention; Behavioral: Pedometer Only
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: stress management
Sponsors: Yale University; Yale University; Hartford Hospital; University of Connecticut Health Center; Hispanic Health Council
Not yet recruiting - verified April 2012 - Conditions: Diabetes Mellitus Type 2; Hypertension
Interventions: Dietary Supplement: Combined Rg3-enriched Korean Red Ginseng (panax Ginseng C.A. Meyer) and American Ginseng (panax Quinquefolius).; Dietary Supplement: 100% Natural Wheat Bran
Sponsors: St. Michael's Hospital, Toronto; St. Michael's Hospital, Toronto; Canadian Diabetes Association
Recruiting - verified April 2012 - Condition: Type 1 Diabetes Mellitus
Intervention: Device: Outpatient Control-to-Range
Sponsors: University of Virginia; University of Virginia; Food and Drug Administration (FDA); Juvenile Diabetes Research Foundation; University of California, Santa Barbara
Recruiting - verified April 2012 - Conditions: Hypertension; Diabetes Mellitus
Intervention: Behavioral: Home blood pressure monitor
Sponsors: Exempla Saint Joseph Hospital; Exempla Saint Joseph Hospital
Recruiting - verified April 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Mesenchymal Precursor Cells (MPCs); Drug: Mesenchymal Precursor Cells (MPCs); Drug: Mesenchymal Precursor Cells (MPCs)
Sponsors: Mesoblast, Ltd.; Mesoblast, Ltd.
Recruiting - verified May 2012 - Condition: Diabetes Mellitus, Type 2
Intervention: Drug: No Intervention (subjects were previously treated with Onglyza®)
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified April 2012 - Condition: Diabetic Nephropathies
Interventions: Drug: Allopurinol; Drug: Placebo
Sponsors: Joslin Diabetes Center; Alessandro Doria; Steno Diabetes Center; University of Michigan; University of Minnesota - Clinical and Translational Science Institute
Not yet recruiting - verified April 2012 - Conditions: Type 2 Diabetes Mellitus; Gestational Diabetes
Interventions: Device: Continuous Glucose Monitoring; Device: Glucose Meter
Sponsors: Lawson Health Research Institute; Dr. Stewart Harris; Juvenile Diabetes Research Foundation
Not yet recruiting - verified April 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 2
Interventions: Drug: liraglutide; Drug: placebo; Drug: insulin
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified April 2012 - Conditions: Chronic Kidney Disease; Type 2 Diabetes
Intervention: Drug: RTA 402
Sponsors: Kyowa Hakko Kirin Company, Limited; Kyowa Hakko Kirin Company, Limited
Recruiting - verified April 2012 - Conditions: Chronic Kidney Disease; Type 2 Diabetes
Intervention: Drug: RTA 402
Sponsors: Kyowa Hakko Kirin Company, Limited; Kyowa Hakko Kirin Company, Limited
Recruiting - verified May 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 2; Healthy
Interventions: Drug: NN9924; Drug: NN9924; Drug: NN9924; Drug: NN9924; Drug: NN9924; Drug: NN9924; Drug: NN9924; Drug: NN9924
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Lixisenatide (AVE0010); Drug: Placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Whey before Breakfast; Dietary Supplement: Water before breakfast
Sponsors: Tel Aviv University; Tel Aviv University
Recruiting - verified April 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 2
Interventions: Drug: insulin degludec; Drug: insulin glargine
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified April 2012 - Conditions: Diabetes Mellitus; Diabetes Mellitus Complications; Gastroparesis
Interventions: Drug: RM-131; Drug: Placebo
Sponsors: Rhythm Pharmaceuticals, Inc.; Rhythm Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Conditions: Hyperlipidemia; Diabetes Mellitus; Metabolic Syndrome; Arterial Hypertension; Obesity
Intervention: Other: first phase insulin secretion (FPIR), Hyperinsulinemic euglycemic clamp (HEC), glucose tracer, and palmitate tracer
Sponsors: University of Aarhus; University of Aarhus; Lundbeck Foundation; Aarhus University Hospital; Vejle Hospital; Sydvestjysk Hospital; Steno Diabetes Center; University of Copenhagen
Not yet recruiting - verified April 2012 - Conditions: Diabetic Foot; Sleep Apnea
Intervention: Device: Positive airway pressure therapy
Sponsors: AGIR à Dom; AGIR à Dom
Recruiting - verified May 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 1
Interventions: Drug: insulin degludec; Drug: insulin glargine
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Other: Treatment as usual; Other: Self-monitoring for patients with Dibetes mellitus
Sponsors: Regione Veneto; Regione Veneto; European Commission; Unità Locale Socio Sanitaria 4 Alto Vicentino
Recruiting - verified January 2012 - Conditions: End-Stage Renal Disease; Type 2 Diabetes Mellitus
Interventions: Drug: Bardoxolone Methyl 20 mg; Drug: Placebo
Sponsors: Reata Pharmaceuticals, Inc.; Reata Pharmaceuticals, Inc.
Not yet recruiting - verified April 2012 - Conditions: Diabetes; Heart Failure
Intervention: Drug: Metformin
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified April 2012 - Condition: Diabetes Mellitus Type 2
Intervention: Behavioral: Web portal
Sponsors: Medical Research Foundation, The Netherlands; Nanne Kleefstra; Isala Klinieken; University Medical Centre Groningen
Recruiting - verified May 2012 - Condition: Diabetes
Intervention: Drug: Exenatide, Liraglutide
Sponsors: University of Dundee; Evan Pearson; Newcastle Hospitals NHS trust; Oxford Hospitals NHS trust; Royal Devon & Exeter NHS foundation trust
Recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Other: Text messages; Other: Usual care
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; McKesson Foundation
Not yet recruiting - verified March 2012 - Conditions: Diabetes Type 1; Pregnancy; Early Motherhood
Intervention: Other: web-based support
Sponsors: Göteborg University; Göteborg University; the Swedish Diabetes Association; Region Västra Götaland; Inger Hultman med flera foundation
Recruiting - verified March 2012 - Conditions: Chronic Renal Insufficiency; Diabetes Mellitus
Interventions: Drug: Sodium bicarbonate; Drug: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified April 2012 - Conditions: Diabetic Polyneuropathy; Weight Loss
Intervention: Other: Weight Achievement and Intensive Treatment (Why WAIT)
Sponsors: Joslin Diabetes Center; Joslin Diabetes Center; NeuroMetrix, Inc.
Not yet recruiting - verified March 2012 - Condition: Diabetes Mellitus Type II
Interventions: Drug: Metformin; Drug: Metformin; Drug: Vildagliptin; Drug: Glimepiride
Sponsors: ikfe-CRO GmbH; ikfe-CRO GmbH; Novartis Pharmaceuticals; IKFE Institute for Clinical Research and Development
Recruiting - verified March 2012 - Conditions: Diabetes; Effects of Liraglutide Administration on Brain Activity; Weight Loss; Hunger
Interventions: Drug: Liraglutide; Drug: Placebo
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center
Recruiting - verified March 2012 - Conditions: Hypertension; Hypercholesterolemia; Type II Diabetes; Obesity; Inflammation
Intervention: Other: vegetable
Sponsors: University of Guelph; University of Guelph; Ontario Ministry of Agriculture, Food and Rural Affairs
Not yet recruiting - verified March 2012 - Conditions: Elevated Triglycerides; Diabetes; Cardiovascular Disease; Dyslipidemia
Intervention: Other: Fructose + Glucose Beverage
Sponsors: The Rogosin Institute; The Rogosin Institute; Weill Medical College of Cornell University
Recruiting - verified March 2012 - Condition: Gestational Diabetes Mellitus
Intervention: Behavioral: Shared glycaemic control care within the local three-tier's antenatal care network
Sponsors: Tianjin Women and Children's Health Center; Tianjin Women and Children's Health Center; Tianjin Medical University; Pennington Biomedical Research Center
Recruiting - verified March 2012 - Conditions: Type 2 Diabetes Mellitus; Hypogonadism
Interventions: Drug: Testosterone; Drug: Placebo
Sponsors: Odense University Hospital; Marianne Andersen; Odense University Hospital
Recruiting - verified March 2012 - Condition: Type 1 Diabetes
Intervention:
Sponsors: Odense University Hospital; Odense University Hospital; University of Copenhagen; Department of Gynaecology and Obstetrics, Rigshospitalet, Copenhagen; Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark; University of Southern Denmark; Diabetes Research Center, Odense University hospital; University of Aarhus; Aarhus University Hospital
Recruiting - verified April 2012 - Conditions: Arterial Stiffness; Dietary Modification; Impaired Glucose Tolerance; Type 2 Diabetes Mellitus
Intervention: Dietary Supplement: protein hydrolysate capsules and placebo capsules
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Recruiting - verified March 2012 - Conditions: Type 2 Diabetes; Obesity
Intervention:
Sponsors: Hvidovre University Hospital; Hvidovre University Hospital; University of Copenhagen
Recruiting - verified March 2012 - Conditions: Impaired Glucose Tolerance; Diabetes
Intervention: Drug: exenatide
Sponsors: The University of Texas Health Science Center at San Antonio; The University of Texas Health Science Center at San Antonio; Amylin Pharmaceuticals, Inc.
Recruiting - verified April 2012 - Condition: Diabetes Mellitus
Interventions: Drug: gamma-amino-butyric acid; Dietary Supplement: Xylitol
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Not yet recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin/metformin XR; Drug: Placebo
Sponsors: Merck; Merck
Not yet recruiting - verified April 2012 - Condition: Diabetes
Intervention: Other: DSA assay
Sponsors: Wuhan General Hospital of Guangzhou Military Command; Wuhan General Hospital of Guangzhou Military Command
Recruiting - verified March 2012 - Condition: Type 1 Diabetes
Intervention: Procedure: Overnight closed-loop insulin delivery
Sponsors: University of Cambridge; Daniela Elleri; Cambridge University Hospitals NHS Foundation Trust
Not yet recruiting - verified March 2012 - Conditions: Diabetes; Obesity
Intervention: Behavioral: PAT Curriculum + Health Information
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified March 2012 - Condition: Adolescent Type 2 Diabetes
Interventions: Drug: Exenatide Once Weekly; Drug: Placebo
Sponsors: Amylin Pharmaceuticals, Inc.; Amylin Pharmaceuticals, Inc.
Recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ranolazine; Drug: Placebo
Sponsors: Gilead Sciences; Gilead Sciences
Not yet recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: LY2189265; Drug: Placebo; Drug: Liraglutide
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Diabetes
Interventions: Device: Subcutaneous delivery via Medtronic Quick-Set; Device: Intradermal delivery via the BD Research Catheter Set
Sponsors: Becton, Dickinson and Company; Becton, Dickinson and Company
Recruiting - verified March 2012 - Condition: Type 1 Diabetes
Intervention:
Sponsors: Uppsala University Hospital; Uppsala University Hospital
Recruiting - verified March 2012 - Condition: Type 2 Diabetes
Interventions: Drug: EV-077; Drug: EV-077
Sponsors: Evolva SA; Evolva SA
Recruiting - verified March 2012 - Conditions: Diabetes Mellitus; Depression
Interventions: Behavioral: Healthy Outcomes through Patient Empowerment (HOPE); Behavioral: Enhanced Usual Care
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified April 2012 - Conditions: Type 2 Diabetes Mellitus; Renal Impairment
Interventions: Drug: LX4211; Drug: LX4211 Placebo
Sponsors: Lexicon Pharmaceuticals; Lexicon Pharmaceuticals
Recruiting - verified March 2012 - Conditions: Renal Insufficiency, Chronic; Diabetes Mellitus, Type 2
Intervention: Drug: Bardoxolone Methyl
Sponsors: Reata Pharmaceuticals, Inc.; Reata Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Condition: Diabetes Mellitus, Type 2
Intervention: Other: Cycling
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Not yet recruiting - verified March 2012 - Conditions: Renal Insufficiency, Chronic; Diabetes Mellitus, Type 2
Intervention: Drug: Bardoxolone Methyl
Sponsors: Reata Pharmaceuticals, Inc.; Reata Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Condition: Glycemic Control
Interventions: Drug: TAK-875; Drug: Sitagliptin; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Centre (Europe) Ltd.
Recruiting - verified May 2012 - Conditions: Diabetes; Pregnancy
Interventions: Other: Dietary counseling, exercise and self blood glucose monitoring; Other: Minimum intervention control group
Sponsors: Stanford University; Stanford University; Santa Clara Valley Health & Hospital System
Recruiting - verified March 2012 - Condition: Prediabetic State
Intervention: Behavioral: Lifestyle Modification
Sponsors: India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals; India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals; Indian Council of Medical Research; Medical Research Council; Imperial College London
Not yet recruiting - verified April 2012 - Condition: Impaired Fasting Glucose
Interventions: Dietary Supplement: psyllium; Dietary Supplement: Microcrystalline Cellulose
Sponsors: Procter and Gamble; Procter and Gamble; Duke University
Recruiting - verified March 2012 - Condition: Diabetic Complications
Interventions: Device: Prontosan; Device: Saline
Sponsors: B. Braun Medical Inc.; B. Braun Medical Inc.
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Metformin; Drug: Metformin; Drug: Placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Diabetes; Retinal Disorders
Intervention:
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Neuro Kinetics; Jules Stein Eye Institute; National Eye Institute (NEI)
Recruiting - verified March 2012 - Condition: Diabetes Mellitus
Intervention: Behavioral: Mobile Diabetes Education Teams intervention
Sponsors: Ryerson University; Ryerson University; Canadian Institutes of Health Research (CIHR); Trillium Health Centre
Not yet recruiting - verified March 2012 - Conditions: Type 1 Diabetes; Hypoglycemia
Interventions: Behavioral: DiabetesDriving.com; Behavioral: DiabetesDriving.com + Motivational Interview
Sponsors: University of Virginia; University of Virginia; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Conditions: Hypertension; Type 2 Diabetes Mellitus
Intervention: Other: EMPOWER-PAR
Sponsors: Ministry of Health, Malaysia; Ministry of Health, Malaysia
Not yet recruiting - verified March 2012 - Conditions: Retinal Dystrophies; Age-related Macular Degeneration; Arterial Hypertension; Diabetes; Traumatic Retinopathy; Toxic Retinopathies
Intervention:
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified March 2012 - Conditions: Hypertension; Diabetes; Infants Small for Gestational Age
Intervention:
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; The Physicians' Services Incorporated Foundation
Not yet recruiting - verified March 2012 - Condition: Type 1 Diabetes Mellitus
Intervention: Device: Artificial Pancreas for DiaPort system with Zone-MPC algorithm
Sponsors: University Hospital, Montpellier; University Hospital, Montpellier
Recruiting - verified March 2012 - Conditions: Type 2 Diabetes Mellitus; Albuminuria
Intervention: Drug: NOX-E36
Sponsors: Noxxon Pharma AG; Noxxon Pharma AG
Recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Metformin; Drug: Ranolazine
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified March 2012 - Condition: Type 2 Diabetes
Intervention:
Sponsors: Diabetes Care Center; Diabetes Care Center; Medtronic
Recruiting - verified March 2012 - Condition: Type 2 Diabetes
Intervention:
Sponsors: VeraLight, Inc.; VeraLight, Inc.
Not yet recruiting - verified March 2012 - Condition: Diabetes Mellitus
Interventions: Other: Low glycaemic index diet; Other: Usual diabetic diet
Sponsors: Hospital Authority, Hong Kong; Hospital Authority, Hong Kong
Recruiting - verified March 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Metformin; Drug: vildagliptin
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified February 2012 - Condition: OLDER PEOPLE WITH TYPE 2 DIABETES
Intervention: Behavioral: education and the exercise programs
Sponsors: Spanish Clinical Research Network - CAIBER; Spanish Clinical Research Network - CAIBER; Hospital Universitario Getafe; European Commission
Not yet recruiting - verified February 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 2
Interventions: Drug: liraglutide; Drug: placebo; Drug: metformin
Sponsors: Novo Nordisk; Novo Nordisk
Not yet recruiting - verified April 2012 - Condition: Hypercholesterolemia With Concomitant Type 2 Diabetes
Interventions: Drug: Atorvastatin; Drug: Rosuvastatin
Sponsors: Listen Trial Group; Listen Trial Group
Recruiting - verified April 2012 - Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Technosphere Insulin Inhalation Powder; Drug: Rapid Acting Analog
Sponsors: Mannkind Corporation; Mannkind Corporation
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Sitagliptin, 50 mg once per day per os
Sponsors: Nagaoka Red Cross Hospital; Nagaoka Red Cross Hospital
Recruiting - verified February 2012 - Conditions: Type 2 Diabetes; Dyslipidemia
Interventions: Drug: Insulin; Drug: insulin; Other: diet; Other: no diet
Sponsors: University of Aarhus; University of Aarhus
Not yet recruiting - verified March 2012 - Condition: Type I Diabetes Mellitus
Intervention: Device: Artificial Pancreas Control Software
Sponsors: Legacy Health System; Legacy Health System; Juvenile Diabetes Research Foundation
Recruiting - verified February 2012 - Conditions: Diabetes; Stroke; Obesity
Intervention:
Sponsors: Children's & Women's Health Centre of British Columbia; Children's & Women's Health Centre of British Columbia
Recruiting - verified March 2012 - Condition: Diabetes Mellitus Type 2
Interventions: Drug: Linagliptin; Drug: Glimepiride
Sponsors: ikfe-CRO GmbH; Marcus Borchert; ikfe-CRO GmbH; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Coronary Artery Disease; Diabetes Mellitus Type 2
Interventions: Drug: Saxagliptin; Drug: Placebo
Sponsors: Oslo University Hospital; Oslo University Hospital
Recruiting - verified April 2012 - Condition: Diabetic Macular Edema
Interventions: Drug: 0.50mg ranibizumab; Procedure: Targeted Pan Retinal Photocoagulation
Sponsors: Greater Houston Retina Research; David M. Brown, M.D.; Genentech
Recruiting - verified March 2012 - Conditions: Diabetes Mellitus, Type 2; Blood Pressure
Intervention:
Sponsors: University of Aarhus; University of Aarhus
Recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Other: Cardiac RMI; Other: Analysis telomere; Other: Stress test; Other: echocardiography
Sponsors: Hospices Civils de Lyon; Hospices Civils de Lyon
Recruiting - verified August 2010 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: PF-05175157; Drug: PF-05175157; Drug: PF-05175157; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Diabetes Mellitus
Interventions: Drug: Matching placebo; Drug: PBL 1427 capsules
Sponsors: Panacea Biotec Ltd; Panacea Biotec Ltd
Not yet recruiting - verified May 2012 - Condition: Obesity
Interventions: Drug: Exenatide; Drug: Placebo; Behavioral: Dietary counseling
Sponsors: Beth Israel Deaconess Medical Center; Eleftheria Maratos-Flier; Amylin Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Condition: Gestational Diabetes
Intervention: Behavioral: Dietary modification and medications
Sponsors: University of Pittsburgh; University of Pittsburgh
Recruiting - verified February 2012 - Condition: Type 1 Diabetes
Interventions: Drug: Pro insulin peptide; Drug: Pro insulin peptide; Drug: Saline
Sponsors: Cardiff University; Cardiff University; Diabetes Vaccine Development Centre; Juvenile Diabetes Research Foundation
Recruiting - verified April 2012 - Conditions: Obesity; Type 2 Diabetes Mellitus
Intervention: Drug: U100 Humulin at 80/mU/m2 surface area per minute one time over 2 hours
Sponsors: Mayo Clinic; Mayo Clinic; Arizona State University
Not yet recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Metformin; Drug: Ranolazine
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified March 2012 - Conditions: Diabetes; Renal Failure; Pancreas Transplantation
Intervention:
Sponsors: Uppsala University; Uppsala University
Not yet recruiting - verified February 2012 - Condition: Diabetes Mellitus Type II,
Intervention: Procedure: Computerised support to the Diabetes type II patients
Sponsors: University of Primorska; University of Primorska; University of Ljubljana School of Medicine, Slovenia
Not yet recruiting - verified March 2012 - Conditions: Hypertension; Diabetes Mellitus; Heart Failure; Chronic Kidney Disease; Sleep Apnea
Intervention: Device: Medtronic Renal Denervation System
Sponsors: Medtronic Vascular; Medtronic Vascular
Recruiting - verified April 2012 - Conditions: Cystic Fibrosis; Diabetes Related Cystic Fibrosis
Intervention: Procedure: Combined pancreatic islet and lung transplantation
Sponsors: University Hospital, Strasbourg, France; University Hospital, Strasbourg, France
Not yet recruiting - verified February 2012 - Conditions: Diabetic Neuropathy; Chemotherapy Induced Neuropathy; HIV Neuropathy; Trauma Induced Neuropathy
Intervention: Drug: Neuron012703 (Medical Food)
Sponsors: Targeted Medical Pharma; Targeted Medical Pharma
Not yet recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus (T2D)
Intervention:
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Not yet recruiting - verified March 2012 - Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Propranolol
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified February 2012 - Conditions: Weight Loss; Diabetes Mellitus; Urinary Incontinence
Interventions: Procedure: Bariatric surgery; Procedure: Bariatric surgery
Sponsors: Helse Fonna; Helse Fonna; Helse Førde; Helse-Bergen HF
Recruiting - verified February 2012 - Condition: Type 1 Diabetes
Intervention: Other: Reducing post-exercise rapid-acting insulin (insulin lispro or aspart) dose
Sponsors: Northumbria University; Northumbria University; Diabetes UK
Recruiting - verified February 2012 - Condition: Prediabetic
Interventions: Drug: DLBS3233; Drug: Placebo of DLBS3233
Sponsors: Dexa Medica Group; Dexa Medica Group
Recruiting - verified February 2012 - Condition: Type 1 Diabetes
Intervention: Device: Easy Check
Sponsors: Rabin Medical Center; Rabin Medical Center
Recruiting - verified April 2012 - Condition: Glucose Metabolism Disorders
Intervention:
Sponsors: Meir Medical Center; Nehama Zuckerman Levin, MD
Not yet recruiting - verified February 2012 - Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Sitagliptin
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University
Recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Anagliptin; Drug: Anagliptin; Drug: Placebo of Anagliptin
Sponsors: JW Pharmaceutical; JW Pharmaceutical
Recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Anagliptin; Drug: Sitagliptin
Sponsors: JW Pharmaceutical; JW Pharmaceutical
Recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Placebo of vildagliptin; Drug: vildagliptin; Drug: Metformin
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified March 2012 - Conditions: Gastric Cancer; Type 2 Diabetes
Intervention: Procedure: Stomach-small intestine reconstruction
Sponsors: Xiamen University; feng Zheng
Recruiting - verified February 2012 - Condition: Type 2 Diabetes
Intervention:
Sponsors: China Cardiometabolic Registries; China Cardiometabolic Registries; Bristol-Myers Squibb; VitalStrategic Research Institute
Not yet recruiting - verified February 2012 - Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Behavioral: guided imaginary; Behavioral: music ONLY
Sponsors: Assaf-Harofeh Medical Center; Assaf-Harofeh Medical Center
Not yet recruiting - verified February 2012 - Condition: Mild to Moderate Edema of Diabetic Legs
Interventions: Device: mild compression diabetic sock; Device: Standard diabetic sock
Sponsors: Rosalind Franklin University of Medicine and Science; Rosalind Franklin University of Medicine and Science; Madigan Army Medical Center
Recruiting - verified February 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Behavioral: Community pharmacist-led diabetes education program; Other: Usual care
Sponsors: Tehran University of Medical Sciences; Tehran University of Medical Sciences; Research Center for Rational Use of Drugs
Recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Intervention: Device: DIAMOND System
Sponsors: Metacure; Metacure
Not yet recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Dapagliflozin; Drug: Dapagliflozin; Drug: Dapagliflozin
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZeneca; Parexel
Not yet recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Metformin IR; Drug: Saxagliptin; Drug: Metformin IR; Drug: Saxagliptin/Metformin XR FDC; Drug: Metformin XR
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZeneca
Not yet recruiting - verified April 2012 - Conditions: Type 2 Diabetes; Hypertriglyceridemia
Intervention: Drug: Saxagliptin
Sponsors: Oregon Health and Science University; Oregon Health and Science University; Bristol-Myers Squibb
Recruiting - verified February 2012 - Condition: Type 1 Diabetes Mellitus
Interventions: Device: Sham Injection; Drug: Rapid Acting insulin with pre-treatment of rHuPH20
Sponsors: Halozyme Therapeutics; Halozyme Therapeutics
Recruiting - verified February 2012 - Condition: Type II Diabetes Mellitus
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified March 2012 - Condition: Immune Tolerance
Intervention: Drug: Cholecalciferol
Sponsors: Medical University of Graz; Medical University of Graz
Recruiting - verified February 2012 - Condition: Type 1 Diabetes Mellitus
Intervention: Device: The Imperial College Closed-Loop Insulin Delivery System
Sponsors: Imperial College London; Imperial College London
Recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Intervention:
Sponsors: Universita di Verona; Universita di Verona; European Foundation for the Study of Diabetes; MIUR, Italian Ministry of Education University and Research
Recruiting - verified February 2012 - Condition: Type 1 Diabetes
Intervention: Drug: ferumoxytol
Sponsors: Massachusetts General Hospital; Jason Gaglia; National Institute of Allergy and Infectious Diseases (NIAID); Harvard University
Recruiting - verified January 2012 - Condition: Diabetes Mellitus
Interventions: Drug: Alogliptin; Drug: Insulin
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Pharmaceutical Company Limited
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Transient Continuous Subcutaneous Insulin Infusion; Drug: Transient Multiple Daily Insulin Injections
Sponsors: Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine
Recruiting - verified April 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 2
Interventions: Drug: biphasic insulin aspart 30; Drug: biphasic insulin aspart 30; Drug: sitagliptin; Drug: metformin
Sponsors: Novo Nordisk; Novo Nordisk
Not yet recruiting - verified May 2012 - Condition: Type-1 Diabetes
Intervention: Device: Dual Hormone closed-loop system
Sponsors: Institut de Recherches Cliniques de Montreal; Institut de Recherches Cliniques de Montreal; McGill University Center for Intelligent Machines; Montreal Children's Hospital
Recruiting - verified January 2012 - Conditions: Diabetes Mellitus; Diabetic Retinopathy
Interventions: Other: Insulin pump; Other: Multiple daily insulin injections; Procedure: Bariatric surgery; Other: Medical therapy for type 2 diabetes
Sponsors: Glostrup University Hospital, Copenhagen; Glostrup University Hospital, Copenhagen
Recruiting - verified January 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Vildagliptin/ Metformin; Drug: Liraglutide; Drug: Metformin
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified January 2012 - Conditions: Foot Ulcers; Arteriosclerosis Obliterans; Diabetes Mellitus; LDL-apheresis
Intervention: Device: LDL-apheresis
Sponsors: Universita di Verona; Universita di Verona
Recruiting - verified February 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: PF-04937319 10 mg; Drug: PF-04937319 50 mg; Drug: PF-04937319 100 mg; Drug: Glimepiride
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Type 2 Diabetes
Intervention:
Sponsors: New York Obesity and Nutrition Research Center; Blandine Laferrere, MD
Not yet recruiting - verified January 2012 - Condition: Diabetes Mellitus, Type 1
Intervention: Behavioral: Motivational Interviewing, CBT and E-mail support
Sponsors: Medical University of Vienna; Medical University of Vienna; National Bank of Austria
Recruiting - verified January 2012 - Condition: Diabetes
Interventions: Behavioral: Parent Computer-Delivered Motivational Intervention; Behavioral: Parent & Child Computer-Delivered Motivational Intervention; Behavioral: Computer-Delivered Information
Sponsors: Wayne State University; Wayne State University
Recruiting - verified January 2012 - A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusCondition: Type II Diabetes Mellitus
Interventions: Drug: ASP1941; Drug: acarbose; Drug: Placebo
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc
Recruiting - verified January 2012 - Condition: Diabetes Mellitus
Interventions: Drug: Golytely (polyethylene glycol electrolyte lavage solution) and placebo; Drug: split dose of Golytely (polyethylene glycol electrolyte lavage solution) + placebo; Drug: split dose of Golytely (polyethylene glycol electrolyte lavage solution) and bisacodyl
Sponsors: University of Oklahoma; University of Oklahoma
Recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: BMS-823778; Drug: BMS-823778; Drug: BMS-823778; Drug: BMS-823778; Drug: Placebo matching with BMS-823778
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified May 2012 - Conditions: Type 1 Diabetes; Eating Disorder
Intervention:
Sponsors: Duke University; Duke University; National Institute of Diabetes & Digestive & Kidney Diseases
Recruiting - verified January 2012 - Condition: Diabetes Mellitus Type 2
Interventions: Dietary Supplement: Low-fat Diet; Dietary Supplement: Low-carbohydrate Diet; Dietary Supplement: Mediterranean Diet
Sponsors: Vårdcentralen Lyckorna; Vårdcentralen Lyckorna
Recruiting - verified January 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 1
Interventions: Drug: insulin degludec; Drug: insulin detemir; Drug: insulin aspart
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Drug: "GLIPULIN:" [insulin glargine, metformin, exenatide (GLP-1-agonist)]; Drug: Insulin glargine, metformin, prandial insulin
Sponsors: University of Washington; University of Washington; Eli Lilly and Company; Sanofi-Aventis; Amylin Pharmaceuticals, Inc.; DexCom, Inc.; Bayer; Medicomp; University of Texas; Department of Veterans Affairs; Biomedical Research Institute of New Mexico
Not yet recruiting - verified February 2012 - Condition: Coronary Artery Disease
Interventions: Device: percutaneous coronary stenting implantation (Cilotax); Device: percutaneous coronary stenting implantation (Xience Prime)
Sponsors: CardioVascular Research Foundation, Korea; Duk-Woo Park; CARDIOTEC CO., LTD.
Recruiting - verified March 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Behavioral: Modified paleolithic diet and exercise under observation; Behavioral: Modified paleolithic diet and general advice on exercise
Sponsors: Umeå University; Umeå University
Recruiting - verified January 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: metformin; Drug: linagliptin; Drug: linagliptin medium dose; Drug: metformin placebo; Drug: metformin placebo
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Lixisenatide (AVE0010)
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Januvia (Sitagliptin phosphate); Other: Placebo
Sponsors: New York Obesity and Nutrition Research Center; Blandine Laferrere, MD; Merck
Not yet recruiting - verified January 2012 - Condition: Type 1 Diabetes
Interventions: Behavioral: Parent education with human patient simulator; Behavioral: Standard care
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: TA-7284 Low; Drug: TA-7284 High
Sponsors: Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation
Recruiting - verified January 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: PL2200 Aspirin Capsules; Drug: Immediate-Release Aspirin Tablets; Drug: Enteric-coated aspirin caplets
Sponsors: PLx Pharma; PLx Pharma
Recruiting - verified January 2012 - Condition: Diabetes Mellitus
Intervention:
Sponsors: GlucoVista; GlucoVista
Recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Insulin Aspart 100 IE/ml
Sponsors: Aarhus University Hospital; Aarhus University Hospital
Not yet recruiting - verified January 2012 - Conditions: Diabetes Mellitus Type I; Diabetic Peripheral Neuropathy; Nerve Conduction Study Not Performed
Intervention:
Sponsors: Landeskrankenhaus Feldkirch; Landeskrankenhaus Feldkirch
Recruiting - verified January 2012 - Condition: Type 2 Diabetes
Interventions: Drug: CAT 1004; Drug: Placebo; Drug: CAT 1004; Drug: CAT 1004; Drug: CAT 1004; Drug: CAT 1004
Sponsors: Catabasis Pharmaceuticals; Catabasis Pharmaceuticals
Recruiting - verified March 2012 - Measuring and Monitoring Blood Glucose Levels Utilizing Non-invasive Blood Glucose Monitoring DeviceCondition: Diabetes Mellitus Type 1
Intervention: Device: Glucometer GM-205
Sponsors: GlucoVista; GlucoVista
Not yet recruiting - verified March 2012 - Conditions: Diabetes Mellitus, Type 2; Hypercholesterolemia
Intervention: Other: BeneFlax - 38% secoisolariciresinol diglucoside (SDG)
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatchewan Health Research Foundation
Recruiting - verified February 2012 - Condition: Obesity
Intervention: Procedure: Laparoscopic Greater Curvature Plication
Sponsors: Singh, Kuldeep, M.D., P.A.; Singh, Kuldeep, M.D., P.A.
Recruiting - verified March 2012 - Condition: Type 1 Diabetes
Interventions: Device: FreeStyle InsuLinx; Device: FreeStyle Freedom Lite
Sponsors: Abbott Diabetes Care; Abbott Diabetes Care
Recruiting - verified April 2012 - Condition: Type 2 Diabetes
Intervention:
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital
Recruiting - verified January 2012 - Condition: Diabetes Mellitus
Interventions: Drug: YH14617; Drug: YH14617; Drug: YH14617; Drug: Placebo
Sponsors: Yuhan Corporation; Yuhan Corporation; Peptron, Inc.
Recruiting - verified January 2012 - Condition: Type II Diabetes Mellitus
Interventions: Drug: ASP1941; Drug: metformin; Drug: Placebo
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc
Recruiting - verified January 2012 - Condition: Assess the Effects of a the 90-day Oral TS Study Regimen on PSA, IPSS, Haemoglobin and Haematocrit, and to Assess Adverse and Serious Adverse Events.
Intervention: Drug: Andriol Testocaps
Sponsors: Singapore Clinical Research Institute; Singapore Clinical Research Institute; Singapore General Hospital; Duke-NUS Graduate Medical School
Recruiting - verified January 2012 - Conditions: Type 2 Diabetes Mellitus; Obesity
Interventions: Drug: Liraglutide; Drug: Saline
Sponsors: University of Texas Southwestern Medical Center; Ildiko Lingvay; Novo Nordisk
Recruiting - verified January 2012 - Conditions: Type 2 Diabetes Mellitus (Non-insulin-dependent); Iron Deficiency Anemia
Interventions: Drug: ferric carboxymaltose; Drug: NaCl (0,9%)
Sponsors: GWT-TUD GmbH; GWT-TUD GmbH; Vifor Pharma
Not yet recruiting - verified May 2012 - Condition: Diabetes Mellitus Type 2
Interventions: Drug: Glucophage; Drug: Glucophage
Sponsors: Merck KGaA; Merck KGaA; Merck, S.L., Spain
Not yet recruiting - verified January 2012 - Condition: Type 2 Diabetes,
Intervention: Other: No intervention, observational study
Sponsors: Royal Devon and Exeter NHS Foundation Trust; Royal Devon and Exeter NHS Foundation Trust; National Institute for Health Research, United Kingdom; University of Exeter
Recruiting - verified December 2011 - Condition: Cancer
Intervention:
Sponsors: Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine; Chinese Society of Endocrinology
Recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Device: Proteus Sustained Behavior Change system; Drug: Regularly prescribed diabetes medicines (metformin, sulfonylureas, thiazolidinediones, DPP-IV inhibitors, alpha-glucosidase inhibitors)
Sponsors: Proteus Biomedical, Inc.; Proteus Biomedical, Inc.
Not yet recruiting - verified December 2011 - Conditions: Diabetes; Peripheral Neuropathy
Interventions: Dietary Supplement: Metanx; Drug: Placebo
Sponsors: St. Luke's Hospital and Health Network, Pennsylvania; St. Luke's Hospital and Health Network, Pennsylvania; Goldfarb Foundation; Pamlab, L.L.C.
Recruiting - verified December 2011 - Condition: Birth-weight
Interventions: Behavioral: Behavioral therapy; Other: Exercise; Other: Behavioral therapy and exercise
Sponsors: University of Turin, Italy; University of Turin, Italy
Recruiting - verified January 2012 - Condition: Type 1 Diabetes
Interventions: Device: MDRS System (Remote & Safety diabetes management system); Procedure: Continuous Glucose Monitoring
Sponsors: Rabin Medical Center; Rabin Medical Center
Recruiting - verified April 2012 - Conditions: Pain; Diabetic Peripheral Neuropathy
Interventions: Drug: DS-5565; Drug: DS-5565; Drug: DS-5565; Drug: Placebo; Drug: Pregabalin capsules
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Co., Ltd.
Recruiting - verified February 2012 - Conditions: Gestational Diabetes; Obesity
Interventions: Dietary Supplement: Magnesium citrate; Dietary Supplement: Placebo; Behavioral: Dietary modification
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified January 2012 - Conditions: Chronic Kidney Disease; Type 2 Diabetes
Interventions: Drug: 20 mg bardoxolone methyl; Drug: Placebo
Sponsors: Reata Pharmaceuticals, Inc.; Reata Pharmaceuticals, Inc.
Recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Vildagliptin; Drug: Placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Diabetes Mellitus, Type 2; Telemedicine
Intervention: Procedure: Telemonitoring of patients with diabetes type 2
Sponsors: Regional Health Authority of Sterea & Thessaly; Regional Health Authority of Sterea & Thessaly; Ministry of Health and Social Welfare, Greece; Municipality of Trikala, Greece; e-trikala SA, Trikala, Greece; Cities Net SA, Trikala, Greece; Biomedical Research & Technology (BIOMED, Larissa, Greece; Institute of Communications and Computer Systems (ICCS), Athens, Greece; Technological Educational Institute of Thessaloniki, Greece; University of Macedonia, Thessaloniki, Greece; Faculty of Medicine, University of Thessaly, Greece
Recruiting - verified December 2011 - Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Dapagliflozin; Drug: Dapagliflozin; Drug: Dapagliflozin; Drug: Dapagliflozin; Drug: Placebo matching Dapagliflozin
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZeneca
Recruiting - verified February 2012 - Conditions: Smoking; Type 2 Diabetes
Interventions: Behavioral: Acceptance and Commitment Therapy; Behavioral: Standard smoking cessation intervention
Sponsors: Rhode Island Hospital; Rhode Island Hospital
Recruiting - verified December 2011 - Conditions: Diabetes; Cancer; Heart Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified October 2011 - Conditions: Diabetes Mellitus, Type 2; Glucose Intolerance; Vitamin D Deficiency
Interventions: Drug: Vitamin D3; Drug: Placebo
Sponsors: Karolinska Institutet; Karolinska Institutet
Not yet recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Vildagliptin; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified January 2012 - Conditions: Obesity; Diabetes
Interventions: Procedure: Gastric By-Pass; Drug: optimized medical management
Sponsors: University Hospital, Lille; University Hospital, Lille
Recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: Group Visits
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Not yet recruiting - verified December 2011 - Conditions: Hypertension; Diabetes
Interventions: Drug: Placebo; Drug: Azilsartan medoxomil; Drug: Azilsartan medoxomil
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Condition: Type 1 Diabetes Mellitus
Interventions: Biological: MenSCs transplantation; Drug: exogenous indulin injection daily
Sponsors: S-Evans Biosciences Co.,Ltd.; S-Evans Biosciences Co.,Ltd.; Zhejiang University; Wenzhou Medical College; Zhenjiang First People's Hospital
Not yet recruiting - verified December 2011 - Condition: Type 1 Diabetes
Interventions: Device: Medtronic MMT-754 Veo Insulin pump testing Low Glucose Suspend (LGS) feature; Device: Medtronic (NO LGS FEATURE ) using Paradigm® Revel™2.0 Pump
Sponsors: Medtronic Diabetes; Medtronic Diabetes
Recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: HOE 901 - New formulation of insulin glargine; Drug: HOE 901 - Insulin glargine
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: HOE 901 - Insulin glargine; Drug: HOE901 - Insulin glargine-new formulation
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Pharmacokinetics
Intervention: Drug: TAK-875 and Glimepiride
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified February 2012 - Condition: Type 1 Diabetes
Intervention: Behavioral: Education to Functional Insulin Therapy
Sponsors: University Hospital, Montpellier; University Hospital, Montpellier
Recruiting - verified January 2012 - Conditions: Type 2 Diabetes; African American; Cholesterol; Lipoprotein; Apolipoprotein
Intervention:
Sponsors: Mercer University; Mercer University; Kathryn Momary, PharmD Mercer University College of Pharmacy and Health Sciences; Dawn Smiley, MD Emory University School of Medicine; H. Robert Superko, M.D., Vice President, Chief of Medical Affairs Celera
Recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: 1mg Glimepiride/10mg Atorvastatin FDC; Drug: 2mg Glimepiride/10mg Atorvastatin FDC; Drug: 3mg Glimepiride/10mg Atorvastatin FDC; Drug: 4mg Glimepiride/10mg Atorvastatin FDC; Drug: 1mg Glimepiride/20mg Atorvastatin FDC; Drug: 2mg Glimepiride/20mg Atorvastatin FDC; Drug: 3mg Glimepiride/20mg Atorvastatin FDC; Drug: 4mg Glimepiride/20mg Atorvastatin FDC; Drug: 1mg Glimepiride; Drug: 2mg Glimepiride; Drug: 3mg Glimepiride; Drug: 4mg Glimepiride; Drug: 10mg Atorvastatin; Drug: 20mg Atorvastatin
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ranolazine; Drug: Placebo
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified April 2012 - Condition: Diabetes Mellitus
Interventions: Behavioral: Pharmacist disease/medication management; Behavioral: Pharmacist-patient encounters; Behavioral: Pharmacist medication intensification and adherence support; Behavioral: Pharmacist communication with primary care physicians; Behavioral: Pharmacist documentation in electronic medical record; Behavioral: Health promoter-patient encounters in-person or by phone; Behavioral: Health promoter medication and lifestyle support; Behavioral: Health promoter communication with pharmacists
Sponsors: University of Illinois; University of Illinois; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 2
Intervention: Other: Diabetes Transitions Tool Kit
Sponsors: Massachusetts General Hospital; Deborah Wexler, MD; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2012 - Condition: Diabetes Type 1
Intervention: Device: MD-logic artificial pancreas system
Sponsors: Rabin Medical Center; Rabin Medical Center
Not yet recruiting - verified January 2012 - Condition: Gestational Diabetes Mellitus (GDM)
Intervention: Behavioral: Lifestyle intervention
Sponsors: Tianjin Women and Children's Health Center; HunKun Liu
Recruiting - verified March 2012 - Conditions: Type 2 Diabetes; Type 1 Diabetes
Interventions: Drug: Native human Glucagon-like Peptide-1 ( GLP-1(7-36)); Drug: NaCl; Drug: Native human Glucagon-like Peptide-1 ( GLP-1(7-36)); Drug: Native human Glucagon-like Peptide-1 ( GLP-1(7-36))
Sponsors: University Hospital, Gentofte, Copenhagen; University Hospital, Gentofte, Copenhagen
Recruiting - verified January 2012 - Condition: Diabetic Peripheral Neuropathy
Interventions: Drug: DS-5565 tablet; Drug: pregabalin capsule; Drug: Placebo
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Recruiting - verified March 2012 - Condition: Type 2 Diabetes
Intervention: Drug: liraglutide
Sponsors: Steno Diabetes Center; Peter Rossing; Novo Nordisk
Not yet recruiting - verified December 2011 - Condition: Type 1 Diabetes
Intervention: Device: SOLO insulin pump
Sponsors: Medingo Ltd; Medingo Ltd
Recruiting - verified December 2011 - Condition: Type-II Diabetes Mellitus
Intervention: Drug: Acarbose
Sponsors: The Catholic University of Korea; The Catholic University of Korea; Bayer
Not yet recruiting - verified October 2011 - Conditions: Diabetes Mellitus; Type 1 Diabetes; Metabolic and Nutritional Disorders
Intervention: Device: TTR controller (Medtronic)
Sponsors: Stanford University; Stanford University; Medtronic
Recruiting - verified December 2011 - Condition: Gestational Diabetes
Intervention: Behavioral: Lifestyle Counseling
Sponsors: Kaiser Permanente; Kaiser Permanente
Recruiting - verified February 2012 - Condition: Type 1 Diabetes
Interventions: Behavioral: Healthy Thinking In Teens; Other: Advanced Diabetes Education.
Sponsors: Children's Memorial Hospital; Children's Memorial Hospital
Recruiting - verified December 2011 - Condition: Type 2 Diabetes
Intervention:
Sponsors: Taipei Veterans General Hospital,Taiwan; Taipei Veterans General Hospital,Taiwan
Recruiting - verified December 2011 - Conditions: Diabetes; Diabetes Mellitus, Type 2
Interventions: Drug: insulin detemir; Drug: insulin aspart; Drug: insulin NPH; Drug: human soluble insulin; Drug: metformin
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified May 2012 - Conditions: Non Alcoholic Fatty Liver Disease; Type 2 Diabetes; Liver Cirrhosis
Interventions: Other: OGTT; Other: IIGI
Sponsors: University Hospital, Gentofte, Copenhagen; University Hospital, Gentofte, Copenhagen
Recruiting - verified December 2011 - Conditions: Type 2 Diabetes Mellitus; Chronic Kidney Disease
Interventions: Drug: CTP-499; Drug: Placebo
Sponsors: Concert Pharmaceuticals; Concert Pharmaceuticals
Recruiting - verified March 2012 - Condition: Type 2 Diabetic Nephropathy
Interventions: Drug: PF-03882845; Drug: PF-03882845; Drug: PF-03882845; Drug: Spironolactone; Other: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Insulin-requiring Type 2 Diabetes Mellitus
Interventions: Drug: nph insulin; Drug: human insulin; Drug: Insulin Glargine; Drug: Insulin glulisine
Sponsors: ikfe-CRO GmbH; ikfe-CRO GmbH; IKFE Institute for Clinical Research and Development
Recruiting - verified December 2011 - Conditions: Pre-diabetes; Impaired Fasting Glucose; Impaired Glucose Tolerance
Intervention: Drug: Dexamethasone
Sponsors: University of Vermont; University of Vermont; Merck
Not yet recruiting - verified December 2011 - Conditions: Diabetes Mellitus; Type 2 Diabetes
Interventions: Drug: Sitagliptin; Drug: Metformin; Drug: Placebo to sitagliptin; Drug: Placebo to metformin
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Type 1 Diabetes; Insulin Dependent Diabetes; Juvenile Onset Diabetes Mellitus; Autoimmune Diabetes
Intervention: Drug: Vildagliptin
Sponsors: Federal University of São Paulo; Federal University of São Paulo; Novartis
Not yet recruiting - verified March 2012 - Conditions: Diabetes Mellitus, Type 2; Plasma Volume
Interventions: Drug: Canagliflozin; Drug: Placebo
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Intervention: Behavioral: Coronary Health Improvement Project Program
Sponsors: Kaiser Permanente; Kaiser Permanente
Not yet recruiting - verified November 2011 - Conditions: Acute Lymphoblastic Leukemia; Hyperglycemia; Insulin Resistance; Diabetes Mellitus
Intervention: Drug: Metformin
Sponsors: Children's Hospital Los Angeles; Children's Hospital Los Angeles
Recruiting - verified December 2011 - Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Glucagon
Sponsors: Legacy Health System; Legacy Health System; Juvenile Diabetes Research Foundation
Recruiting - verified November 2011 - Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Glargine; Drug: LY2605541; Drug: Insulin Lispro
Sponsors: Eli Lilly and Company; Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Type 2 Diabetes Mellitus; Obesity
Interventions: Procedure: Laparoscopic Silastic Ring Roux-en-Y Gastric Bypass; Procedure: Laparoscopic Sleeve gastrectomy
Sponsors: North Shore Hospital, New Zealand; North Shore Hospital, New Zealand
Recruiting - verified December 2011 - Condition: Diabetic Polyneuropathy
Intervention: Procedure: peripheral nerve stimulation
Sponsors: Medical University of Graz; Medical University of Graz
Recruiting - verified April 2012 - Conditions: Hypertension; Diabetes
Interventions: Dietary Supplement: L-Arginine; Dietary Supplement: Placebo Supplement
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: TAK-875; Drug: TAK-875; Drug: Glimepiride
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Conditions: Peripheral Neuropathy; Type 1 Diabetes
Intervention: Drug: Salsalate
Sponsors: University of Michigan; University of Michigan
Recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Metformin; Drug: Placebo
Sponsors: University of Glasgow; University of Glasgow; NHS Greater Glasgow and Clyde; Juvenile Diabetes Research Foundation; Imperial College London; University of Wisconsin School of Medicine and Public Health; University of Dundee; Merck Serono S.A., Geneva; Itamar-Medical, Israel; University of Western Ontario, Canada; University of Melbourne; Steno Diabetes Center; Maastricht University Medical Center
Recruiting - verified January 2012 - Conditions: Diabetes; Obesity
Interventions: Behavioral: Alive-PD; Behavioral: Usual Care
Sponsors: Berkeley Analytics, Inc.; Berkeley Analytics, Inc.
Not yet recruiting - verified November 2011 - Condition: Diabetes Mellitus, Type 2
Intervention: Drug: PB1023 Injection
Sponsors: PhaseBio Pharmaceuticals Inc.; PhaseBio Pharmaceuticals Inc.
Recruiting - verified January 2012 - Condition: Diabetes
Interventions: Drug: central insulin; Drug: Placebo
Sponsors: German Diabetes Center; German Diabetes Center
Recruiting - verified November 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Atorvastatin; Other: Placebo to sitagliptin; Other: Placebo to atorvastatin; Drug: Metformin; Drug: Glimepiride; Drug: Placebo to glimepiride
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Type I Diabetes
Interventions: Drug: Anakinra; Drug: Placebo
Sponsors: University of Colorado, Denver; University of Colorado, Denver; Anakinra Foundation
Not yet recruiting - verified November 2011 - Condition: Type 2 Diabetes
Intervention: Behavioral: High Glycemic Diet
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Biological: albiglutide; Biological: placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified January 2012 - Condition: Gestational Diabetes Mellitus
Intervention:
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Eli Lilly and Company
Recruiting - verified December 2011 - Condition: Gestational Diabetes
Interventions: Dietary Supplement: inositol + folic acid; Dietary Supplement: inositol + folic acid; Drug: Folic Acid
Sponsors: AGUNCO Obstetrics and Gynecology Centre; AGUNCO Obstetrics and Gynecology Centre
Recruiting - verified January 2012 - Conditions: Type 2 Diabetes; Hypertension
Interventions: Behavioral: Step count prescription; Behavioral: Usual care
Sponsors: McGill University Health Center; McGill University Health Center; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Conditions: Hypoglycemia Unawareness; Type 1 Diabetes; Healthy
Intervention: Device: Real Time Continuous Glucose Monitor (RT-CGM)
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified November 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin Lispro; Drug: Insulin Aspart
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: GK1-399 (formerly TTP399); Drug: GK1-399 (formerly TTP399); Drug: GK1-399 (formerly TTP399); Drug: Placebo
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified January 2012 - Conditions: Type 2 Diabetes; Diabetes Mellitus, Type 2; Metabolic Diseases; Cardiovascular Diseases; Obese; Dyslipidemia
Interventions: Drug: GFT505 120mg - old formulation; Drug: GFT505 120mg - new formulation; Drug: GFT505 180mg - new formulation; Drug: GFT505 240mg - new formulation; Drug: GFT505 300mg - new formulation; Drug: Placebo
Sponsors: Genfit; Genfit; SGS Aster S.A.S.; NATURALPHA
Recruiting - verified January 2012 - Conditions: Overweight; Obese; Insulin Resistance; Diabetes
Intervention: Dietary Supplement: n-3 PUFA in protein-enriched low-GI diet
Sponsors: Medical University of Vienna; Medical University of Vienna; Enervit Srl (company); Fa. Winkelbauer GmbH (company)
Recruiting - verified November 2011 - Condition: Type 2 Diabetes Mellitus ;Obesity,High Triglycerides；TCM
Interventions: Drug: Metformin; Drug: Jiangtangtiaozhi decoction
Sponsors: Guang'anmen Hospital of China Academy of Chinese Medical Sciences; Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Recruiting - verified December 2011 - Conditions: Type 2 Diabetes; Anxiety; Depression
Intervention: Behavioral: CBT-based Guided Self-Help
Sponsors: University of Edinburgh; University of Edinburgh
Not yet recruiting - verified November 2011 - Condition: Diabetes Mellitus
Interventions: Drug: Abciximab; Drug: control
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital
Recruiting - verified November 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Exenatide; Drug: Normal saline
Sponsors: Chang Gung Memorial Hospital; Chang Gung Memorial Hospital
Recruiting - verified November 2011 - Conditions: Obesity; Non-insulin-dependent Diabetes Mellitus
Interventions: Procedure: HBO therapy; Procedure: Hyperbaric room air
Sponsors: German Diabetes Center; German Diabetes Center; Heinrich-Heine University, Duesseldorf
Not yet recruiting - verified November 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Glucose; Dietary Supplement: Placebo
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Recruiting - verified November 2011 - Condition: Prediabetes
Intervention: Behavioral: ADAPT tool
Sponsors: Boston University; Boston University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified November 2011 - Conditions: Obesity; Diabetes Mellitus, Non-Insulin-Dependent
Intervention: Procedure: surgery
Sponsors: German Diabetes Center; German Diabetes Center; Dep.of General-, Visceral- and Pediatric Surgery, HHU, Duesseldorf; Dep.for Metabolic Diseases, HHU, Duesseldorf
Not yet recruiting - verified November 2011 - Condition: Painful Diabetic Peripheral Neuropathy (PDPN)
Intervention: Drug: QUTENZA
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc
Recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ranolazine; Drug: Placebo
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified April 2012 - Condition: Type-2 Diabetes Mellitus
Intervention: Drug: DLBS3233
Sponsors: Dexa Medica Group; Dexa Medica Group
Recruiting - verified November 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Metformin; Drug: Sitagliptin / Metformin; Drug: Placebo to Metformin; Drug: Placebo to Sitagliptin / Metformin
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Hyperglycemia; Chronic Heart Failure
Interventions: Drug: liraglutide; Drug: placebo
Sponsors: Flyvbjerg, Allan, DMSc; Flyvbjerg, Allan, DMSc; Novo Nordisk
Not yet recruiting - verified November 2011 - Conditions: Type 2 Diabetes; Metabolic Syndrome
Intervention: Other: water, glucose with or without amino acid
Sponsors: Minneapolis Veterans Affairs Medical Center; Minneapolis Veterans Affairs Medical Center
Recruiting - verified November 2011 - Condition: Diabetes Mellitus
Interventions: Behavioral: Conversation Maps Diabetes Education; Behavioral: Usual Care
Sponsors: University of Sao Paulo; University of Sao Paulo
Recruiting - verified November 2011 - Condition: Type 1 Diabetes
Intervention: Behavioral: CGM Family Teamwork
Sponsors: Joslin Diabetes Center; Joslin Diabetes Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Jaeb Center for Health Research
Recruiting - verified November 2011 - Condition: Diabetes
Intervention: Drug: Glargine
Sponsors: Joslin Diabetes Center; Joslin Diabetes Center; Sanofi-Aventis
Recruiting - verified November 2011 - Condition: Type 1 Diabetes Mellitus
Intervention: Device: portable artificial pancreas system with CTR algorithms
Sponsors: University of Virginia; University of Virginia; University Hospital, Montpellier; University of Padova; University of California, Santa Barbara
Recruiting - verified November 2011 - Condition: Diabetes
Interventions: Drug: ZYGK1; Drug: Placebo
Sponsors: Cadila Healthcare Limited; Cadila Healthcare Limited
Recruiting - verified February 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2605541; Drug: Insulin Glargine; Drug: Insulin Lispro
Sponsors: Eli Lilly and Company; Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: LY2189265; Drug: Sulfonylureas (SU); Drug: Biguanides; Drug: Thiazolidinedione (TZD); Drug: alpha-glucosidase inhibitor (a-GI); Drug: Glinides
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified March 2012 - Conditions: Type 2 Diabetes; Obesity
Intervention:
Sponsors: Hvidovre University Hospital; Hvidovre University Hospital; University of Copenhagen
Recruiting - verified November 2011 - Condition: Type 1 Diabetes Mellitus
Intervention: Device: GBP CGM
Sponsors: University of Virginia; University of Virginia; Juvenile Diabetes Research Foundation; Becton, Dickinson and Company
Recruiting - verified November 2011 - Condition: Diabetic Peripheral Neuropathy
Interventions: Drug: Novolin Toronto insulin; Drug: Normal saline
Sponsors: University of Calgary; University of Calgary
Recruiting - verified November 2011 - Conditions: Hypoglycemia; Type 1 Diabetes Mellitus
Intervention:
Sponsors: Assaf-Harofeh Medical Center; Assaf-Harofeh Medical Center; Soroka University Medical Center; Wolfson Medical Center; The Chaim Sheba Medical Center; Kaplan Medical Center
Not yet recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine /lixisenatide fixed combination (HOE901/AVE0010); Drug: Insulin glargine (HOE901)
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Type I Diabetes Mellitus
Interventions: Dietary Supplement: Glutamine; Dietary Supplement: Placebo
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; Thrasher Research Fund
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Drug: MK-0431/ONO-5435; Drug: Placebo, MK-0431/ONO-5435
Sponsors: Ono Pharma; Ono Pharma; MSD K.K.
Recruiting - verified March 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: GSK2376497; Drug: 0.9% sodium chloride
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Conditions: Colorectal Cancer; Breast Cancer; Coronary Heart Disease; Diabetes
Intervention: Other: risk assessment survey; decision support for providers for prevention based on risk
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital
Not yet recruiting - verified May 2012 - Conditions: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
Intervention:
Sponsors: Medtronic Diabetes; Medtronic Diabetes
Recruiting - verified December 2011 - Conditions: Metabolic Syndrome; Type 2 Diabetes; Cardiovascular Disease; Abdominal Obesity
Interventions: Dietary Supplement: High content of SMC-SFA; Dietary Supplement: Whey; Dietary Supplement: Low content of SMC-SFA; Dietary Supplement: Casein
Sponsors: University of Aarhus; University of Aarhus; Aarhus University Hospital; Arla Foods; Wageningen University; University of Dublin, Trinity College
Recruiting - verified February 2012 - Conditions: Vitamin D Deficiency; Obesity; Type 2 Diabetes Mellitus
Intervention: Dietary Supplement: Vitamin D3
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center; University of Washington
Recruiting - verified May 2012 - Conditions: Type 2 Diabetics; Chronic Kidney Disease; Protein in Urine
Interventions: Drug: ABT-614; Drug: Placebo Comparator
Sponsors: Abbott; Abbott
Recruiting - verified December 2011 - Conditions: Morbid Obesity; Diabetes
Intervention: Procedure: SADI-S 250
Sponsors: Hospital San Carlos, Madrid; Hospital San Carlos, Madrid
Recruiting - verified October 2011 - Conditions: Foot Ulcer; Diabetes Mellitus; Diabetic Neuropathy
Interventions: Device: CACIPLIQ20 and Nonremovable, Windowed, Fiberglass Cast Boot; Device: Placebo and Nonremovable, Windowed, Fiberglass Cast Boot
Sponsors: Organ, Tissue, Regeneration, Repair and Replacement; Organ, Tissue, Regeneration, Repair and Replacement
Recruiting - verified November 2011 - Condition: Diabetes
Interventions: Other: Constitution of a biological bank; Other: Metabolic studies
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified December 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Comparator: Placebo; Biological: Insulin Glargine; Drug: Metformin
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Type 1 Diabetes Mellitus
Intervention: Device: Sansum Closed-Loop Glucose Control Device
Sponsors: Sansum Diabetes Research Institute; Sansum Diabetes Research Institute; University of California, Santa Barbara
Recruiting - verified November 2011 - Condition: Type 2 Diabetes Mellitus
Intervention: Drug: INSULIN GLARGINE HOE 901
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified December 2011 - Conditions: Obesity; Insulin Resistance; Type 2-diabetes; Inflammation
Intervention: Procedure: gastric bypass
Sponsors: University of Aarhus; University of Aarhus; Novo Nordisk; The Danish Medical Research Council
Recruiting - verified November 2011 - Condition: Type 1 Diabetes
Interventions: Drug: Diazoxide; Drug: Placebo
Sponsors: University of Dundee; University of Dundee; Juvenile Diabetes Research Foundation
Not yet recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: PF-04991532; Drug: PF-04991532; Drug: PF-04991532; Drug: PF-0499132; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: GLIMEPIRIDE; Drug: METFORMIN
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NPH; Drug: Detemir; Drug: Glargine
Sponsors: University of Aarhus; University of Aarhus
Not yet recruiting - verified October 2011 - Condition: Diabetes Type 2
Intervention: Drug: Cabergoline
Sponsors: Mashhad University of Medical Sciences; Mashhad University of Medical Sciences
Not yet recruiting - verified October 2011 - Conditions: Atrial Fibrillation; Hypertension; Diabetes; Chronic Heart Failure; Vascular Disease
Intervention: Device: Medtronic Reveal XT implantable loop recorder
Sponsors: Medical University of Graz; Medical University of Graz; Medtronic
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Glimepiride and Metformin hydrochloride combination (HOE490); Drug: Glimepiride (HOE490)
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Training and liraglutide; Drug: Training and placebo; Drug: Liraglutide
Sponsors: University Hospital, Gentofte, Copenhagen; University Hospital, Gentofte, Copenhagen
Recruiting - verified September 2011 - Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: a specific frequency of SMBG
Sponsors: Medical Research Foundation, The Netherlands; Medical Research Foundation, The Netherlands; Sanofi-Aventis
Recruiting - verified October 2011 - Condition: Type 2 Diabetes
Intervention: Drug: Glyburide
Sponsors: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Recruiting - verified October 2011 - Conditions: Type 2 Diabetes Mellitus; Hypertension
Interventions: Drug: Aliskiren; Drug: any angiotensin receptor blockers
Sponsors: Shiga University; Shiga University
Recruiting - verified November 2011 - Condition: Diabetes
Intervention: Drug: Technosphere® Insulin Inhalation System
Sponsors: South Orange County Endocrinology; South Orange County Endocrinology
Not yet recruiting - verified October 2011 - Condition: Type 2 Diabetes
Interventions: Drug: ITCA 650; Other: ITCA placebo
Sponsors: Intarcia Therapeutics; Intarcia Therapeutics
Not yet recruiting - verified April 2012 - Condition: Type 2 Diabetes
Interventions: Drug: ITCA 650 60 mcg/day; Drug: glimepiride
Sponsors: Intarcia Therapeutics; Intarcia Therapeutics
Not yet recruiting - verified April 2012 - Condition: Type 2 Diabetes
Interventions: Drug: ITCA 650 60 mcg/day; Drug: sitagliptin
Sponsors: Intarcia Therapeutics; Intarcia Therapeutics
Not yet recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Drug: ITCA 650; Drug: glimepiride
Sponsors: Intarcia Therapeutics; Intarcia Therapeutics
Not yet recruiting - verified April 2012 - Condition: Type 2 Diabetes
Interventions: Drug: ITCA 650 60 mcg/day; Drug: sitagliptin
Sponsors: Intarcia Therapeutics; Intarcia Therapeutics
Not yet recruiting - verified April 2012 - Condition: Type 2 Diabetes
Interventions: Drug: ITCA 650; Other: ITCA placebo
Sponsors: Intarcia Therapeutics; Intarcia Therapeutics
Not yet recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: TAK-875; Drug: TAK-875
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Condition: Type 1 Diabetes Mellitus
Interventions: Device: Insulin pump therapy (CSII) plus continuous glucose monitoring (CGM); Other: Multiple daily insulin injections (MDI)
Sponsors: Steno Diabetes Center; Steen Andersen; Medtronic
Not yet recruiting - verified October 2011 - Condition: Type 2 Diabetes
Intervention:
Sponsors: Foundation for the National Institutes of Health; Foundation for the National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile Diabetes Research Foundation; Amylin Pharmaceuticals, Inc.; Merck; Pfizer; Eli Lilly and Company; Takeda Global Research & Development Center, Inc.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Novartis
Recruiting - verified October 2011 - Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Glargine; Drug: LY2605541; Drug: Insulin Lispro
Sponsors: Eli Lilly and Company; Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Diabetes Mellitus
Intervention: Drug: AMG 151
Sponsors: Amgen; Amgen
Recruiting - verified May 2012 - Condition: Diabetes Mellitus
Interventions: Other: Pharmaceutical care; Other: Usual care
Sponsors: Nantou Hospital; Nantou Hospital
Recruiting - verified October 2011 - Condition: Diabetes Mellitus
Intervention: Drug: Alogliptin
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Pharmaceutical Company Limited
Recruiting - verified May 2012 - Conditions: Gastroparesis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: 10mg TZP-102; Drug: 20mg TZP-102
Sponsors: Tranzyme, Inc.; Tranzyme, Inc.
Recruiting - verified April 2012 - Condition: Obesity
Interventions: Behavioral: LIPOXmax; Behavioral: 60% VO2peak; Behavioral: Good Medical Practices; Dietary Supplement: supplementation in fruits and vegetables
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; François Favier
Not yet recruiting - verified October 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Diet oil; Dietary Supplement: Olive oil; Dietary Supplement: Carrot
Sponsors: University of Copenhagen; University of Copenhagen
Recruiting - verified October 2011 - Conditions: Metabolic Disease; Diabetes Mellitus
Interventions: Other: No drug; Other: No drug
Sponsors: Bayer; Bayer
Not yet recruiting - verified May 2012 - Condition: Painful Diabetic Peripheral Neuropathy
Interventions: Drug: pregabalin; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Technosphere Insulin; Drug: Technosphere Inhalation Powder
Sponsors: Mannkind Corporation; Mannkind Corporation
Recruiting - verified May 2012 - Condition: Type 1 Diabetes
Intervention: Drug: DiaPep277
Sponsors: Rabin Medical Center; Rabin Medical Center
Not yet recruiting - verified December 2011 - Condition: Diabetic Foot Ulcers
Intervention: Device: LeucoPatch ™
Sponsors: Reapplix; Reapplix
Recruiting - verified February 2012 - Condition: Diabetes Mellitus
Interventions: Drug: HM11260C; Drug: Placebo
Sponsors: Hanmi Pharmaceutical Company Limited; Hanmi Pharmaceutical Company Limited
Not yet recruiting - verified October 2011 - Conditions: Renal Failure Chronic Requiring Hemodialysis; Metabolic Syndrome; Diabetes Mellitus Type 2; Hyperlipidemia
Intervention: Drug: Atorvastatin
Sponsors: Poznan University of Medical Sciences; Poznan University of Medical Sciences
Recruiting - verified October 2011 - Condition: Diabetes Mellitus
Interventions: Drug: LY2963016; Drug: Lantus
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified January 2012 - Conditions: Diabetic Nephropathy; Type 2 Diabetes Mellitus
Interventions: Drug: Placebo; Drug: CCX140-B; Drug: CCX140-B
Sponsors: ChemoCentryx; ChemoCentryx
Recruiting - verified May 2012 - Condition: Diabetes Mellitus Type II
Interventions: Procedure: Harvesting and Implantation of Stem Cells; Procedure: Harvesting and Implantation of Adipose-Derived Stem Cells (ASCs)
Sponsors: Ageless Regenerative Institute; Ageless Regenerative Institute; Instituto de Medicina Regenerativa, S.A. de C.V.
Recruiting - verified November 2011 - Condition: Diabetes Mellitus, Type 1
Intervention: Device: Meos ePortal use
Sponsors: University Hospital, Grenoble; University Hospital, Grenoble
Recruiting - verified January 2012 - Conditions: Obstructive Sleep Apnea; Diabetes Mellitus
Intervention: Behavioral: PreDx Diabetes Risk Score
Sponsors: Mike O'Callaghan Federal Hospital; Mike O'Callaghan Federal Hospital
Recruiting - verified April 2012 - Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Technosphere Insulin with MedToneC Inhaler in combination with a basal insulin; Drug: Technosphere Insulin with Gen2C Inhaler in combination with a basal insulin; Drug: Insulin Aspart in combination with a basal insulin
Sponsors: Mannkind Corporation; Mannkind Corporation
Recruiting - verified May 2012 - Conditions: Diabetes Mellitus,; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Interventions: Device: Personalized Glucose Predictive and Therapy Advisory System (DIAdvisor); Device: Personalized Glucose Predictive and Therapy Advisory System (DIAdvisor)
Sponsors: University Hospital, Montpellier; University Hospital, Montpellier
Recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Sitagliptin
Sponsors: The Catholic University of Korea; The Catholic University of Korea; Merck
Not yet recruiting - verified October 2011 - Conditions: Addison's Disease; Adrenal Insufficiency; Diabetes Mellitus Type I
Intervention: Procedure: Spiroergometry
Sponsors: University of Wuerzburg; University of Wuerzburg
Recruiting - verified October 2011 - Condition: Type 1 Diabetes Mellitus
Intervention: Device: portable artificial pancreas system with Control-To-Range algorithms
Sponsors: University of Virginia; University of Virginia; University Hospital, Montpellier; University of Padova; University of California, Santa Barbara
Recruiting - verified October 2011 - Condition: Type 1 Diabetes Mellitus
Intervention: Device: portable artificial pancreas system with Control-To-Range algorithms
Sponsors: University of Virginia; University of Virginia; University of Padova; University Hospital, Montpellier; University of California, Santa Barbara
Recruiting - verified October 2011 - Condition: Diabetes Mellitus
Intervention: Drug: AMG 876
Sponsors: Amgen; Amgen
Recruiting - verified March 2012 - Condition: Type 1 Diabetes
Interventions: Device: Closed-loop control; Other: Open-loop control
Sponsors: Hvidovre University Hospital; Hvidovre University Hospital; Technical University of Denmark; Novo Nordisk
Not yet recruiting - verified September 2011 - Condition: Diabetes Insulin Dependent
Intervention: Other: Therapeutic education
Sponsors: University Hospital, Angers; University Hospital, Angers
Not yet recruiting - verified September 2011 - Conditions: Type 2 Diabetes; Obesity
Interventions: Other: Portion-controlled diet; Dietary Supplement: Usual Diet
Sponsors: Nutrisystem, Inc.; Nutrisystem, Inc.; University of Pennsylvania
Recruiting - verified September 2011 - Condition: Type 1 Diabetes
Interventions: Device: Dbees; diabetes mobile phone application; Device: control group
Sponsors: Medical Research Foundation, The Netherlands; Medical Research Foundation, The Netherlands
Recruiting - verified April 2012 - Condition: Diabetic Nephropathy
Intervention:
Sponsors: Aristotle University Of Thessaloniki; Aristotle University Of Thessaloniki; AHEPA University Hospital
Not yet recruiting - verified September 2011 - Conditions: Diabetic Nephropathy; Type 2 Diabetes Mellitus
Interventions: Drug: Placebo; Drug: CCX140-B
Sponsors: ChemoCentryx; ChemoCentryx
Recruiting - verified September 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Dextromethorphan hydrobromide; Drug: Amantadine; Drug: Pacebo 1 (placebo for Amantadine); Drug: Placebo 2 (fo Dextromethorphan)
Sponsors: Profil Institut für Stoffwechselforschung GmbH; Profil Institut für Stoffwechselforschung GmbH; Heinrich-Heine University, Duesseldorf
Recruiting - verified September 2011 - Condition: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
Interventions: Device: ACCU-CHEK AVIVA EXPERT MMOL/L (651); Other: No Intervention
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified August 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: metformin placebo; Drug: linagliptin placebo; Drug: metformin; Drug: placebo metformin; Drug: metformin; Drug: linagliptin
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Pistachios; Other: control diet
Sponsors: Institut Investigacio Sanitaria Pere Virgili; Institut Investigacio Sanitaria Pere Virgili; Western Pistachio Association
Recruiting - verified September 2011 - Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin glargine; Drug: Insulin detemir
Sponsors: Buckinghamshire Healthcare NHS Trust; Buckinghamshire Healthcare NHS Trust; Novo Nordisk
Recruiting - verified November 2011 - Condition: Type 1 Diabetes Mellitus
Interventions: Other: Closed-loop; Other: Conventional insulin pump delivery
Sponsors: University of Cambridge; University of Cambridge; Diabetes UK
Not yet recruiting - verified September 2011 - Conditions: Obesity; Diabetes; Cancer; Metabolic Syndrome; Sleep Deprivation
Intervention:
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Not yet recruiting - verified September 2011 - Condition: Diabetes Mellitus
Intervention: Device: jet injection device
Sponsors: Radboud University; Radboud University; European Pharma Group (EPG)
Recruiting - verified August 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Placebo; Drug: PF-04937319 - 3mg; Drug: PF-04937319 - 20mg; Drug: PF-04937319 - 50mg; Drug: PF-04937319 - 100mg; Drug: Sitagliptin - 100mg
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo matching with Saxagliptin; Drug: Metformin IR; Drug: Metformin XR; Drug: Saxagliptin; Drug: Saxagliptin
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZeneca
Not yet recruiting - verified February 2012 - Condition: Diabetes Mellitus
Interventions: Drug: TAK-875; Drug: TAK-875
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Pharmaceutical Company Limited
Recruiting - verified May 2012 - Condition: Diabetes Mellitus
Interventions: Drug: TAK-875; Drug: TAK-875
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Pharmaceutical Company Limited
Recruiting - verified May 2012 - Condition: Diabetes Mellitus
Interventions: Drug: TAK-875; Drug: TAK-875; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Pharmaceutical Company Limited
Recruiting - verified January 2012 - Conditions: Prediabetes; Vitamin D Deficiency
Interventions: Drug: oral cholecalciferol + life style counselling; Drug: placebo + life style counselling
Sponsors: Postgraduate Institute of Medical Education and Research; Postgraduate Institute of Medical Education and Research
Recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Glargine; Drug: LY2605541
Sponsors: Eli Lilly and Company; Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Procedure: Gastric Bypass; Drug: Exenatide
Sponsors: Third Military Medical University; Wu Qinan
Recruiting - verified September 2011 - Condition: Diabetes Mellitus
Intervention: Drug: SYR-472
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Pharmaceutical Company Limited
Recruiting - verified January 2012 - Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Closed loop with pramlintide; Device: Closed loop without pramlintide; Drug: Open loop with pramlintide
Sponsors: University of Virginia; University of Virginia; The Paul Manning Foundation (private)
Recruiting - verified September 2011 - Conditions: Diabetes Mellitus; Obesity
Interventions: Procedure: Sleeve gastrectomy; Drug: Intensive medical management
Sponsors: Postgraduate Institute of Medical Education and Research; Postgraduate Institute of Medical Education and Research
Recruiting - verified May 2012 - Condition: Prediabetes
Intervention: Other: Prediabetes screening and prospective follow-up over 5 years
Sponsors: Genfit; Genfit
Recruiting - verified September 2011 - Condition: Type 2 Diabetes Mellitus
Intervention: Device: PaQ continuous subcutaneous insulin infusion (CSII) device
Sponsors: CeQur Corporation; CeQur Corporation; International Diabetes Center at Park Nicollet
Not yet recruiting - verified February 2012 - Glucose Variability in Type 1 Diabetes and Its Effect on Factors That Influence New Vessel FormationCondition: Type 1 Diabetes
Intervention: Device: Continuous Glucose Monitor (CGM) and Telemedicine (Enlite Guardian real-time system Medtronic®)
Sponsors: University of Dundee; University of Dundee
Not yet recruiting - verified September 2011 - Condition: Prediabetes
Interventions: Behavioral: Lifestyle Intervention; Behavioral: Structured and Guided Education
Sponsors: Duke University; Duke University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 2011 - Condition: Diabetes, Type 2
Interventions: Behavioral: Community Health Worker Diabetes Education: Print media; Behavioral: CHW Diabetes Education: tailored web site
Sponsors: University of Michigan; University of Michigan; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified December 2011 - Condition: Type 2 Diabetes
Intervention: Drug: T2-18C3 therapeutic antibody
Sponsors: XBiotech, Inc.; XBiotech, Inc.
Recruiting - verified March 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Single Dose PB1023; Drug: Single Dose PB1023
Sponsors: PhaseBio Pharmaceuticals Inc.; PhaseBio Pharmaceuticals Inc.
Recruiting - verified February 2012 - Condition: Complications of Diabetes Mellitus
Intervention: Drug: Intravitreal Avastin injection
Sponsors: Seoul St. Mary's Hospital; Seoul St. Mary's Hospital
Recruiting - verified September 2011 - Condition: Diabetes Prevention
Intervention: Other: FDD program
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Not yet recruiting - verified August 2011 - Condition: Type 2 Diabetes
Intervention: Behavioral: Structured self-management group education during 2 years
Sponsors: Centre Hospitalier Departemental Felix Guyon; Centre Hospitalier Departemental Felix Guyon; Ministry of Health, France
Recruiting - verified February 2012 - Condition: Type 1 Diabetes
Intervention:
Sponsors: Wolfson Medical Center; Wolfson Medical Center; Tel Aviv Medical Center; Sheba Medical Center
Recruiting - verified August 2011 - Conditions: Congestive Heart Failure; Type 2 Diabetes Mellitus
Interventions: Drug: liraglutide; Drug: glimepiride; Drug: Metformin
Sponsors: Karolinska Institutet; Thomas Nystrom; Örebro University, Sweden
Recruiting - verified January 2012 - Condition: Diabetic Foot Ulcer
Interventions: Drug: IZN-6D4 Gel; Other: Placebo hydrogel
Sponsors: Izun Pharma Ltd; Izun Pharma Ltd
Not yet recruiting - verified August 2011 - Conditions: Depression; Impaired Glucose Tolerance
Interventions: Other: The Blues Program; Other: Hey Durham
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes of Health Clinical Center (CC)
Recruiting - verified June 2011 - Condition: Type 1 Diabetes
Interventions: Drug: basal insulin glargine; Drug: standard therapy
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National University of Rwanda; Association Rwandese des Diabetiques
Recruiting - verified August 2011 - Conditions: Angina Pectoris; Coronary Artery Disease; Type 2 Diabetes Mellitus
Intervention: Drug: Ranolazine
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified March 2012 - Condition: Diabetes
Intervention:
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified March 2012 - Conditions: Low-grade Chronic Inflammation; Intestinal Permeability; Type 2 Diabetes Mellitus; Cardiovascular Disease; Obesity
Interventions: Other: Fructose-sweetened beverages; Other: Glucose-sweetened beverages; Other: High-fructose corn syrup-sweetened beverages
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center; National Heart, Lung, and Blood Institute (NHLBI); University of Washington
Recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 10773; Drug: BI 10773; Drug: BI 10773; Drug: linagliptin; Drug: BI 10773 linagliptin FDC; Drug: BI 10773 linagliptin FDC; Drug: high dose BI 10773 placebo; Drug: high dose BI 10773 placebo; Drug: high dose BI 10773 placebo; Drug: low dose BI 10773 placebo; Drug: low dose BI 10773 placebo; Drug: low dose BI 10773 placebo; Drug: linagliptin; Drug: linagliptin; Drug: high dose FDC placebo; Drug: high dose FDC placebo; Drug: high dose FDC placebo; Drug: high dose FDC placebo; Drug: low dose FDC placebo; Drug: low dose FDC placebo; Drug: low dose FDC placebo; Drug: linagliptin placebo; Drug: linagliptin placebo; Drug: linagliptin placebo; Drug: BI 10773; Drug: BI 10773 high dose; Drug: BI 10773 low dose
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Type 2 Diabetes; Coronary Artery Disease; Hypertension; Dyslipidemia
Interventions: Other: intensive control; Other: standard control
Sponsors: Kyoto University, Graduate School of Medicine; Takeshi Morimoto; University of the Ryukyus
Recruiting - verified August 2011 - Condition: Diabetes Mellitus Type 2
Interventions: Procedure: non- surgical periodontal treatment; Procedure: Prophylaxis
Sponsors: University of Sao Paulo; University of Sao Paulo; Federal University of São Paulo
Recruiting - verified August 2011 - Conditions: Lower Extremity Chronic Ulcers; Diabetes Mellitus
Interventions: Biological: Curexcell; Biological: Sham injection
Sponsors: Macrocure Ltd.; Macrocure Ltd.; Averion International Corporation
Recruiting - verified September 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2963016; Drug: Lantus; Drug: Oral Antihyperglycemic Medications (OAMs)
Sponsors: Eli Lilly and Company; Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Atazanavir
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Institutes of Health (NIH)
Not yet recruiting - verified August 2011 - Condition: Type 1 Diabetes Mellitus
Interventions: Procedure: Closed-loop therapy; Procedure: Standard Insulin Pump Therapy
Sponsors: Children's Hospital Boston; Children's Hospital Boston
Recruiting - verified August 2011 - Condition: Type 2 Diabetes Patients
Intervention: Other: questionnaire
Sponsors: Assuta Hospital Systems; Assuta Hospital Systems
Not yet recruiting - verified July 2011 - Conditions: Diabetes; Foot Ulcers; Infection
Intervention: Drug: antibiotics
Sponsors: King's College Hospital NHS Trust; King's College Hospital NHS Trust
Not yet recruiting - verified January 2011 - Conditions: Diabetes Mellitus, Type 2; Hypertension; Dyslipidemias; Cholesterol, LDL; Comorbitdity
Interventions: Other: Facilitation; Other: Passive diffusion (usual implementation strategy)
Sponsors: Fonds de la Recherche en Santé du Québec; Fonds de la Recherche en Santé du Québec; Université de Montréal
Recruiting - verified August 2011 - Conditions: Periodontal Disease; Type 2 Diabetes
Interventions: Drug: Systemic Doxycycline and Sham aPDT; Drug: aPDT + Doxycycline Placebo
Sponsors: University of Sao Paulo; University of Sao Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified May 2012 - Conditions: Endocrine Disease; Diabetes
Intervention: Drug: Mifepristone
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified June 2011 - Conditions: Heart Failure; Diabetes Mellitus
Intervention: Procedure: 12-week supervised weight loss intervention
Sponsors: University of California, Irvine; University of California, Irvine; University of California, Los Angeles
Recruiting - verified August 2011 - Condition: Type 2 Diabetes
Interventions: Behavioral: High Dose of Exercise Training; Behavioral: Moderate Dose of Exercise Training
Sponsors: University of Central Arkansas; University of Central Arkansas
Recruiting - verified July 2011 - Conditions: Diabetes Mellitus; Coronary Artery Disease
Intervention: Other: hold hypoglycemic meds
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified August 2011 - Condition: Type 2 Diabetes
Intervention: Drug: Exenatide
Sponsors: University of Chicago; University of Chicago
Recruiting - verified August 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Placebo; Drug: Bethanechol (25 mg); Drug: Bethanechol (50 mg); Drug: Bethanechol (100 mg)
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2012 - Condition: Type 2 Diabetes
Intervention: Other: Internet Communication
Sponsors: Endocrine Research Society; Endocrine Research Society
Recruiting - verified October 2011 - Conditions: Interleukin 7; Diabetes; Islet Transplantation; Kidney Transplantation; Liver Transplantation
Intervention: Procedure: transplantation
Sponsors: University Hospital, Lille; University Hospital, Lille
Recruiting - verified September 2011 - Conditions: Type-2 Diabetes Mellitus; Ischemic Heart Disease
Intervention:
Sponsors: Thebiosignals.com; Thebiosignals.com
Recruiting - verified August 2011 - Condition: Patients Undergoing Coronary Angiography
Intervention:
Sponsors: University of Ioannina; University of Ioannina; University Hospital of Ioannina; Cetheterization Laboratory of 1st IKA Hospital, Athens; Department of Endocrinology, University Hospital of Ioannina
Recruiting - verified April 2012 - Conditions: Hypertension; Diabetes Type 2
Interventions: Drug: BNP, GLP-1, sitagliptin/placebo; Drug: Substance P, BK, sitagliptin/placebo
Sponsors: Vanderbilt University; Vanderbilt University
Not yet recruiting - verified August 2011 - Condition: Type 2 Diabetes
Intervention: Drug: Cholecalciferol
Sponsors: Florida International University; Florida International University
Recruiting - verified August 2011 - Condition: Type 2 Diabetes
Intervention: Biological: MSC
Sponsors: Shandong University; Shandong University
Recruiting - verified July 2011 - Condition: Type 2 Diabetes Mellitus
Intervention: Other: Glucose-dependent Insulinotropic polypeptide
Sponsors: University Hospital, Gentofte, Copenhagen; University Hospital, Gentofte, Copenhagen
Recruiting - verified May 2011 - Condition: Diabetes Complications
Intervention: Drug: Avastin (bevacizumab)
Sponsors: Seoul St. Mary's Hospital; Seoul St. Mary's Hospital
Recruiting - verified September 2011 - Conditions: Hypertension; Diabetes Mellitus
Intervention: Other: Self-monitoring-nurse-primary care provider feedback loop
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester; Reliant Medical Group; University of Massachusetts, Amherst
Recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Other: GI and fiber meals; Other: meals
Sponsors: Hospital de Clinicas de Porto Alegre; Hospital de Clinicas de Porto Alegre; Federal University of Rio Grande do Sul; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Recruiting - verified August 2011 - Conditions: Type 2 Diabetes; Inpatient
Interventions: Drug: Intravenous insulin; Drug: Subcutaneous Insulin
Sponsors: Ohio State University; Kathleen Dungan
Recruiting - verified March 2012 - Condition: Blood Pressure
Interventions: Other: DASH diet plus exercise; Other: ADA diet
Sponsors: Hospital de Clinicas de Porto Alegre; Hospital de Clinicas de Porto Alegre
Recruiting - verified October 2011 - Condition: Type 2 Diabetes
Intervention: Behavioral: Internet Insulin Education
Sponsors: University of Kansas; University of Kansas; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified August 2011 - Conditions: Diabetes Mellitus; Bipolar Disorder; Depression; Psychotic Disorders; Schizophrenia
Intervention: Behavioral: Targeted Training in Illness Management (TTIM)
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Exenatide, Placebo
Sponsors: Sun Pharmaceutical Industries Limited; Sun Pharmaceutical Industries Limited
Not yet recruiting - verified November 2011 - Conditions: Healthy; Diabetes Mellitus, Type 2
Interventions: Drug: oral NNC 0113-0987; Drug: oral NNC 0113-0987; Drug: I.v. NNC 0113-0987; Drug: oral placebo
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified April 2012 - Conditions: Diabetes Mellitus; Overweight; Obesity
Intervention: Dietary Supplement: Salba (Salvia hispanica L.)
Sponsors: St. Michael's Hospital, Toronto; St. Michael's Hospital, Toronto; Canadian Diabetes Association
Recruiting - verified June 2009 - Condition: Diabetes
Intervention: Other: Daily text messages
Sponsors: University of Southern California; University of Southern California
Recruiting - verified July 2011 - Condition: Postoperative Complications
Intervention:
Sponsors: Hospital Italiano de Buenos Aires; Hospital Italiano de Buenos Aires
Not yet recruiting - verified June 2011 - Conditions: Diabetes Mellitus; Glucose Intolerance
Intervention:
Sponsors: Hillel Yaffe Medical Center; Hillel Yaffe Medical Center
Not yet recruiting - verified June 2011 - Condition: Diabetes Mellitus, Type 2
Intervention:
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Gestational Diabetes Mellitus; Type 2 Diabetes Mellitus
Intervention: Device: Home Blood Glucose Telemonitoring System
Sponsors: Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Ontario Ministry of Health and Long Term Care
Recruiting - verified November 2011 - Conditions: Nonalcoholic Fatty Liver Disease; Nonalcoholic Steatohepatitis; Type 2 Diabetes
Intervention: Drug: Liraglutide-metformin vs insulin-metformin
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Diabete Quebec; Radiological Society of North America Research and Education Foundation; Canadian Heads of Academic Radiology-GE Healthcare Development Award
Recruiting - verified July 2011 - Condition: Type 2 Diabetes Mellitus (T2DM)
Intervention: Drug: LIK066 or a matching placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Diabetes Mellitus
Intervention: Other: SMARTCARE service
Sponsors: SK Telecom Consortium; SK Telecom Consortium
Recruiting - verified January 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: aleglitazar; Drug: lisinopril; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Aspart, Insulin Glargine; Other: Standard care
Sponsors: Medical University of Graz; Medical University of Graz
Recruiting - verified April 2012 - Condition: Type I Diabetes
Interventions: Biological: Insulin Lispro; Biological: Insulin Lispro
Sponsors: Wockhardt; Wockhardt
Not yet recruiting - verified July 2011 - Condition: Type 2 Diabetes
Intervention: Other: Diet intervention
Sponsors: Aarhus University Hospital; Aarhus University Hospital
Recruiting - verified May 2011 - Conditions: Newly Diagnosed Type 2 Diabetes (During the Last 12 Months); Healthy Subjects
Interventions: Biological: intravenous glucose tolerance test; Biological: hyperinsulinemic euglycemic clamp
Sponsors: German Diabetes Center; German Diabetes Center
Recruiting - verified July 2011 - Condition: Prediabetes
Interventions: Behavioral: PREPARE education program; Other: standard of care presentation
Sponsors: Brescia University College; Brescia University College
Recruiting - verified July 2011 - Condition: Diabetes Mellitus Type 2
Interventions: Drug: Vildagliptin; Drug: Sitagliptin
Sponsors: Novartis; Novartis
Recruiting - verified May 2012 - Conditions: Cardiovascular Disease; Diabetes Mellitus, Type 2
Interventions: Drug: Dulaglutide; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Paricalcitol; Other: placebo
Sponsors: Mario Negri Institute for Pharmacological Research; Mario Negri Institute for Pharmacological Research; Abbott
Not yet recruiting - verified July 2011 - Conditions: Type 2 Diabetes; Oxidative Stress
Intervention: Drug: N-acetylcysteine
Sponsors: Utzschneider, Kristina, M.D.; Utzschneider, Kristina, M.D.; VA Puget Sound Health Care System
Recruiting - verified January 2012 - Conditions: Obesity; Diabetes Mellitus
Intervention:
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified July 2011 - Conditions: Type 2 Diabetes Mellitus; High HbA1c Level; Inadequate Glycaemic Control
Interventions: Drug: dapagliflozin; Drug: placebo
Sponsors: AstraZeneca; AstraZeneca; Bristol-Myers Squibb
Recruiting - verified May 2012 - Condition: Diabetes Mellitus, Type 1
Intervention: Drug: BI 10773
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Type 2 Diabetes Mellitus; End-stage Renal Disease
Intervention: Drug: Liraglutide
Sponsors: Rigshospitalet, Denmark; Bo Feldt-Rasmussen; Novo Nordisk; The GCP unit at Copenhagen University Hospital
Recruiting - verified September 2011 - Condition: Infection
Intervention: Drug: cholecalciferol
Sponsors: University of Tromso; University of Tromso
Recruiting - verified July 2011 - Conditions: Diabetes Mellitus Type 1 and 2; Diabetes Mellitus Complications; Gastroparesis; Gastrointestinal Motility Disorder
Interventions: Drug: RM-131; Drug: Placebo
Sponsors: Rhythm Pharmaceuticals, Inc.; Rhythm Pharmaceuticals, Inc.
Recruiting - verified March 2012 - Condition: Type 1 Diabetes
Interventions: Drug: Glucose; Device: Continuous glucose monitoring
Sponsors: AZ-VUB; AZ-VUB; Vrije Universiteit Brussel; University Hospital, Ghent; University Hospital, Antwerp
Recruiting - verified July 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: PF-05231023; Drug: PF-05231023; Drug: PF-05231023; Drug: PF-05231023; Other: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Diabetes; Weight Loss; Physical Function; Cognitive Function
Interventions: Behavioral: Lifestyle intervention; Behavioral: Diabetes Support Education
Sponsors: Wake Forest University; Wake Forest University; Pennington Biomedical Research Center; University of Colorado, Denver; University of Tennessee; University of Pittsburgh
Recruiting - verified September 2011 - Conditions: Pancreatic Cancer; Chronic Pancreatitis; Type II Diabetes; Pancreatic Cysts; Control
Intervention: Procedure: Blood Draw
Sponsors: University of Michigan; University of Michigan
Recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: liraglutide; Drug: Insulin
Sponsors: Radboud University; Radboud University
Recruiting - verified July 2011 - Conditions: Diabetes Mellitus, Type 2; Erectile Dysfunction
Interventions: Drug: Insulin; Drug: Insulin
Sponsors: Jothydev's Diabetes and Research Centre; Jothydev's Diabetes and Research Centre
Recruiting - verified February 2012 - Condition: Diabetes Mellitus Type II
Intervention:
Sponsors: Fairbanks Institute; Fairbanks Institute; Indiana University School of Medicine; Richard M. Fairbanks Foundation; BioCrossroads; Regenstrief Institute, IU Center for Aging Research
Recruiting - verified June 2011 - Conditions: Type I Diabetes Mellitus Without Complication; Eating Disorder
Intervention:
Sponsors: Park Nicollet Institute; Park Nicollet Institute; Park Nicollet Foundation; Melrose Institute; International Diabetes Center at Park Nicollet
Not yet recruiting - verified February 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Metformin glycinate; Drug: Metformin hydrochloride
Sponsors: Laboratorios Silanes S.A. de C.V.; Laboratorios Silanes S.A. de C.V.; Instituto Mexicano del Seguro Social
Not yet recruiting - verified June 2011 - Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hypersensitivity; Immediate Hypersensitivity; Allergy
Intervention: Procedure: Allergy tests
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Institut Pasteur; Institut National de la Santé Et de la Recherche Médicale, France
Not yet recruiting - verified June 2011 - Conditions: Type 2 Diabetes; Impaired Glucose Tolerance; Obesity; Physical Activity
Intervention: Behavioral: Lifestyle intervention
Sponsors: Region Skane; Region Skane
Recruiting - verified August 2011 - Condition: Proliferative Diabetic Retinopathy
Interventions: Procedure: Panretinal photocoagulation; Procedure: Procedure: Panretinal Photocoagulation (PRP) Drug: Intravitreous injection of Bevacizumab
Sponsors: Instituto do Coracao; Instituto do Coracao; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Recruiting - verified January 2011 - Condition: Type 1 Diabetes Mellitus
Intervention:
Sponsors: Soroka University Medical Center; Soroka University Medical Center; Clalit Health Services
Not yet recruiting - verified June 2011 - Condition: Diabetes Type 2
Intervention: Other: Computer Assisted Decision Support
Sponsors: Walter Reed Army Medical Center; Walter Reed Army Medical Center; Wilford Hall Medical Center; University of Hawaii
Not yet recruiting - verified June 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: Canagliflozin 100mg; Drug: Canagliflozin 300mg
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Recruiting - verified May 2012 - Conditions: Diabetes Mellitus; Glucose Intolerance
Intervention:
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital
Recruiting - verified May 2011 - Condition: Type 2 Diabetes
Interventions: Drug: Pentoxifylline; Drug: Placebo
Sponsors: Ajou University School of Medicine; Ajou University School of Medicine; Bundang CHA Hospital; Hallym University Medical Center; Gangnam Severance Hospital; Yonsei University; Myongji Hospital
Recruiting - verified June 2011 - Conditions: Diabetes; Hypothyroidism
Intervention: Drug: Euthyrox (levothyroxine)
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Recruiting - verified January 2012 - A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin.Condition: Diabetes Mellitus, Type 2
Interventions: Drug: GSK256073 1mg; Drug: GSK256073 5mg; Drug: GSK256073 10mg; Drug: GSK256073 25mg; Drug: Placebo; Drug: Sitagliptin 100mg
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified June 2011 - Condition: Diabetes Mellitus
Interventions: Other: Educational intervention for family members/caregivers of people with diabetes mellitus through telephone contact; Other: Educational intervention group for people with diabetes through Diabetes Conversation Maps
Sponsors: University of Sao Paulo; University of Sao Paulo
Recruiting - verified February 2010 - Condition: Type 1 Diabetes Mellitus
Intervention: Drug: insulin
Sponsors: Kaplan Medical Center; Kaplan Medical Center
Recruiting - verified April 2011 - Conditions: Diabetic Foot Ulcers; Equinus Deformity
Intervention:
Sponsors: Georgetown University; Georgetown University
Recruiting - verified January 2012 - Condition: Diabetes
Intervention:
Sponsors: University Hospital, Gentofte, Copenhagen; University Hospital, Gentofte, Copenhagen
Recruiting - verified May 2011 - Condition: Diabetes
Intervention: Device: Technology-Assisted Case Management (TACM with the FORA 2-in-1 Telehealth System)
Sponsors: Medical University of South Carolina; Medical University of South Carolina; Department of Defense
Recruiting - verified April 2011 - Condition: T2DM (Type 2 Diabetes Mellitus)
Intervention:
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified June 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide; Drug: placebo
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; Amylin Pharmaceuticals, Inc.
Recruiting - verified February 2012 - Condition: Diabetes Mellitus
Intervention:
Sponsors: Xijing Hospital; Xijing Hospital
Recruiting - verified May 2010 - Conditions: Smoking Cessation; Diabetes
Interventions: Drug: varenicline; Drug: placebo tablet is made of lactose
Sponsors: Universita degli Studi di Catania; Universita degli Studi di Catania
Recruiting - verified April 2012 - Conditions: Impaired Fasting Glucose; Impaired Glucose Tolerance
Intervention: Drug: Vitamin D
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: sitagliptin; Other: Sugar pill
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Recruiting - verified February 2012 - Conditions: Type 1 Diabetes Mellitus; Diabetic Nephropathy
Intervention:
Sponsors: University Hospital, Grenoble; University Hospital, Grenoble
Recruiting - verified December 2011 - Conditions: Coronary Artery Disease; Left Ventricular Dysfunction; Type 2 Diabetes Mellitus
Intervention: Drug: Exenatide
Sponsors: Charles University, Czech Republic; Charles University, Czech Republic; Eli Lilly and Company
Recruiting - verified June 2011 - Conditions: Wounds; Diabetes Complications; Diabetic Foot; Foot Ulcer
Intervention: Other: Online Wound Electronic Medical Record
Sponsors: New York University School of Medicine; New York University School of Medicine; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified March 2012 - Condition: Type 2 Diabetes
Intervention: Dietary Supplement: diet intervention
Sponsors: German Diabetes Center; German Diabetes Center
Recruiting - verified May 2012 - Conditions: Diabetes; Immunosuppression
Intervention: Procedure: Gastric emptying test
Sponsors: The University of Texas, Galveston; The University of Texas, Galveston; Novartis Pharmaceuticals
Recruiting - verified June 2011 - Conditions: Diabetes Mellitus; Polyneuropathies; Arthropathy, Neurogenic
Interventions: Other: Intracutaneous injection of Candida albicans antigen.; Procedure: Punch skin biopsy; Other: Temperature measurement.
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Not yet recruiting - verified June 2011 - Conditions: Hypertension; Stage 2 Hypertension; Diabetes
Interventions: Drug: Valturna + amlodipine; Drug: valturna + placebo; Drug: Valturna + chlorthalidone
Sponsors: Novartis; Novartis
Recruiting - verified May 2012 - Conditions: Acute Ischemic Stroke; Diabetes; Hyperglycemia
Interventions: Drug: IV insulin to maintain target glucose concentration of 80-130 mg/dL; Drug: Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
Sponsors: University of Virginia; University of Virginia; Neurological Emergencies Treatment Trials Network (NETT); Medical University of South Carolina; Medical Automation Systems, an Alere Company; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified May 2012 - Condition: Infection; Diabetic Foot
Interventions: Drug: Ertapenem sodium; Drug: Piperacillin/tazobactam sodium; Drug: Piperacillin/tazobactam-matching placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Diabetes Mellitus
Interventions: Drug: Metformin; Drug: CJ-30001/CJ-30002
Sponsors: CJ Cheiljedang Corporation; CJ Cheiljedang Corporation
Recruiting - verified June 2011 - Condition: Pre-diabetes
Interventions: Dietary Supplement: Honey; Dietary Supplement: High Fructose Corn Syrup 55 (HFCS 55); Dietary Supplement: CHO (sugar)
Sponsors: USDA Grand Forks Human Nutrition Research Center; USDA Grand Forks Human Nutrition Research Center
Recruiting - verified August 2011 - Conditions: Gestational Diabetes Mellitus; Pregestational Diabetes Mellitus; Mild Gestational Hyperglycemia
Interventions: Other: Home care; Other: Hospital care
Sponsors: UPECLIN HC FM Botucatu Unesp; UPECLIN HC FM Botucatu Unesp
Recruiting - verified September 2011 - Condition: Obesity Surgery and Diabetes
Intervention:
Sponsors: Imperial College London; Imperial College London
Not yet recruiting - verified November 2011 - Condition: Prediabetic State
Interventions: Behavioral: DE-PLAN; Behavioral: Control group
Sponsors: Basque Health Service; Basque Health Service
Recruiting - verified June 2011 - Condition: Type 2 Diabetes
Intervention: Other: Macronutrients
Sponsors: Lund University; Lund University
Not yet recruiting - verified May 2011 - Conditions: Pre-diabetes; Pre-hypertension
Interventions: Drug: Metformin+Enalapril+Simvastatin; Drug: Placebo tablet
Sponsors: Ramathibodi Hospital; Ramathibodi Hospital; Ubon Ratchathani Public Health Office, Thailand; National Health Security Office, Thailand; The Government Pharmaceutical Organization
Not yet recruiting - verified May 2011 - Conditions: Gastric Cancer; Diabetes
Intervention: Procedure: Roux-en Y gastrojejunostomy
Sponsors: Yonsei University; Yonsei University
Recruiting - verified October 2011 - Conditions: Cerebral Edema; Diabetic Ketoacidosis
Interventions: Other: Intravenous fluid; Other: intravenous fluid; Other: intravenous fluid; Other: Intravenous fluid
Sponsors: University of California, Davis; University of California, Davis; Children's Hospital of Philadelphia; Washington University School of Medicine; University of Utah; Children's Research Institute; Children's Hospital Boston; Columbia University; University of Colorado, Denver; Nationwide Children's Hospital; Children's Memorial Hospital; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified June 2011 - Conditions: Obesity; Type 2 Diabetes
Interventions: Drug: Liraglutide treatment 12 weeks; Drug: insulin glargine treatment; Drug: GLP-1 receptor antagonist
Sponsors: VU University Medical Center; VU University Medical Center
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Acipimox; Drug: Placebo
Sponsors: University of Colorado, Denver; University of Colorado, Denver; Department of Veterans Affairs; Pfizer
Recruiting - verified April 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Exenatide; Drug: Placebo
Sponsors: University of Colorado, Denver; University of Colorado, Denver; Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Recruiting - verified May 2011 - Conditions: Diabetes; Chronic Kidney Insufficiency
Interventions: Drug: Epoetin beta; Drug: Saline 0.9%
Sponsors: Western Galilee Hospital-Nahariya; Western Galilee Hospital-Nahariya
Not yet recruiting - verified May 2011 - Condition: Type 1 Diabetes
Intervention: Drug: Cholecalciferol
Sponsors: Medical University of Graz; Medical University of Graz; Medical University of Vienna
Recruiting - verified February 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Biological: albiglutide (GSK716155); Biological: albiglutide (GSK716155)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Vildagliptin; Drug: Placebo
Sponsors: Novartis; Novartis
Recruiting - verified May 2012 - Conditions: Diabetes; Painful Neuropathy
Intervention: Drug: Duloxetine
Sponsors: Rambam Health Care Campus; Rambam Health Care Campus; Eli Lilly and Company
Recruiting - verified December 2009 - Condition: Dysglycaemia
Interventions: Procedure: closed-loop insulin delivery; Drug: Usual diabetes treatment regimen
Sponsors: University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: vildagliptin; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Type 1 Diabetes; Diabetes Mellitus
Intervention: Other: Educational tool
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified November 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin human/Insuman Comb 25 (HR1799); Drug: Insulin human/Novolin® 30R
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified March 2012 - Condition: Type1 Diabetes
Intervention: Biological: Glargine
Sponsors: Wockhardt; Wockhardt
Recruiting - verified May 2011 - Condition: Type 2 Diabetes
Intervention: Biological: Glycaemic optimisation before surgery
Sponsors: Imperial College London; Imperial College London
Recruiting - verified January 2012 - Condition: Type 1 Diabetes Mellitus With Diabetic Neuralgia
Intervention: Device: InsuPad
Sponsors: Insuline Medical Ltd.; Insuline Medical Ltd.; FIDAM GmbH
Recruiting - verified May 2012 - Condition: Type 1 Diabetes
Intervention: Other: Transition Coordinator
Sponsors: University of Western Ontario, Canada; University of Western Ontario, Canada; Juvenile Diabetes Research Foundation
Not yet recruiting - verified March 2012 - Condition: Diabetes
Intervention: Device: DRMS
Sponsors: Tulane University School of Medicine; Tulane University School of Medicine; Eli Lilly and Company
Recruiting - verified September 2011 - Condition: Type 2 Diabetes
Interventions: Drug: Metformin; Drug: Placebo Comparator
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Institutes of Health Research (CIHR); Mount Sinai Hospital, Canada
Recruiting - verified June 2011 - Condition: Type 1 Diabetes
Interventions: Other: Transplantation of encapsulated beta cells.; Other: Transplantation of encapsulated beta cells.
Sponsors: AZ-VUB; AZ-VUB; Universitair Ziekenhuis Brussel; Universitaire Ziekenhuizen Leuven
Recruiting - verified April 2011 - Conditions: Overweight; Obese; Obesity; Diabetic; Type 2 Diabetes
Interventions: Other: Higher Carbohydrate, Lower Fat Diet; Other: Lower carbohydrate, Higher fat diet; Other: Individualized Counseling
Sponsors: University of California, San Diego; University of California, San Diego; HealthPartners Research Foundation; University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified February 2012 - Conditions: Gestational Diabetes; Obesity
Intervention: Behavioral: Lifestyle Counseling
Sponsors: Kaiser Permanente; Kaiser Permanente; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified May 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI1356 low dose; Drug: placebo; Drug: BI1356 high dose
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Primary Prevention; Diabetes Mellitus; Asthma; Cardiovascular Diseases; Heart Failure; Mental Health; Osteoporosis
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Regenstrief Institute, IU Center for Aging Research
Not yet recruiting - verified March 2012 - Condition: Hypertension
Intervention: Drug: Nifedipine (Adalat CR, BAYA1040)
Sponsors: Bayer; Bayer
Recruiting - verified May 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Sitagliptin; Drug: Glimepiride; Drug: Metformin; Drug: Insulin
Sponsors: Jothydev's Diabetes and Research Centre; Jothydev's Diabetes and Research Centre
Recruiting - verified February 2012 - Condition: Type 1 Diabetes
Intervention: Procedure: immunosuppression and stem cell transplantation
Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Recruiting - verified July 2011 - Condition: Type 2 Diabetes
Intervention:
Sponsors: Ajou University School of Medicine; Ajou University School of Medicine
Recruiting - verified April 2011 - Conditions: Ischemic Heart Disease; Heart Failure; Chronic Kidney Disease; Diabetes; Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: iCDM
Sponsors: Simon Fraser University; Simon Fraser University; Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research
Recruiting - verified April 2011 - Conditions: Chronic Kidney Disease; Diabetes
Interventions: Drug: Febuxostat; Drug: Sugar pill
Sponsors: University of Utah; University of Utah; Takeda Pharmaceutical Company Limited
Recruiting - verified October 2011 - Condition: Diabetes
Interventions: Behavioral: Peer Modeling; Behavioral: Control
Sponsors: University of Western Ontario, Canada; University of Western Ontario, Canada
Recruiting - verified June 2011 - Condition: Type 2 Diabetes
Intervention: Drug: Vildagliptin
Sponsors: University of Zurich; University of Zurich
Recruiting - verified August 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Behavioral: Structured Education; Behavioral: Conventional Diabetes Education; Drug: Scilin®M30
Sponsors: Chinese Diabetes Society; Chinese Diabetes Society
Recruiting - verified April 2011 - Conditions: Diabetes Mellitus Type 2; GI Side Effect
Intervention:
Sponsors: Merck KGaA; Merck KGaA; Merck Ltd., Thailand
Recruiting - verified January 2012 - Condition: Type 2 Diabetes
Intervention: Drug: Insulin glargine
Sponsors: University of Alberta; University of Alberta; Sanofi-Aventis
Recruiting - verified December 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Placebo
Sponsors: Laval University; Laval University; Merck
Recruiting - verified May 2012 - Condition: Diabetic Retinopathy
Intervention:
Sponsors: Medical University of Vienna; Medical University of Vienna
Not yet recruiting - verified April 2011 - Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Other: Insulin Pump Therapy; Other: Multiple daily injection therapy (usual care)
Sponsors: University of Schleswig-Holstein; University of Schleswig-Holstein; German Research Foundation; Roche Diagnostics GmbH; University of Luebeck; Institute of Medical Biometrics and Statistics
Recruiting - verified March 2011 - Conditions: Diabetes Mellitus; Macular Edema
Interventions: Biological: VEGF Trap-Eye (BAY86-5321); Biological: VEGF Trap-Eye (BAY86-5321); Procedure: Laser treatment
Sponsors: Bayer; Bayer; Regeneron Pharmaceuticals
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Procedure: Point-of-care "finger-poke" HbA1c determination.; Procedure: HbA1c blood test; Procedure: HbA1c finger poke test; Procedure: Blood test; Procedure: Blood test
Sponsors: University of British Columbia; University of British Columbia; Vancouver General Hospital
Recruiting - verified April 2012 - Condition: Hypoglycaemia
Intervention: Procedure: Insulin clamp
Sponsors: Hillerod Hospital, Denmark; Hillerod Hospital, Denmark; University of Southern Denmark; Rigshospitalet, Denmark; Hypo-Safe A/S
Recruiting - verified January 2012 - Conditions: Type 2 Diabetes; Vitamin D Deficiency
Interventions: Drug: Vitamin D2; Drug: Sugar pill
Sponsors: University of Alabama at Birmingham; Ambika Ashraf, M.D.
Recruiting - verified April 2012 - Conditions: Diabetes; Diabetic Retinopathy
Intervention: Behavioral: Diabetes Education
Sponsors: Diabetic Retinopathy Clinical Research Network; Diabetic Retinopathy Clinical Research Network; National Eye Institute (NEI); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified April 2012 - Conditions: Renal Insufficiency; Diabetes
Intervention: Procedure: Truncal block
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Recruiting - verified February 2012 - Condition: Placebo Analgesia
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Condition: Gestational Diabetes Mellitus
Interventions: Drug: Glyburide; Drug: Metformin; Drug: Glyburide-Metformin combination
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); University of Washington; University of Pittsburgh; University of Texas; Indiana University School of Medicine; RTI International
Recruiting - verified January 2012 - Condition: Diabetes Mellitus
Interventions: Drug: Metformin; Drug: Placebo
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Vitamin C; Drug: glyburide
Sponsors: Al-Neelain University; Al-Neelain University
Recruiting - verified November 2011 - Conditions: Type 1 Diabetes Mellitus; Retinopathy; Diabetic Nephropathy
Interventions: Drug: Fenofibrate; Drug: Inert lactose placebo
Sponsors: University of Sydney; University of Sydney; Abbott; University of Melbourne; St Vincents Hospital, Melbourne; Melbourne Health; Royal Prince Alfred Hospital, Sydney, Australia
Not yet recruiting - verified March 2011 - Condition: Type 2 Diabetes
Interventions: Behavioral: virtual world; Behavioral: face to face
Sponsors: Boston Medical Center; Boston Medical Center; University of Massachusetts, Worcester
Recruiting - verified July 2011 - Conditions: Diabetes; Cardiovascular Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified September 2011 - Condition: Type 2 Diabetes
Interventions: Device: Use of Few Touch Application (FTA); Device: Use of FTA and health counseling based on TTM and CBT
Sponsors: University Hospital of North Norway; University Hospital of North Norway; Oslo University College; European Commission; The Research Council of Norway
Recruiting - verified May 2012 - Condition: Diabetes
Intervention: Behavioral: Guided self-determination
Sponsors: Haukeland University Hospital; Haukeland University Hospital
Recruiting - verified January 2012 - Conditions: Hypo-unawareness; Type 1 Diabetes.
Intervention: Dietary Supplement: Medium chain triglycerides
Sponsors: Yale University; Yale University; Juvenile Diabetes Research Foundation
Recruiting - verified January 2012 - Conditions: Type 2 Diabetes Mellitus; Hospitalization; Hyperglycemia
Interventions: Drug: Sitagliptin; Drug: sitagliptin and glargine; Drug: glargine and lispro + SSI
Sponsors: Emory University; Emory University; Merck
Not yet recruiting - verified May 2011 - Conditions: Type 2 Diabetes; Coronary Artery Disease; Heart Failure; Atrial Fibrillation; Other Arrhythmias
Intervention: Behavioral: Health coaching
Sponsors: South Karelia, Social and Health Care; South Karelia, Social and Health Care
Recruiting - verified November 2011 - Condition: Type 2 Diabetes Mellitus
Intervention: Device: V-Go™
Sponsors: Valeritas, Inc.; Valeritas, Inc.; Integrated Medical Development, LLC
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Sirolimus; Drug: Tacrolimus; Drug: Mycophenolate mofetil; Drug: Mycophenolic acid
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network (ITN)
Available - verified April 2012 - Condition: Type 2 Diabetes
Intervention:
Sponsors: China Cardiometabolic Registries; China Cardiometabolic Registries; Merck; Gerontological Society of China
Not yet recruiting - verified February 2011 - Condition: Diabetes Mellitus Type 2
Interventions: Behavioral: home exercise/physical activity (PA) enhancement program with behavioral support; Behavioral: flex and toning health education program
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Type 1 Diabetes
Interventions: Device: MD Logic Pump Advisor; Other: Control Group
Sponsors: Rabin Medical Center; Rabin Medical Center; Medtronic
Recruiting - verified December 2011 - Conditions: Diabetic Retinopathy; Retinal Neovascularisation
Interventions: Drug: Ranibizumab; Drug: Saline
Sponsors: Moorfields Eye Hospital NHS Foundation Trust; Moorfields Eye Hospital NHS Foundation Trust; Novartis
Recruiting - verified May 2011 - Conditions: Cataract; Hypertension; Diabetes
Intervention:
Sponsors: Wenzhou Medical College; yin ying zhao
Recruiting - verified October 2011 - Conditions: Type 1 Diabetes; Type 2 Diabetes
Intervention: Drug: 18F-AV-133
Sponsors: Avid Radiopharmaceuticals; Avid Radiopharmaceuticals
Recruiting - verified April 2012 - Condition: Obesity, Insulin Sensitivity, Type 2 Diabetes Mellitus
Intervention: Dietary Supplement: Comparison of different combinations of polyphenols with respect to effects on fat oxidation
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center; Alpro Foundation
Recruiting - verified September 2011 - Conditions: Diabetes; Pre-Diabetes
Intervention: Drug: water-soluble cinnamon extract (Cinnulin PF)
Sponsors: Mike O'Callaghan Federal Hospital; Mike O'Callaghan Federal Hospital
Not yet recruiting - verified April 2012 - Conditions: Pre-Diabetes; Diabetes; Cardiovascular Risks
Intervention:
Sponsors: Mike O'Callaghan Federal Hospital; Mike O'Callaghan Federal Hospital
Recruiting - verified April 2012 - Condition: Diabetes
Interventions: Drug: Group 1: Metformin; Dietary Supplement: Group 2: Cinnamon Bark; Dietary Supplement: Group 3: Cinnulin PF
Sponsors: Mike O'Callaghan Federal Hospital; Mike O'Callaghan Federal Hospital
Not yet recruiting - verified April 2012 - Conditions: Gestational Diabetes; Gestational Hypertension
Interventions: Other: Placebo; Dietary Supplement: Folic Acid
Sponsors: Mike O'Callaghan Federal Hospital; Mike O'Callaghan Federal Hospital
Not yet recruiting - verified April 2012 - Condition: Diabetes
Interventions: Device: blood pressure with telemetry; Device: Home blood pressure monitor without telemetry
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified January 2012 - Conditions: Diabetes; Diabetic Retinopathy
Intervention:
Sponsors: Taipei Veterans General Hospital,Taiwan; Taipei Veterans General Hospital,Taiwan; Yen Tjing Ling Medical Foundation
Recruiting - verified December 2011 - Condition: Type 1 Diabetes
Interventions: Device: Simultaneous RT-CGM and Pump Initiation; Device: Delayed Initiation of RT-CGM
Sponsors: Children's Hospital of Eastern Ontario; Children's Hospital of Eastern Ontario; JDRF Canadian Clinical Trial Network
Recruiting - verified November 2011 - Conditions: Diabetes Mellitus, Type 2; Diabetic Neuropathy
Intervention: Other: inpatient integrative treatment
Sponsors: Universität Duisburg-Essen; Universität Duisburg-Essen
Recruiting - verified January 2012 - Conditions: Coronary Artery Disease; Diabetes Mellitus
Interventions: Device: Taxus Element stent; Device: Integrity Resolute stent; Device: Xience Prime stent
Sponsors: Policlinico Casilino ASL RMB; Policlinico Casilino ASL RMB; Azienda Ospedaliera - Universitaria di Modena
Recruiting - verified August 2011 - Condition: Diabetes Mellitus
Intervention: Drug: Vildagliptin
Sponsors: University Hospital, Toulouse; University Hospital, Toulouse; Institute of Molecular Medicine of Rangueil (I2MR); Faculty of Medicine, Toulouse; Novartis Pharmaceuticals
Recruiting - verified October 2011 - Condition: Macular Edema Following Cataract Surgery
Interventions: Drug: Trientine Hydrochloride; Other: For Arm B there is no therapeutic intervention other than standard of care, which is cataract surgery.
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified April 2012 - Conditions: Type 1 Diabetes; Diabetes Mellitus; Peripheral Diabetic Neuropathy
Interventions: Drug: CBX129801; Drug: Placebo
Sponsors: Cebix Incorporated; Cebix Incorporated
Recruiting - verified February 2012 - Conditions: Hypertension; Diabetes; Death From Cardiovascular Disease; Myocardial Infarction; Stroke
Intervention:
Sponsors: Imperial College London; Imperial College London; Pfizer
Not yet recruiting - verified December 2011 - Conditions: Diabetes Mellitus, Type 2; Obesity
Interventions: Procedure: laparoscopic Roux-en-Y gastric bypass (RYGB) procedure; Behavioral: Lifestyle Intervention
Sponsors: University of Washington; University of Washington; Group Health; Fred Hutchinson Cancer Research Center
Recruiting - verified September 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Sitagliptin 100mg; Drug: BI 10773; Drug: BI 10773; Drug: BI 10773; Drug: BI 10773; Drug: BI 10773; Drug: BI 10773; Drug: BI 10773; Drug: BI 10773; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Chronic Kidney Disease; Hypertension; Diabetes
Intervention: Behavioral: Exercise training
Sponsors: Springfield College; Springfield College
Recruiting - verified January 2011 - Condition: Diabetes Mellitus, Type 1
Intervention: Biological: Autologous Hematopoietic Stem Cell Transplantation
Sponsors: Northwestern University; Richard Burt, MD; University of Sao Paulo General Hospital
Recruiting - verified April 2012 - Condition: Diabetes
Interventions: Behavioral: Picture good health/Imaginate una buena salud; Behavioral: Diabetes lecture
Sponsors: University of Chicago; University of Chicago; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified September 2011 - Condition: Type 2 Diabetes Mellitus
Intervention: Other: Other: Retrospective chart review; one participant encounter visit.
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Behavioral: Education and patient liaison combination; Behavioral: Control group
Sponsors: Meharry Medical College; Meharry Medical College; National Center for Research Resources (NCRR)
Recruiting - verified July 2011 - Conditions: Obesity; Type 2 Diabetes; Metabolic Syndrome
Intervention:
Sponsors: Joslin Diabetes Center; Joslin Diabetes Center
Recruiting - verified April 2012 - Condition: Gestational Diabetes Mellitus
Intervention: Behavioral: Supervised home-based exercise
Sponsors: The University of Western Australia; The University of Western Australia; King Edward Memorial Hospital
Recruiting - verified March 2012 - Conditions: Diabetes Mellitus; Diabetes Mellitus, Type 2; Obesity
Interventions: Drug: exenatide; Drug: exenatide + exendin (9-39); Drug: placebo
Sponsors: VU University Medical Center; VU University Medical Center; Eli Lilly and Company
Recruiting - verified September 2011 - Conditions: High Risk Proliferative Diabetic Retinopathy; Diabetes Mellitus Type I; Diabetes Mellitus Type II
Interventions: Procedure: Panretinal Photocoagulation (PRP); Drug: Intravitreous injection of pegaptanib
Sponsors: Association for Innovation and Biomedical Research on Light and Image; Association for Innovation and Biomedical Research on Light and Image
Recruiting - verified September 2011 - Condition: Type 2 Diabetes
Interventions: Behavioral: Active titration algorithm; Behavioral: Usual titration algorithm
Sponsors: Mackay Memorial Hospital; Mackay Memorial Hospital
Recruiting - verified November 2010 - Conditions: Obesity; Type 2 Diabetes
Interventions: Procedure: laparoscopic roux en y gastric bypass operation; Other: medical management
Sponsors: The Cleveland Clinic; The Cleveland Clinic
Recruiting - verified March 2012 - Conditions: Hypertension; Hyperlipidemia; Diabetes; Smoking
Intervention: Behavioral: Prioritized Clinical Decision Support
Sponsors: HealthPartners Research Foundation; HealthPartners Research Foundation; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified November 2011 - Condition: Type 2 Diabetes
Intervention: Other: Retrospective chart review; one participant encounter visit.
Sponsors: Merck; Merck
Recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Intervention:
Sponsors: Pennington Biomedical Research Center; Pennington Biomedical Research Center
Recruiting - verified July 2011 - Conditions: Brain Aging; Obesity; Diabetes
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Aging (NIA)
Not yet recruiting - verified October 2010 - Conditions: Diabetes Mellitus, Type 2; Bariatric Surgery Candidate
Interventions: Procedure: gastric bypass surgery; Procedure: abdominal surgery; Behavioral: very low caloric diet
Sponsors: Cantonal Hospital of St. Gallen; Cantonal Hospital of St. Gallen; European Foundation for the Study of Diabetes; Medical University of Graz
Recruiting - verified December 2011 - Condition: Type 2 Diabetes
Interventions: Drug: Liraglutide; Drug: placebo
Sponsors: Mount Sinai Hospital, Canada; Mount Sinai Hospital, Canada; Novo Nordisk
Recruiting - verified August 2011 - Condition: Type 1 Diabetes
Intervention: Device: Control-to-Range Automated Insulin Management System
Sponsors: Juvenile Diabetes Research Foundation Artificial Pancreas Project Consortium; Juvenile Diabetes Research Foundation Artificial Pancreas Project Consortium
Recruiting - verified February 2012 - Conditions: Diabetes; Hypertension; HIV
Interventions: Behavioral: HIV testing; Behavioral: General Health Screen
Sponsors: North Bronx Healthcare Network; North Bronx Healthcare Network
Not yet recruiting - verified August 2011 - Conditions: Type 1 Diabetes; New Onset Type 1 Diabetes
Interventions: Drug: Exenatide; Drug: Rapid and long acting insulin; Drug: long acting insulin + rapid acting + 1.25 mcg Exenatide
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified May 2012 - Condition: Type 1 Diabetes
Intervention: Drug: Leptin ( Metreleptin )
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; Juvenile Diabetes Research Foundation; Amylin Pharmaceuticals, Inc.
Recruiting - verified August 2011 - Condition: Type 1 Diabetes
Intervention: Device: Medtronic ePID 2.0
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University
Recruiting - verified May 2012 - Condition: Type 1 Diabetes
Interventions: Drug: Pramlintide; Drug: Exenatide; Drug: Insulin
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified May 2012 - Conditions: Acute Graft Rejection; Diabetes
Interventions: Drug: Tacrolimus; Drug: Tacrolimus
Sponsors: University of British Columbia; University of British Columbia; Astellas Pharma Canada, Inc.
Not yet recruiting - verified October 2011 - Condition: Type 1 Diabetes
Interventions: Drug: Estradiol, medroxyprogesterone, hydrocortisone, growth hormone; Drug: Matching placebo
Sponsors: Sansum Diabetes Research Institute; Sansum Diabetes Research Institute
Not yet recruiting - verified July 2011 - Conditions: Type 2 Diabetes; Nonalcoholic Steatohepatitis
Interventions: Drug: sitagliptin; Drug: placebo
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; PSI Foundation inc
Recruiting - verified June 2011 - Conditions: Diabetes; Obesity
Intervention: Drug: Acipimox
Sponsors: University of Aarhus; University of Aarhus
Recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Welchol for oral suspension placebo proxy; Drug: Welchol for oral suspension
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Recruiting - verified April 2012 - Conditions: Type 2 Diabetes Mellitus; Obesity; Bariatric Surgery
Intervention: Drug: Insulin
Sponsors: Imperial College London; Imperial College London
Recruiting - verified January 2012 - Conditions: Renal Insufficiency, Chronic; Diabetes Mellitus, Type 2
Interventions: Drug: Placebo; Drug: Bardoxolone Methyl: 20 mg
Sponsors: Reata Pharmaceuticals, Inc.; Reata Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Conditions: Diabetic Retinopathy; Macular Oedema
Intervention: Drug: Ranibizumab
Sponsors: Novartis; Novartis
Recruiting - verified April 2012 - Condition: Cystic Fibrosis
Interventions: Drug: Sitagliptin; Drug: Placebo
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified December 2011 - Conditions: Obesity; Type 2 Diabetes
Intervention: Dietary Supplement: Lactobacillus reuteri
Sponsors: German Diabetes Center; German Diabetes Center; Heinrich-Heine University, Duesseldorf
Recruiting - verified July 2011 - Condition: Diabetes Mellitus, Type 2
Intervention: Drug: BI 10773
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Diabetes Mellitus Type 2
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified February 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: glimepride placebo; Drug: linagliptin placebo; Drug: linagliptin; Drug: glimepiride
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Intervention: Dietary Supplement: Mirtoselect
Sponsors: University of Aberdeen; University of Aberdeen
Recruiting - verified April 2012 - Conditions: Diabetic Nephropathy; Chronic Kidney Disease
Intervention: Drug: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE
Sponsors: The Nazareth Hospital, Israel; The Nazareth Hospital, Israel; Western Galilee Hospital-Nahariya
Not yet recruiting - verified March 2012 - Condition: Diabetes
Interventions: Dietary Supplement: Oral nutritional supplement, food for special medical purposes; Dietary Supplement: Oral nutritional supplement, food for special medical purposes
Sponsors: Fresenius Kabi; Fresenius Kabi
Recruiting - verified November 2010 - Condition: Type 1 Diabetes
Interventions: Device: MD-logic Artificial Pancreas (MDLAP); Device: Standard treatment with CSII
Sponsors: Rabin Medical Center; Rabin Medical Center
Recruiting - verified October 2011 - Conditions: Diabetes; Obesity
Intervention: Drug: Detemir
Sponsors: Vanderbilt University; Vanderbilt University; Novo Nordisk
Recruiting - verified July 2011 - Conditions: Ankle Equinus; Ankle Contracture; Diabetes Mellitus
Interventions: Other: Standard of care; Device: Dynasplint
Sponsors: Dynasplint Systems, Inc.; Dynasplint Systems, Inc.
Recruiting - verified April 2012 - Condition: Type 2 Diabetes
Intervention:
Sponsors: Park Nicollet Institute; Park Nicollet Institute; International Diabetes Center at Park Nicollet; Sanofi-Aventis
Recruiting - verified February 2012 - Conditions: Gestational Diabetes Mellitus; Type 2 Diabetes Mellitus; Metabolic Syndrome; Impaired Glucose Tolerance; Impaired Fasting Glucose
Interventions: Drug: Metformin XR only; Drug: Metformin XR plus liraglutide
Sponsors: BC Women's Hospital & Health Centre; BC Women's Hospital & Health Centre; Novo Nordisk
Recruiting - verified February 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE (HOE901); Drug: INSULIN GLULISINE (HMR1964)
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Not yet recruiting - verified February 2012 - Conditions: Diabetes Mellitus, Insulin-Dependent; Hypercholesterolemia
Interventions: Drug: Atorvastatin; Drug: Atorvastatin Placebo
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; Pfizer; Medtronic; Quest Diagnostics
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Interventions: Drug: liraglutide; Drug: insulin detemir; Drug: liraglutide plus insulin detemir
Sponsors: Indiana University; Indiana University; Novo Nordisk
Recruiting - verified June 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Gliclazide MR; Drug: Insulin Detemir
Sponsors: Ankara University; Ankara University; Hacettepe University; Tubitak
Recruiting - verified August 2011 - Conditions: Metabolic Syndrome; Diabetes
Intervention: Dietary Supplement: high fat overfeeding
Sponsors: University of Adelaide; University of Adelaide
Recruiting - verified October 2010 - Conditions: Coronary Artery Disease; Diabetes Mellitus, Type 2; Atherosclerosis
Interventions: Behavioral: Exercise; Behavioral: Control
Sponsors: Oslo University Hospital; Oslo University Hospital
Recruiting - verified October 2010 - Conditions: Cardiovascular Disease; Diabetes; Obesity; Aging
Intervention: Behavioral: Physical Activity and Diet Intervention via Alive2
Sponsors: Berkeley Analytics, Inc.; Berkeley Analytics, Inc.
Recruiting - verified June 2011 - Conditions: Diabetes; Hyperlipidemia; Heart Disease; High Blood Pressure
Intervention: Other: Care team
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified April 2012 - Condition: Foot Ulcer, Diabetic
Intervention: Device: PriMatrix
Sponsors: TEI Biosciences Inc.; TEI Biosciences Inc.; Beth Israel Deaconess Medical Center
Recruiting - verified June 2011 - Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Insulin glargine (HOE901); Drug: NPH insulin
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified January 2012 - Condition: Diabetes
Intervention: Drug: Vildagliptin
Sponsors: Lund University; Lund University
Not yet recruiting - verified June 2011 - Conditions: Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug
Interventions: Drug: High Dose GGQL Decoction; Drug: Mild dose GGQL Decoction; Drug: Low dose GGQL Decoction; Drug: Placebo
Sponsors: Guang'anmen Hospital of China Academy of Chinese Medical Sciences; Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Recruiting - verified May 2012 - Condition: Type 1 Diabetes
Interventions: Behavioral: PRIMAS; Behavioral: ZI Treatment and Education programme
Sponsors: Forschungsinstitut der Diabetes Akademie Mergentheim; Forschungsinstitut der Diabetes Akademie Mergentheim
Recruiting - verified August 2010 - Conditions: Diabetes; Hypertension; Hyperlipidemia
Intervention: Behavioral: Health coaching by medical assistants in primary care
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified March 2012 - Condition: Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus
Interventions: Drug: Reparixin; Drug: No experimental intervention
Sponsors: Dompé s.p.a.; Dompé s.p.a.
Recruiting - verified June 2011 - Condition: Gestational Diabetes Mellitus
Interventions: Drug: Insulin; Drug: Metformin, glyburide and insulin
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Fonds de la Recherche en Santé du Québec
Recruiting - verified November 2011 - Condition: Diabetic Retinopathy
Intervention:
Sponsors: Association for Innovation and Biomedical Research on Light and Image; Association for Innovation and Biomedical Research on Light and Image; Fundação para a Ciência e a Tecnologia; Instituto Financeiro para o Desenvolvimento Regional
Recruiting - verified September 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin lispro; Drug: Glargine
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Diabetes Mellitus
Interventions: Other: Diet; Other: No intervention
Sponsors: Mario Negri Institute for Pharmacological Research; Mario Negri Institute for Pharmacological Research; Istituto Superiore di Sanita
Recruiting - verified June 2011 - Condition: Type 2 Diabetes
Interventions: Behavioral: pre-bariatric weight loss program; Procedure: bariatric surgery
Sponsors: University of South Alabama; University of South Alabama; American Society for Metabolic and Bariatric Surgery
Recruiting - verified November 2011 - Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Human insulin
Sponsors: Mayo Clinic; Mayo Clinic
Not yet recruiting - verified February 2012 - Condition: Diabetes
Intervention: Procedure: Lispro insulin
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Condition: Diabetic Kidney Disease
Interventions: Drug: Vitamin D3; Drug: Vitamin D3
Sponsors: Medical University of South Carolina; Medical University of South Carolina
Recruiting - verified October 2010 - Condition: Type 1 Diabetes Mellitus
Intervention: Biological: Ex vivo Expanded Human Autologous CD4+CD127lo/-CD25+ Polyclonal Regulatory T Cells
Sponsors: University of California, San Francisco; University of California, San Francisco; Juvenile Diabetes Research Foundation; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Condition: Diabetes Mellitus, Type 1
Interventions: Drug: liraglutide; Drug: placebo
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Intervention:
Sponsors: Postgraduate Institute of Medical Education and Research; Postgraduate Institute of Medical Education and Research
Recruiting - verified September 2010 - Condition: Type 2 Diabetes
Interventions: Drug: Saxagliptin; Drug: Placebo (Saxagliptin); Drug: Metformin IR; Drug: Placebo (Metformin); Drug: Metformin (Active Rescue)
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZeneca
Recruiting - verified February 2012 - Condition: Diabetes Mellitus, Type 1
Interventions: Drug: INSULIN GLARGINE; Drug: INSULIN GLULISINE
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Conditions: Type 2 Diabetes; Obesity
Intervention:
Sponsors: Hvidovre University Hospital; Hvidovre University Hospital; University of Copenhagen
Recruiting - verified November 2011 - Condition: Type 1 Diabetes
Interventions: Drug: Insulin; Drug: Insulin; Drug: Insulin LISPRO
Sponsors: Hompesch, Marcus, M.D.; Hompesch, Marcus, M.D.; Profil Institute for Clinical Research, Inc.
Not yet recruiting - verified June 2011 - Condition: Diabetic Nephropathies
Interventions: Drug: PF-00489791; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Obesity; Type 2 Diabetes
Intervention:
Sponsors: CPL Associates; CPL Associates; VascuFlo Inc.
Recruiting - verified June 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Procedure: Sleeve Gastrectomy and Ileal transposition; Dietary Supplement: dietary and medical management
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston
Recruiting - verified February 2012 - Condition: Diabetes Type 2
Intervention: Other: Exercise
Sponsors: Norwegian University of Science and Technology; Norwegian University of Science and Technology
Recruiting - verified October 2011 - Conditions: Type 2 Diabetes Mellitus; Hypertension; Dyslipidaemia
Interventions: Other: Care Coordinator + Decision Support Software; Other: Usual care
Sponsors: Public Health Foundation of India; Public Health Foundation of India; National Heart, Lung and Blood Institute, USA; United Health Group, USA; All India Institute of Medical Sciences, New Delhi; Madras Diabetes Research Foundation, Chennai; Aga Khan University
Recruiting - verified September 2011 - Condition: Type 2 Diabetes
Interventions: Drug: Dapagliflozin; Drug: Placebo matching Dapagliflozin
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZeneca
Recruiting - verified November 2011 - Condition: Diabetes Mellitus, Type 1
Interventions: Drug: HUMAN INSULIN (BIOSYNTHETIC); Drug: Insuplant
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified April 2012 - Condition: Type 1 Diabetes
Intervention: Drug: Formoterol
Sponsors: Yale University; Yale University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2012 - Conditions: Nutritional and Metabolic Diseases; Inflammation; Physiological Phenomena
Interventions: Dietary Supplement: Placebo; Dietary Supplement: 10G; Dietary Supplement: 20G; Dietary Supplement: 40G; Dietary Supplement: Placebonofiber
Sponsors: Institute for Food Safety and Health, United States; Institute for Food Safety and Health, United States; California Strawberry Commission
Recruiting - verified January 2012 - Conditions: Medication Understanding; Diabetes; Hypertension
Intervention: Other: Enhanced Label
Sponsors: Northwestern University; Northwestern University; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified July 2011 - Conditions: Diabetic Retinopathy; Macular Edema
Interventions: Drug: bevacizumab; Drug: dexamethasone
Sponsors: University of Sydney; University of Sydney; National Health and Medical Research Council, Australia
Recruiting - verified February 2012 - Conditions: Heart Failure; Diabetes
Interventions: Other: Metabolic substrate modulation; Other: metabolic substrate modulation
Sponsors: University of Aarhus; University of Aarhus; Danish Heart Foundation
Recruiting - verified March 2012 - Conditions: Type 2 Diabetes; Heart Failure
Interventions: Other: all antidiabetic drugs will be appliable; Other: no intervention
Sponsors: University of Aarhus; University of Aarhus; The Danish Diabetes Association
Recruiting - verified March 2012 - Conditions: Androgen Deficiency; AD; Erectile Dysfunction; ED; Cardiovascular Adverse Events; Cerebrovascular Adverse Events
Intervention:
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified November 2011 - Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Intranasal insulin
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; University of Washington; University of Arkansas; VA Boston Healthcare System; University of Massachusetts, Worcester
Recruiting - verified June 2011 - Condition: Type 2 Diabetes
Intervention: Behavioral: eHealth program in the VE platform Second Life
Sponsors: Duke University; Duke University
Recruiting - verified March 2012 - Condition: Type 2 Diabetes
Intervention: Drug: Sitagliptin, Glimepiride
Sponsors: Japan Association for Diabetes Education and Care; Japan Association for Diabetes Education and Care; Merck
Recruiting - verified March 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Pioglitazone 15 mg; Drug: Pioglitazone 45 mg; Drug: Pioglitazone 30 mg; Drug: BI 1356 / Pioglitazone 15 mg FDC; Drug: BI 1356; Drug: BI 1356 / Pioglitazone 30 mg FDC; Drug: BI 1356 / Pioglitazone 45 mg FDC
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Intervention: Device: Insulin Pump (Medtronic Minimed Paradigm® VEO)
Sponsors: Medtronic; Medtronic
Recruiting - verified March 2012 - Condition: Type 2 Diabetes
Intervention: Dietary Supplement: Mirtoselect
Sponsors: University of Aberdeen; University of Aberdeen
Recruiting - verified April 2012 - Condition: Diabetes Mellitus
Intervention:
Sponsors: University Hospital Inselspital, Berne; University Hospital Inselspital, Berne; Cantonal Hospital of St. Gallen
Recruiting - verified October 2011 - Condition: Type 2 Diabetes Mellitus
Intervention: Other: Aerobic Exercise Training
Sponsors: Baltimore VA Medical Center; Baltimore VA Medical Center; University of Maryland
Recruiting - verified July 2011 - Condition: Type 1 Diabetes Mellitus
Intervention: Procedure: Blood draw
Sponsors: City of Hope Medical Center; City of Hope Medical Center
Recruiting - verified March 2012 - Conditions: Pancreatitis; Diabetes
Interventions: Drug: Sitagliptin; Drug: Placebo
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified August 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Lispro; Drug: Insulin Glargine
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Other: Remote Blood Glucose Monitoring; Other: Continuous Glucose Monitoring; Other: SMBG; Other: SMBG With Knowledge
Sponsors: Endocrine Research Society; Endocrine Research Society
Recruiting - verified August 2010 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Lispro; Drug: Insulin Glargine
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified March 2012 - Conditions: Diabetes; Hepatic Steatosis
Intervention: Other: exercise
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Recruiting - verified February 2012 - Condition: Type 2 Diabetes
Intervention: Other: Diagnostic
Sponsors: Norwegian University of Science and Technology; Norwegian University of Science and Technology; Volda Hospital
Recruiting - verified December 2011 - Conditions: Diabetes Mellitus; Type 2 Diabetes Mellitus
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University; Weill Cornell Medical College in Qatar; Hamad Medical Corporation
Recruiting - verified August 2011 - Condition: Type 1 Diabetes Mellitus
Intervention:
Sponsors: University of Michigan; University of Michigan
Recruiting - verified May 2010 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Vitamin D3; Drug: Placebo
Sponsors: King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center
Recruiting - verified December 2011 - Conditions: Diabetes Mellitus; Vitamin D Deficiency
Interventions: Drug: vitamin D3 2000 IU; Drug: vitamin D3 5000 IU; Drug: Placebo
Sponsors: King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center
Recruiting - verified December 2011 - Condition: Diabetes, Obesity
Intervention: Behavioral: Tu Salud Si Cuenta Behavioral Intervention
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston
Recruiting - verified February 2012 - Conditions: Constipation; Diabetes
Intervention: Drug: Lubiprostone
Sponsors: Emory University; Emory University
Recruiting - verified June 2011 - Conditions: Diabetic Retinopathy; Diabetic Macular Edema
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified June 2011 - Condition: Gestational Diabetes Mellitus
Interventions: Drug: Metformin; Drug: Placebo
Sponsors: Intermountain Health Care, Inc.; Intermountain Health Care, Inc.
Recruiting - verified April 2012 - Conditions: Diabetes Mellitus; Peripheral Neuropathy; Small Fibre Neuropathy; Autonomic Neuropathy
Intervention:
Sponsors: Haukeland University Hospital; Haukeland University Hospital; Aarhus University Hospital
Recruiting - verified July 2011 - Condition: Type 1 Diabetes
Intervention: Behavioral: Mentoring program
Sponsors: Samsung Medical Center; Samsung Medical Center
Recruiting - verified July 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: sitagliptin phosphate; Drug: Comparator: Placebo; Drug: Comparator: Acarbose
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Hypogonadotropic Hypogonadism; Type 2 Diabetes
Interventions: Drug: testosterone; Drug: clomiphene; Drug: placebo; Drug: placebo
Sponsors: State University of New York at Buffalo; State University of New York at Buffalo; American Diabetes Association
Recruiting - verified July 2011 - Conditions: Diabetes; Heart Disease; Hypertension
Intervention: Behavioral: CARIÑO Project
Sponsors: University of Miami; University of Miami; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 2011 - Conditions: Type 1 Diabetes; Insulin Pump Therapy
Interventions: Device: MD Logic Pump Advisor; Other: No intervention
Sponsors: Rabin Medical Center; Rabin Medical Center; Medtronic
Recruiting - verified July 2011 - Conditions: Diabetes Mellitus, Type 2; Hypertension
Intervention: Other: Change of time of administration
Sponsors: University of Aarhus; University of Aarhus; Regionshospitalet Silkeborg; The Ministry of Science, Technology and Innovation, Denmark; The Health Research Fund of Central Denmark Region
Recruiting - verified February 2012 - Condition: Type 2 Diabetes
Intervention:
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Recruiting - verified August 2011 - Condition: Diabetes
Interventions: Drug: Isoglycemic Clamp; Drug: Comparator: insulin glargine
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Diabetes; Sleep Apnea
Interventions: Device: CPAP mask; Drug: Placebo
Sponsors: University of Chicago; University of Chicago
Recruiting - verified July 2010 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Vildagliptin and metformin; Drug: Glimepiride and metformin
Sponsors: Samsung Medical Center; Samsung Medical Center
Recruiting - verified July 2011 - Condition: Diabetes Mellitus, Type 1
Intervention: Procedure: human pancreatic islet transplantation
Sponsors: University Hospital, Grenoble; University Hospital, Grenoble
Recruiting - verified March 2012 - Conditions: Diabetes; Hypoglycemia
Intervention: Drug: Vildagliptin
Sponsors: Lund University; Lund University
Recruiting - verified May 2011 - Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Lispro
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Intervention:
Sponsors: Ohio State University; Sashwati Roy
Recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Exenatide Once Weekly; Drug: Placebo
Sponsors: Amylin Pharmaceuticals, Inc.; Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Recruiting - verified December 2011 - Condition: Acute Coronary Syndrome
Interventions: Drug: lixisenatide (AVE0010); Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Diabetes
Interventions: Drug: metformin+ NPH insulin; Drug: metformin + sitagliptin +/- repaglinide
Sponsors: Norwegian University of Science and Technology; Norwegian University of Science and Technology
Recruiting - verified March 2012 - Conditions: Contrast Induced Nephropathy; Diabetes Mellitus
Interventions: Drug: pentoxyphylline; Drug: placebo; Drug: pentoxiphylline; Drug: placebo
Sponsors: Meir Medical Center; Meir Medical Center
Not yet recruiting - verified May 2011 - Condition: Metabolic Syndrome
Interventions: Dietary Supplement: Diet enriched in omega-3 fatty acids; Dietary Supplement: Diet enriched in polyphenols; Dietary Supplement: Control diet; Dietary Supplement: diet enriched in omega-tre and polyphenols
Sponsors: Federico II University; Federico II University
Recruiting - verified June 2011 - Condition: Type 2 Diabetes
Interventions: Drug: Dapagliflozin; Drug: Placebo matching Dapagliflozin
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZeneca
Recruiting - verified November 2011 - Condition: Diabetic Foot Ulcers
Interventions: Drug: Santyl; Other: White Petrolatum
Sponsors: Healthpoint; Healthpoint
Recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo BI 10773 low dose; Drug: Placebo BI 10773 low dose; Drug: Placebo BI 10773 high dose; Drug: Placebo BI 10773 high dose; Drug: BI 10773 low dose; Drug: BI 10773 high dose
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Cardiovascular Disease; Hypertension; Diabetes; Hyperlipidemia
Intervention: Behavioral: Pharmacist CVD
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Intervention: Drug: INSULIN GLARGINE
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Intervention: Device: Accu-Chek Integra Glucometer
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified June 2010 - Condition: Type 1 Diabetes Mellitus
Intervention: Procedure: Autologous hematopoietic stem cell transplantation
Sponsors: Hospital Universitario Dr. Jose E. Gonzalez; Hospital Universitario Dr. Jose E. Gonzalez
Recruiting - verified April 2010 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE; Drug: NPH insulin (insulin isophane); Drug: INSULIN GLULISINE; Drug: Regular insulin
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified April 2012 - Condition: Type 2 Diabetes
Interventions: Drug: Exenatide; Drug: Placebo
Sponsors: University Hospital, Caen; University Hospital, Caen; Eli Lilly and Company
Recruiting - verified March 2012 - Conditions: Obesity; Glucose Intolerance; Diabetes
Intervention:
Sponsors: University Hospital, Lille; University Hospital, Lille
Recruiting - verified August 2009 - Condition: Diabetes
Intervention: Device: Insupatch
Sponsors: Insuline Medical Ltd.; Insuline Medical Ltd.
Not yet recruiting - verified June 2011 - Condition: Cystic Fibrosis Related Diabetes
Intervention:
Sponsors: Johns Hopkins University; Johns Hopkins University; Cystic Fibrosis Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Minnesota - Clinical and Translational Science Institute; Vanderbilt University; Northwestern University; Emory University
Recruiting - verified June 2011 - Condition: Type 2 Diabetes Mellitus
Intervention: Drug: injection of 6-DIG
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified December 2011 - Condition: Diabetes Mellitus Type 2
Intervention: Behavioral: Behavioural change programme
Sponsors: Norwegian University of Science and Technology; Norwegian University of Science and Technology
Recruiting - verified September 2011 - Conditions: Diabetic Kidney Disease; Diabetic Nephropathy; Diabetic Glomerulosclerosis
Interventions: Drug: LY2382770; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Diabetes; Prediabetes
Interventions: Behavioral: SCT-based Resistance Training exercise program; Other: Standard Intervention with minimal contact
Sponsors: Virginia Polytechnic Institute and State University; Virginia Polytechnic Institute and State University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified May 2011 - Condition: Type 1 Diabetes
Intervention: Other: Hyperglycemia
Sponsors: University of Aarhus; University of Aarhus
Not yet recruiting - verified April 2012 - Conditions: Diabetes Mellitus, Type 2; Diabetic Nephropathy; Obesity
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: CKD-501 0.5mg; Drug: Pioglitazone 15mg
Sponsors: Chong Kun Dang Pharmaceutical; Chong Kun Dang Pharmaceutical
Recruiting - verified February 2012 - Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Anti-Thymocyte Globin plus pegylated GCSF; Drug: Placebo
Sponsors: University of Florida; University of Florida; The Helmsley Charitable Trust; Genzyme
Recruiting - verified February 2012 - Condition: Type 1 Diabetes Mellitus
Interventions: Drug: DiaPep277; Drug: Placebo
Sponsors: Andromeda Biotech Ltd.; Andromeda Biotech Ltd.
Recruiting - verified September 2011 - Conditions: Metabolic Diseases; Diabetes Mellitus; Endocrine System Diseases; Glucose Metabolism Disorders
Interventions: Drug: Renin-Angiotensin-Aldosterone System (RAAS) Activation; Drug: Administration of Aliskiren, Spironolactone, or Placebo; Drug: Increased Dose, Combination, or Placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified August 2011 - Condition: Diabetic Foot Ulcers
Interventions: Procedure: Normal Saline; Procedure: Biatin Ag (Foam); Procedure: Hydrocolloid; Procedure: Hydrogel; Procedure: Ceredak
Sponsors: M.V. Hospital for Diabetes; M.V. Hospital for Diabetes
Recruiting - verified April 2012 - Condition: Diabetes Mellitus
Intervention: Drug: Filgrastim, hrG-CSF
Sponsors: University of Padova; University of Padova
Recruiting - verified April 2012 - Condition: Type 2 Diabetes
Interventions: Drug: ACEI or ARB; Drug: Lisinopril
Sponsors: University of Virginia; University of Virginia
Recruiting - verified December 2011 - Condition: Diabetes
Interventions: Drug: sitagliptin; Drug: insulin dose increase
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital
Recruiting - verified October 2011 - Condition: Diabetes
Interventions: Drug: Vildagliptin; Drug: Sulphonylurea dose-up
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital
Recruiting - verified January 2012 - Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Trinitrin; Drug: Neosynephrine 10% collyrium; Drug: Iontophoresis with acetylcholine delivery; Device: Dynamic Vessel Analyzer
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2011 - Conditions: Cystic Fibrosis; Diabetes
Intervention: Drug: Once-daily insulin detemir
Sponsors: Sydney Children's Hospital; Sydney Children's Hospital; The Children's Hospital at Westmead; John Hunter Children's Hospital
Recruiting - verified July 2011 - Condition: Type 2 Diabetes
Interventions: Drug: Dapagliflozin; Drug: Dapagliflozin; Drug: Metformin; Drug: Dapagliflozin Placebo; Drug: Pioglitazone
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb; AstraZeneca
Recruiting - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Intervention: Behavioral: Physical exercise
Sponsors: University Hospital, Strasbourg, France; University Hospital, Strasbourg, France
Recruiting - verified March 2012 - Conditions: Wound Healing; Diabetes; Metabolic Control
Intervention: Procedure: surgery
Sponsors: University of Sao Paulo; University of Sao Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified March 2010 - Conditions: Obesity; Diabetes
Interventions: Procedure: Adjustable gastric banding; Behavioral: Dietary and lifestyle modification
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified December 2011 - Condition: Type 2 Diabetes
Interventions: Drug: Exenatide; Drug: Insulin Glargine
Sponsors: Park Nicollet Institute; Park Nicollet Institute; International Diabetes Center at Park Nicollet; Sanofi-Aventis
Recruiting - verified February 2012 - Conditions: Psoriasis; Cardiovascular Diseases; Diabetes Mellitus, Type 2
Interventions: Drug: Adalimumab treatment arm; Drug: Fumaric acid esters treatment group; Other: Narrow band UVB radiation
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified January 2012 - Condition: Type 2 Diabetes
Intervention: Drug: Intensive insulin
Sponsors: Ohio University; Ohio University
Recruiting - verified July 2010 - Conditions: Type 1 Diabetes; Type 2 Diabetes
Interventions: Radiation: Radiography; Other: Urine and Blood sampling; Other: Echography
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified January 2012 - Conditions: Obesity; Bariatric Surgery; Morbid Obesity; Diabetes Mellitus Type 2; Diet Therapy
Interventions: Procedure: Roux-en-Y Gastric Bypass; Behavioral: Caloric Restriction
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified August 2011 - Condition: Type 2 Diabetes
Intervention:
Sponsors: China Cardiometabolic Registries; China Cardiometabolic Registries; Roche Pharma AG; VitalStrategic Research Institute; Chinese College of Cardiovascular Physicians; China Endocrinologist Association
Recruiting - verified February 2010 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: sitagliptin phosphate (+) metformin hydrochloride; Drug: Comparator: metformin; Drug: Comparator: sitagliptin; Drug: Comparator: Placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Type 1 Diabetes
Intervention: Biological: Mesenchymal stem cells
Sponsors: Uppsala University Hospital; Uppsala University Hospital
Recruiting - verified March 2012 - Conditions: Type 2 Diabetes Mellitus; Obesity
Interventions: Procedure: Laparoscopic Adjustable Gastric Band; Procedure: Roux-en-Y Gastric Bypass (Surgery); Other: Intensive Medical Diabetes & Weight Management; Device: Allergan Adjustable Gastric Band
Sponsors: Joslin Diabetes Center; Allison Goldfine; Brigham and Women's Hospital
Recruiting - verified March 2012 - Condition: Diabetes Mellitus
Interventions: Drug: BGP-15 100 mg QD; Drug: BGP-15 100 mg BID; Drug: Placebo BID; Drug: BGP-15 200 mg QD; Drug: BGP-15 200 mg BID; Drug: BGP-15 400 mg QD
Sponsors: N-Gene Research Laboratories, Inc.; N-Gene Research Laboratories, Inc.; Integrium; Msource Medical Development GmbH; Kinexum LLC; Thermo Fisher Scientific; Haupt Pharma Wülfing GmbH; BARC nv
Recruiting - verified June 2011 - Conditions: Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic
Interventions: Behavioral: Computer assisted education and motivational interviewing.; Behavioral: Group talks/social chat
Sponsors: University of Colorado, Denver; University of Colorado, Denver; Robert Wood Johnson Foundation; National Center for Research Resources (NCRR)
Recruiting - verified July 2011 - Conditions: Hypertension; Diabetes Mellitus, Type II
Intervention: Drug: Bisoprolol
Sponsors: Merck KGaA; Merck KGaA; Merck Ltd.
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Non-Insulin-Dependent
Intervention: Drug: Sitagliptin/metformin
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Diabetes Mellitus Non-insulin-dependent
Intervention: Drug: Sitagliptin
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Cardiomyopathy
Intervention:
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified December 2011 - Condition: Diabetes Mellitus
Interventions: Genetic: genetic testing for type 2 diabetes; Other: Conventional risk counseling for type 2 diabetes
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Duke University
Recruiting - verified May 2012 - Conditions: Diabetes Mellitus Type 2; Insulin Resistance
Intervention: Device: Telemedical device
Sponsors: Medical University of Vienna; Medical University of Vienna; National Bank of Austria
Recruiting - verified August 2011 - Conditions: Gestational Diabetes; Gestational Diabetes Mellitus; Diabetes Mellitus, Gestational; Pregnancy-Induced Diabetes; Diabetes, Pregnancy Induced
Intervention: Other: INDUCTION of LABOUR
Sponsors: IRCCS Burlo Garofolo; IRCCS Burlo Garofolo
Recruiting - verified August 2011 - Conditions: Type 1 Diabetes; Hypoglycemia
Interventions: Drug: Angiotensin II receptor antagonists (Candesartan); Drug: Placebo
Sponsors: Hillerod Hospital, Denmark; Hillerod Hospital, Denmark
Recruiting - verified January 2010 - Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Intervention:
Sponsors: German Diabetes Center; German Diabetes Center
Recruiting - verified July 2011 - Conditions: Obesity; Overweight; Diabetes Mellitus, Type 2
Intervention:
Sponsors: Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra; Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra
Recruiting - verified March 2012 - Conditions: Type 1 Diabetes; Hypoglycemia Unawareness
Interventions: Drug: Naltrexone; Drug: Naltrexone
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American Diabetes Association
Recruiting - verified August 2011 - Conditions: Diabetes Mellitus; Hip Fracture
Interventions: Other: Diabetes interdisciplinary program; Other: Rehabilitation program, nursing care
Sponsors: Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Health Research Institutes, Taiwan
Recruiting - verified February 2012 - Conditions: Diabetes; Obesity; Weight Gain
Intervention: Behavioral: Behavioral Weight Loss Program
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified December 2011 - Conditions: Obesity; Type 2 Diabetes Mellitus
Interventions: Other: Laboratory evaluations, sleep study; Other: Best Medical Management; Procedure: Roux-en-Y gastric bypass surgery
Sponsors: Ohio State University; Asem Ali; Covidien
Recruiting - verified May 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: aleglitazar; Drug: pioglitazone
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified October 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Aleglitazar; Drug: Placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified March 2012 - Conditions: Diabetes Mellitus; Hypertension; Albuminuria; Arterial Stiffness
Intervention:
Sponsors: Istanbul University; Istanbul University
Recruiting - verified June 2011 - Condition: Type 2 Diabetes
Interventions: Procedure: Roux-en-Y Gastric Bypass surgery; Procedure: Laparoscopic Adjustable Gastric Banding surgery; Behavioral: Intensive Lifestyle Modification
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified November 2011 - Condition: Type 2 Diabetes
Interventions: Drug: Sitagliptin; Other: life style modification at base line
Sponsors: India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals; India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
Not yet recruiting - verified June 2011 - Conditions: Islets of Langerhans Transplantation; Diabetes Mellitus, Type 1; Kidney Transplantation
Intervention: Drug: Belatacept
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; Bristol-Myers Squibb
Recruiting - verified November 2011 - Conditions: Autoantibody Positive; Non-diabetic Relatives at Risk for Type 1 Diabetes; High Risk; Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Research Resources (NCRR); Juvenile Diabetes Research Foundation; American Diabetes Association
Recruiting - verified February 2012 - Condition: Type 1 Diabetes
Intervention: Behavioral: Family-based cognitive-behavioral treatment
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified June 2011 - Condition: Diabetes Complications
Interventions: Drug: Ranibizumab; Drug: 0.9% Sodium Chloride
Sponsors: King's College Hospital NHS Trust; King's College Hospital NHS Trust; Novartis
Recruiting - verified February 2011 - Condition: Gestational Diabetes Mellitus
Intervention: Procedure: 50 g oral glucose challenge test - 75 g oral glucose tolerance test
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Canadian Diabetes Association
Recruiting - verified November 2011 - Condition: Diabetes Mellitus, Type II
Intervention: Other: Metabolic Testing
Sponsors: University of Washington; University of Washington; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified September 2011 - Conditions: Diabetes Mellitus; Metabolic Integrity
Intervention: Procedure: Humulin, Humalog, Novolog
Sponsors: Global Infusion and Aspiration Systems, LLC; Global Infusion and Aspiration Systems, LLC
Recruiting - verified June 2011 - Condition: Type 2 Diabetes
Intervention: Behavioral: Exercise group
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified February 2012 - Condition: Type 2 Diabetes
Intervention: Drug: Insulin
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified May 2011 - Conditions: Diabetes; Obesity; Metabolic Syndrome; Cardiovascular Disease
Interventions: Other: Carbohydrate; Other: Carbohydrate Load; Other: Carbohydrate plus Protein; Other: Carbohydrate plus Fat; Other: Fiber
Sponsors: Tufts University; Tufts University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified November 2011 - Condition: Diabetes Mellitus, Type 2
Intervention: Procedure: acupuncture
Sponsors: Dresden University of Technology; Dresden University of Technology
Recruiting - verified December 2011 - Condition: Diabetes
Interventions: Drug: NutropinAq (GH) and Increlex (IGF-I); Drug: NutropinAq and placebo
Sponsors: Karolinska University Hospital; Karolinska University Hospital
Recruiting - verified November 2009 - Condition: Insulin-dependent Gestational Diabetes
Interventions: Drug: vildagliptin; Drug: inactive pill
Sponsors: Institut fur Diabetesforschung, Munich, Germany; Institut fur Diabetesforschung, Munich, Germany
Recruiting - verified June 2011 - Condition: Type 2 Diabetes
Interventions: Behavioral: Telephone support and behavior change; Other: Diabetes self-management education
Sponsors: State University of New York - Upstate Medical University; State University of New York - Upstate Medical University
Recruiting - verified July 2011 - Conditions: Coronary Artery Disease; Diabetes Mellitus Type 2
Intervention: Drug: Glucagon-Like-Peptide-1/Regadenoson/Perflutren Lipid Microsphere
Sponsors: Mayo Clinic; Mayo Clinic; University of Nebraska; Astellas Pharma US, Inc.; Lantheus Medical Imaging
Recruiting - verified January 2012 - Conditions: Pregnancy; Obesity; Diabetes
Intervention: Behavioral: Nutritional counseling and twice weekly exercise groups
Sponsors: Sorlandet Hospital HF; Sorlandet Hospital HF
Recruiting - verified December 2011 - Condition: Prediabetic State
Interventions: Drug: Sitagliptin + Pioglitazone PLACEBO; Drug: Sitagliptin + Pioglitazone; Drug: Sitagliptin placebo + Pioglitazone placebo
Sponsors: Emory University; Emory University
Recruiting - verified July 2011 - Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: placebo; Drug: pioglitazone; Dietary Supplement: Vitamin E
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified February 2012 - Condition: Type I Diabetes
Interventions: Behavioral: Education; Device: CGM; Behavioral: Problem Solving; Behavioral: Social Learning; Behavioral: Behavior Modification
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Diabetic Neuropathy
Intervention: Procedure: Nerve conduction study and Ultrasound of the PTN
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Recruiting - verified November 2011 - Condition: Type 1 Diabetes
Interventions: Drug: Xoma 052; Drug: Placebo
Sponsors: XOMA (US) LLC; XOMA (US) LLC; Juvenile Diabetes Research Foundation
Recruiting - verified September 2011 - Conditions: Diabetes Mellitus, Type 2; Obesity
Interventions: Behavioral: Sport; Drug: Tocilizumab; Drug: Sitagliptin
Sponsors: University of Zurich; University of Zurich; Donath M.Y.; European Foundation for the Study of Diabetes
Recruiting - verified March 2012 - Conditions: Chronic Periodontitis; Type 2 Diabetes
Interventions: Procedure: Non-surgical periodontal treatment; Other: Delayed non-surgical periodontal therapy
Sponsors: Stony Brook University; Stony Brook University; University of Alabama at Birmingham; University of Minnesota - Clinical and Translational Science Institute; The University of Texas Health Science Center, Houston; University of Texas; National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified December 2011 - Conditions: Diabetes Mellitus, Type 2; Atherosclerosis; Prediabetic State
Interventions: Drug: ACZ885 (Canakinumab); Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Type 2 Diabetes; Obesity
Intervention: Behavioral: 8-month group lifestyle programme
Sponsors: The Royal Bournemouth Hospital; The Royal Bournemouth Hospital
Recruiting - verified August 2011 - Condition: Diabetes Mellitus, Non-insulin-dependent
Interventions: Drug: sitagliptin phosphate (+) metformin hydrochloride; Drug: Comparator: glimepiride
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Diabetic Polyneuropathy
Intervention: Procedure: Surgery
Sponsors: Timothy J. Best Medicine Professional Corporation; Timothy J. Best Medicine Professional Corporation; The Physicians' Services Incorporated Foundation
Recruiting - verified December 2011 - Conditions: Diabetes Type 2; Hypertension
Interventions: Drug: acetyl-L-carnitine/statin (simvastatin); Drug: placebo
Sponsors: Mario Negri Institute for Pharmacological Research; Mario Negri Institute for Pharmacological Research; Sigma Tau Pharmaceuticals, Inc.
Recruiting - verified June 2011 - Conditions: Heart Diseases; Diabetes Mellitus, Type 2; Behavior; Motivation
Intervention: Behavioral: Intervention Group (IG)
Sponsors: Freie Universität Berlin; Freie Universität Berlin; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified June 2011 - Condition: Diabetes
Intervention: Dietary Supplement: Zinc acetate
Sponsors: University of Maryland; University of Maryland; Johns Hopkins University
Recruiting - verified July 2011 - Condition: Diabetes Mellitus
Intervention: Drug: Vildagliptin
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified September 2009 - Conditions: Diabetes; Hypertension
Interventions: Behavioral: Tailored telephone-based case management; Behavioral: Nurse Education
Sponsors: Duke University; Duke University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified June 2011 - Conditions: Cancer; Liver Transplantation; Diabetes
Intervention: Behavioral: Patient's access to a practice-integrated OPPC service
Sponsors: Oslo University Hospital; Oslo University Hospital; The Research Council of Norway
Recruiting - verified May 2011 - Conditions: Diabetes Mellitus, Type 2; Acute Coronary Syndrome
Interventions: Drug: Alogliptin; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified March 2012 - Conditions: Cystic Fibrosis; Prediabetes
Intervention: Drug: sitagliptin phosphate
Sponsors: Emory University; Emory University; Ohio State University; Children's Healthcare of Atlanta; Merck; FDA Office of Orphan Products Development
Recruiting - verified January 2012 - Condition: Pre-Diabetes
Interventions: Behavioral: Aerobic Exercise; Behavioral: Aerobic Exercise; Behavioral: Aerobic Exercise; Behavioral: Exercise and Diet
Sponsors: Duke University; Duke University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide; Drug: insulin lispro
Sponsors: Amylin Pharmaceuticals, Inc.; Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Recruiting - verified March 2012 - Conditions: Obesity, Morbid; Diabetes Mellitus, Type 2; Gastric Bypass
Intervention:
Sponsors: CPL Associates; CPL Associates; Synergy Bariatrics; Sisters of Charity Hospital; The New York State Center of Excellence in Bioinformatics & Life Sciences
Recruiting - verified June 2011 - Conditions: Obesity, Morbid; Diabetes Mellitus Type 2
Intervention:
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Post-Traumatic Stress Disorder; Depression; Diabetes; Cardiovascular Disease
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified January 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin; Drug: Alogliptin; Drug: Alogliptin; Drug: Alogliptin; Drug: Alogliptin
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified January 2012 - Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Rilonacept
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Recruiting - verified December 2010 - Condition: Hypertension in Type 2 Diabetes
Interventions: Device: Resperate; Device: Resperate
Sponsors: Medical Research Foundation, The Netherlands; Medical Research Foundation, The Netherlands
Recruiting - verified March 2012 - Condition: Diabetic Neuropathy
Interventions: Behavioral: Exercise; Behavioral: Exercise
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified April 2012 - Conditions: At-risk Drinking; Type 2 Diabetes
Interventions: Behavioral: Brief alcohol intervention; Behavioral: General health education
Sponsors: Rhode Island Hospital; Rhode Island Hospital
Recruiting - verified July 2009 - Condition: Type 1 Diabetes
Intervention: Device: monitor Paradigm 754 VEO, MINILINK Real Time, Medtronic, CE
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified July 2009 - Conditions: Type 1 Diabetes; Eating Disorder
Intervention:
Sponsors: Park Nicollet Institute; Park Nicollet Institute; International Diabetes Center at Park Nicollet; Park Nicollet Eating Disorder Institute; Park Nicollet Foundation
Recruiting - verified February 2012 - Condition: Diabetes Mellitus
Intervention: Drug: Generex Oral-lyn™
Sponsors: Generex Biotechnology Corp.; Generex Biotechnology Corp.
Available - verified September 2011 - Conditions: Diabetes Mellitus, Type 2; Hyperglycemia
Interventions: Behavioral: Exercise intervention; Behavioral: No exercise
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center; ZonMw: The Netherlands Organisation for Health Research and Development
Recruiting - verified July 2011 - Condition: Type 1 Diabetes Mellitus
Interventions: Device: Continuous Glucose Sensor; Other: Standard Care; Behavioral: CGS + Behavior Therapy
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic
Recruiting - verified July 2011 - Conditions: Diabetes Mellitus, Type 2; Cardiomyopathy, Dilated
Interventions: Drug: Acipimox; Drug: Cellulosum Mycrocryst
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center; Center for Translational Molecular Medicine
Recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Detemir insulin, Aspart insulin, Metformin
Sponsors: University Hospital, Toulouse; University Hospital, Toulouse
Recruiting - verified December 2011 - Condition: TYPE 2 DIABETES
Interventions: Device: placebo; Device: IVS; Device: PDAphone
Sponsors: Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète; Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète; Novo Nordisk
Recruiting - verified March 2010 - Condition: SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors
Intervention: Drug: Vildagliptin
Sponsors: Johann Wolfgang Goethe University Hospitals; Johann Wolfgang Goethe University Hospitals
Recruiting - verified July 2009 - Condition: Gestational Diabetes Mellitus
Intervention: Other: Determining a change in heart rate variability post delivery of the baby
Sponsors: Christiana Care Health Services; Christiana Care Health Services
Recruiting - verified October 2011 - Conditions: Metabolic Diseases; Endocrine System Diseases; Heart Disease; Vascular Diseases; Diabetes; Cardiovascular Disease; Glucose Metabolism Disorders; Hypertension
Intervention: Drug: omega-3 acid ethyl esters
Sponsors: Denver Health and Hospital Authority; Denver Health and Hospital Authority; National Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline
Recruiting - verified July 2011 - Conditions: Type 2 Diabetes; Atherosclerosis
Intervention: Drug: Atorvastatin
Sponsors: Korea University; Korea University
Not yet recruiting - verified July 2009 - Condition: Diabetes Type 1
Interventions: Drug: insulin Glargine + Insulin Apidra; Drug: Insulin NPH + Insulin Apidra: Active Comparator
Sponsors: Rabin Medical Center; Rabin Medical Center; Sanofi-Aventis
Recruiting - verified October 2011 - Conditions: Hypertension; Dyslipidemia; Diabetes
Intervention: Behavioral: physical activity
Sponsors: National Institute of Health and Nutrition; National Institute of Health and Nutrition
Recruiting - verified June 2009 - Conditions: Hypertriglyceridemia; Diabetic Neuropathy
Intervention: Drug: omega-3-acie ethyl esters
Sponsors: Eastern Virginia Medical School; Eastern Virginia Medical School; GlaxoSmithKline
Recruiting - verified July 2011 - Condition: Diabetic Foot Ulcer
Interventions: Drug: HO/03/03 10µg; Drug: Placebo
Sponsors: HealOr; HealOr; Clinigene International Ltd; Cato Research
Recruiting - verified December 2011 - Conditions: Gestational Diabetes Mellitus; Type 2 Diabetes
Intervention: Procedure: Oral glucose tolerance test
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Recruiting - verified November 2011 - Condition: Diabetic Foot Ulcers
Interventions: Drug: FGF-1 141; Drug: FGF-1 141
Sponsors: Phage Pharmaceuticals, Inc.; Phage Pharmaceuticals, Inc.
Not yet recruiting - verified March 2012 - Conditions: Type 2 Diabetes; Renal Insufficiency
Interventions: Drug: Glargine & glulisine; Drug: Glargine & glulisine
Sponsors: Loyola University; Loyola University; Sanofi-Aventis
Recruiting - verified September 2011 - Conditions: Diabetes Mellitus, Type 2; Insulin Resistance; Dyslipidemias
Intervention:
Sponsors: Mayo Clinic; Mayo Clinic; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Conditions: Diabetic Nephropathies; Proteinuria; Oxidative Stress
Interventions: Dietary Supplement: N-acetylcysteine; Dietary Supplement: silibin; Dietary Supplement: high-dose silibin; Dietary Supplement: N-acetylcysteine placebo; Dietary Supplement: silibin placebo
Sponsors: The University of Texas Health Science Center at San Antonio; The University of Texas Health Science Center at San Antonio; National Center for Complementary and Alternative Medicine (NCCAM); Department of Veterans Affairs
Recruiting - verified August 2011 - Conditions: Proliferative Diabetic Retinopathy; Macular Edema
Interventions: Drug: Tromethamine ketorolac; Drug: Alcohol polivinilico
Sponsors: Hospital Juarez de Mexico; Hospital Juarez de Mexico
Recruiting - verified March 2010 - Conditions: Type 1 Diabetes; Type 2 Diabetes; Immunologically Mediated Type 1 Diabetes; Anti Beta-Cell Autoantibodies; Autoimmunity
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified September 2011 - Conditions: Congestive Heart Failure; Type II Diabetes Mellitus
Interventions: Drug: vildagliptin; Drug: placebo of vildagliptin
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Diabetic Neuropathy
Intervention:
Sponsors: Tameside Hospital NHS Foundation Trust; Tameside Hospital NHS Foundation Trust
Recruiting - verified May 2009 - Conditions: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
Intervention: Device: GlucoTrack
Sponsors: Integrity Applications Ltd.; Integrity Applications Ltd.
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type I
Interventions: Biological: Purified Pancreatic Islets; Drug: Etanercept
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified January 2012 - Conditions: Healthy; Type 2 Diabetes
Interventions: Drug: Sitagliptin; Drug: placebo
Sponsors: Lund University; Lund University
Recruiting - verified May 2011 - Conditions: Type 1 Diabetes Mellitis; Cognition
Intervention:
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Institutes of Health (NIH)
Recruiting - verified November 2011 - Condition: Diabetes
Interventions: Drug: Cyclo-Z; Drug: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type I
Intervention: Device: Real-time glucose sensor
Sponsors: Seattle Children's Hospital; Seattle Children's Hospital; The Gerber Foundation; Medtronic
Recruiting - verified August 2011 - Conditions: Type 1 Diabetes; Rejection of Pancreas Transplant; Desensitization
Intervention:
Sponsors: Northwestern University; Northwestern University; Northwestern Medical Foundation
Recruiting - verified August 2011 - Conditions: Type 2 Diabetes Mellitus; Vascular Disease
Interventions: Drug: Spironolactone; Drug: hydrochlorothiazide + potassium; Other: placebo
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Institutes of Health (NIH)
Recruiting - verified June 2011 - Condition: Type 2 Diabetes
Intervention: Drug: Detemir or Glargine
Sponsors: Institut de Recherches Cliniques de Montreal; Institut de Recherches Cliniques de Montreal; Novo Nordisk; McMaster University
Recruiting - verified June 2011 - Condition: Diabetes Mellitus Type II Non Insulin Dependent
Interventions: Dietary Supplement: Vitamin E; Dietary Supplement: Vitamin C; Dietary Supplement: Lipid Oxidation
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified August 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Nateglinide; Drug: Glimepiride
Sponsors: Ajou University School of Medicine; Ajou University School of Medicine; Korea University Guro Hospital; Hanyang University; Inha University Hospital; Kyunghee University Medical Center; Myongji Hospital; Bundang CHA Hospital; Yonsei University; Hallym University Medical Center
Recruiting - verified June 2011 - Conditions: Type 2 Diabetes Mellitus; Diabetic Peripheral Neuropathy
Interventions: Drug: Exenatide; Drug: Glargine
Sponsors: University of Michigan; University of Michigan; Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Recruiting - verified August 2011 - Conditions: Coronary Artery Disease; Acute Coronary Syndrome; Diabetes; Metabolic Syndrome
Intervention:
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified June 2011 - Condition: Diabetes Mellitus
Intervention: Behavioral: Role modeling in Shared medical appointments to Promote Establishing Collaborative Teams (ReSPECT)
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Case Western Reserve University; The Cleveland Clinic
Recruiting - verified January 2012 - Conditions: Obesity; Type 2 Diabetes
Interventions: Drug: pioglitazone; Drug: placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; National Institutes of Health (NIH)
Recruiting - verified August 2011 - Conditions: Asthma; Diabetes; Obesity; Premature Birth; Autistic Disorder
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Diabetes Mellitus, Type 2
Intervention:
Sponsors: BC Women's Hospital & Health Centre; BC Women's Hospital & Health Centre
Recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Behavioral: DDR; Behavioral: Treadmill
Sponsors: Charles Drew University of Medicine and Science; Charles Drew University of Medicine and Science; American Diabetes Association
Recruiting - verified February 2012 - Conditions: Uveitis; Diabetic Retinopathy; Choroidal Neovascularization
Intervention: Drug: adalimumab
Sponsors: Rafic Hariri University Hospital; Rafic Hariri University Hospital; American University of Beirut Medical Center
Recruiting - verified September 2009 - Conditions: Diabetic Retinopathy; Diabetic Macular Edema
Interventions: Procedure: islet cell transplant; Other: Medical therapy
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Condition: Diabetes, Gestational
Intervention: Device: The Seven Continuous Glucose Monitoring System
Sponsors: Stanford University; Stanford University; DexCom, Inc.
Recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Intervention: Behavioral: Intensive Lifestyle Intervention
Sponsors: Yale University; Yale University; Donaghue Medical Research Foundation
Recruiting - verified January 2012 - Conditions: Type 2 Diabetes; Oxidative Stress
Intervention: Biological: ascorbic acid (Vitamin C)
Sponsors: University of Kansas; University of Kansas
Recruiting - verified July 2011 - Conditions: Wound; Diabetes; Amputation
Intervention:
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital
Recruiting - verified August 2011 - Conditions: Nephropathy; Retinopathy; Hypertension; Obesity; Diabetes
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified January 2012 - Condition: Type 1 Diabetes Mellitus
Interventions: Device: Microneedle; Device: Subcutaneous insulin catheter
Sponsors: Emory University; Eric Felner, MD, MSCR; Emory University
Recruiting - verified March 2012 - Condition: Diabetes
Intervention:
Sponsors: Western Galilee Hospital-Nahariya; Western Galilee Hospital-Nahariya
Recruiting - verified November 2010 - Conditions: Coronary Heart Disease; Acute Coronary Syndrome; Impaired Glucose Tolerance; Type 2 Diabetes Mellitus (T2DM)
Interventions: Drug: Acarbose; Drug: Matching Placebo
Sponsors: University of Oxford; University of Oxford; Bayer
Recruiting - verified September 2011 - Condition: Diabetic Peripheral Neuropathic Pain
Interventions: Behavioral: CBT plus standard pharmaceutical care (CBT/SC); Behavioral: Diabetic Education plus standard pharmaceutical care (ED/SC)
Sponsors: VA Connecticut Healthcare System; VA Connecticut Healthcare System
Recruiting - verified March 2012 - Conditions: Cardiovascular; Diabetes; Orthostatic Hypotension; Type 2 Diabetes
Intervention: Behavioral: Home-based walking program (Aerobic Exercise)
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Conditions: Diabetes; Prediabetes
Intervention:
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital
Recruiting - verified January 2012 - Condition: Type 1 Diabetes
Interventions: Other: Medtronic CareLink therapy management system; Other: regular home use and Medtronic CareLink Therapy Management
Sponsors: Rabin Medical Center; Rabin Medical Center
Recruiting - verified October 2011 - Conditions: Congestive Heart Failure; Diabetes Mellitus
Interventions: Drug: Intravenous insulin; Drug: Subcutaneous insulin
Sponsors: Ohio State University; Kathleen Dungan; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Conditions: Congestive Heart Failure; Diabetes Mellitus
Interventions: Drug: Intravenous insulin; Drug: Subcutaneous insulin
Sponsors: Ohio State University; Kathleen Dungan; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Condition: Type 1 Diabetes Mellitus
Intervention: Procedure: Immunosuppression and autologous stem cell transplantation
Sponsors: Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine
Recruiting - verified March 2010 - Conditions: Type 1 Diabetes; Hypoglycemia Unawareness
Intervention:
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified August 2011 - Condition: Type 1 Diabetes Mellitus
Intervention: Device: Encapsulated human islets in a "Monolayer Cellular Device"
Sponsors: Cliniques universitaires Saint-Luc- Université Catholique de Louvain; Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Recruiting - verified August 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin phosphate; Drug: Placebo
Sponsors: Merck; Merck; Duke Clinical Research Institute, Oxford Diabetes Trials Unit
Recruiting - verified May 2012 - Conditions: Type 1 Diabetes; Type 2 Diabetes
Intervention: Biological: Autologous CD34+ stem cells
Sponsors: Imperial College London; Imperial College London
Recruiting - verified July 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Welchol; Drug: placebo tablets
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Recruiting - verified January 2012 - Conditions: Obesity; Diabetes
Interventions: Behavioral: TSSC; Behavioral: TSSC Randomized Behavioral Intervention for weight loss
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; National Center on Minority Health and Health Disparities (NCMHD)
Recruiting - verified February 2012 - Conditions: Type 2 Diabetes Mellitus; Prediabetic State
Interventions: Other: Glucose challenge test; Other: Glucose tolerance test
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Emory University
Recruiting - verified January 2012 - Condition: Type 1 Diabetes
Intervention:
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified August 2011 - Conditions: Type 2 Diabetes Mellitus; Weight Gain
Intervention: Device: Sensewear Bodymedia armband
Sponsors: Radboud University; Radboud University
Recruiting - verified September 2009 - Conditions: Diabetes; Physical Activity
Interventions: Behavioral: Tailored Diet and Physical Activity; Behavioral: Standard of Care
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of Maryland; University of Michigan
Recruiting - verified May 2012 - Conditions: Non-healing Wounds; Diabetes
Intervention: Other: Blood draw
Sponsors: Ohio State University; Sashwati Roy; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2012 - Conditions: Pre-diabetes; Type 2 Diabetes
Interventions: Drug: Exenatide; Drug: Sitagliptin; Drug: Glimepiride
Sponsors: University of Pennsylvania; University of Pennsylvania; Pennsylvania Department of Health
Recruiting - verified November 2011 - Conditions: Type 2 Diabetes Mellitus; Congestive Heart Failure
Interventions: Drug: exenatide; Drug: Insulin glargine
Sponsors: VU University Medical Center; VU University Medical Center
Recruiting - verified May 2012 - Conditions: Diabetes; Glycemic Control
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Other: Telephone counseling; Other: No telephone counseling
Sponsors: German Cancer Research Center; German Cancer Research Center; University of Heidelberg; German Federal Ministry of Education and Research
Recruiting - verified April 2012 - Conditions: Diabetes Mellitus; Healthy Volunteers
Intervention:
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified June 2011 - Conditions: Vitamin D Deficiency; Insulin Resistance; Type 2 Diabetes Mellitus; Cardiovascular Disease; Hypertension
Interventions: Drug: Vitamin D3; Drug: Placebo
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Heart, Lung, and Blood Institute (NHLBI); American Diabetes Association
Recruiting - verified November 2011 - Condition: Type II Diabetes Mellitus
Intervention: Other: RAS 130 with diet and exercise
Sponsors: American Scitech International; American Scitech International; Proactive Clinical Research
Not yet recruiting - verified July 2011 - Condition: Type 2 Diabetes
Interventions: Drug: aspirin; Drug: aspirin
Sponsors: University of Vigo; University of Vigo
Recruiting - verified March 2012 - Condition: Type 2 Diabetes
Intervention:
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified May 2011 - Conditions: Non-alcoholic Fatty Liver Disease; Diabetes
Interventions: Other: Dietary intervention (calorie restricted diet); Other: Dietary intervention (calorie restricted diet)
Sponsors: University of California, San Francisco; University of California, San Francisco; Touro University; American Diabetes Association
Recruiting - verified April 2012 - Conditions: Type 2 Diabetes Mellitus; Cardiovascular Disease
Interventions: Drug: add-on pioglitazone; Drug: add-on sulphonylurea
Sponsors: Italian Society of Diabetology; Italian Society of Diabetology; Associazione Medici Diabetologi (AMD); Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO)
Recruiting - verified August 2011 - Condition: Diabetes Mellitus
Interventions: Drug: placebo; Drug: exenatide
Sponsors: Amylin Pharmaceuticals, Inc.; Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Recruiting - verified June 2011 - Conditions: Type 2 Diabetes Mellitus; Impaired Glucose Tolerance (Prediabetes)
Interventions: Behavioral: Aerobic exercise training; Behavioral: Detraining (cessation of exercise)
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of Maryland
Recruiting - verified March 2012 - Condition: Painful Diabetic Neuropathy
Intervention: Procedure: Nerve Decompression
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Recruiting - verified August 2011 - Condition: Diabetes Type 2
Interventions: Drug: Metformin 1500 mg daily; Drug: Metformin + Janufer (Janumet)
Sponsors: Meir Medical Center; Meir Medical Center; Clalit Health Services
Recruiting - verified March 2012 - Conditions: Diabetes Mellitus; Hypoglycemia; Autonomic Failure
Interventions: Drug: naloxone; Dietary Supplement: fructose; Behavioral: exercise
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; National Institutes of Health (NIH)
Recruiting - verified February 2012 - Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Islets of Langerhans transplantation
Sponsors: University of Illinois; University of Illinois
Recruiting - verified August 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Other: multidisciplinary approach; Other: multifactorial approach - for enhanced care group; Other: reflects current patterns of care
Sponsors: University of Alberta; University of Alberta; Alberta Heritage Foundation for Medical Research
Recruiting - verified November 2011 - Condition: Lipodystrophy
Intervention: Drug: metreleptin
Sponsors: Amylin Pharmaceuticals, Inc.; Amylin Pharmaceuticals, Inc.
Recruiting - verified March 2012 - Conditions: Atherosclerosis; Diabetes Mellitus; Obesity; Dyslipidemia; Hypertension
Interventions: Behavioral: Exercise; Behavioral: Weight Loss
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified November 2011 - Condition: Type 2 Diabetes
Interventions: Drug: placebo; Drug: exenatide; Drug: exenatide
Sponsors: Amylin Pharmaceuticals, Inc.; Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Recruiting - verified August 2011 - Conditions: Type 2 Diabetes Mellitus; Nephropathy
Interventions: Drug: Valsartan; Drug: Placebo; Drug: Probucol
Sponsors: Guangdong General Hospital; Guangdong General Hospital
Recruiting - verified December 2011 - Conditions: Type 1 Diabetes; Osteoporosis
Intervention:
Sponsors: Creighton University; Creighton University
Recruiting - verified October 2011 - Conditions: Amputation; Diabetes Complications
Interventions: Device: Custom prosthetic socket with mechanical vibrators (stochastic resonance); Device: Conventional prosthetic socket (current clinical practice)
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of Texas
Recruiting - verified May 2012 - Condition: Type 1 Diabetes Mellitus
Intervention: Biological: cotransplantation of islet and mesenchymal stem cell
Sponsors: Fuzhou General Hospital; Fuzhou General Hospital
Recruiting - verified June 2011 - Conditions: Preeclampsia; Gestational Diabetes
Intervention: Other: Physical exercise
Sponsors: Universidade Estadual da Paraiba; Universidade Estadual da Paraiba; University of Campinas, Brazil
Recruiting - verified December 2011 - Conditions: Obesity; Type 2 Diabetes Mellitus; Insulin Resistance
Interventions: Procedure: gastric bypass surgery or sleeve gastrectomy; Behavioral: Liquid Diet
Sponsors: Columbia University; Columbia University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2012 - Condition: Diabetes
Interventions: Behavioral: psychological intervention; Behavioral: emotional support; Other: no intervention
Sponsors: Rabin Medical Center; Rabin Medical Center
Recruiting - verified May 2012 - Conditions: Diabetes Mellitus; Chronic Ulcers of the Lower Limb
Interventions: Procedure: Hyperbaric Oxygen Therapy; Procedure: Placebo Hyperbaric Oxygen Chamber
Sponsors: St. Joseph's Healthcare Hamilton; St. Joseph's Healthcare Hamilton; Judy Dan Research and Treatment Centre Ontario Wound Care Inc; University Health Network, Toronto
Recruiting - verified July 2011 - Conditions: Carotid Artery Disease; Carotid Artery Stenosis; Diabetes; Cognition
Intervention: Procedure: Shunt
Sponsors: Columbia University; Columbia University
Recruiting - verified October 2011 - Condition: Diabetes Mellitus
Intervention:
Sponsors: Mayo Clinic; Mayo Clinic
Not yet recruiting - verified July 2011 - Conditions: Birth Defects; Type 2 Diabetes; Preterm Birth
Intervention:
Sponsors: INC Research; INC Research; Amylin Pharmaceuticals, Inc.
Recruiting - verified March 2012 - Condition: Type 2 Diabetes
Intervention: Other: Hyperinsulinemic Hypoglycemic Clamp
Sponsors: University of Maryland; University of Maryland; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Condition: Type 1 Diabetes
Interventions: Drug: Alprazolam; Drug: Placebo
Sponsors: University of Maryland; University of Maryland; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Condition: Gestational Diabetes
Interventions: Drug: Exenatide; Genetic: Buccal Sample Collection
Sponsors: Georgetown University; Georgetown University; Washington Hospital Center
Recruiting - verified November 2011 - Conditions: Kidney Disease; Nephropathy; Type 2 Diabetes
Interventions: Drug: losartan; Drug: lisinopril; Drug: losartan
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Conditions: Type 1 Diabetes; Pregnancy
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified September 2011 - Condition: Type 2 Diabetes Mellitus
Interventions: Other: Paleolithic diet; Other: ADA ( American Diabetes Association) recommended diet
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified April 2012 - Conditions: Coronary Artery Disease; Diabetes Mellitus
Intervention: Procedure: exercise testing - coronary angiography - revascularization
Sponsors: Azienda Unita' Sanitaria Locale Di Modena; Azienda Unita' Sanitaria Locale Di Modena
Recruiting - verified May 2010 - Condition: Type 1 Diabetes Mellitus
Interventions: Drug: pioglitazone; Drug: Placebo control
Sponsors: Stony Brook University; Stony Brook University
Recruiting - verified August 2011 - Condition: Diabetes, Type I
Intervention: Device: 2 continuous glucose sensors, temperature sensor and insulin pump
Sponsors: Rabin Medical Center; Rabin Medical Center
Recruiting - verified October 2011 - Conditions: Islet Cell Transplantation; Type 1 Diabetes
Intervention: Drug: Islet cell transplantation
Sponsors: Baylor Research Institute; Baylor Research Institute; Baylor Health Care System
Recruiting - verified February 2012 - Condition: Diabetes
Interventions: Drug: Benazepril; Drug: Valsartan; Drug: Benazepril/Valsartan
Sponsors: Mario Negri Institute for Pharmacological Research; Mario Negri Institute for Pharmacological Research; Agenzia Italiana del Farmaco
Recruiting - verified June 2011 - Condition: Diabetes
Interventions: Drug: Benazepril; Drug: Valsartan; Drug: Benazepril/Valsartan
Sponsors: Mario Negri Institute for Pharmacological Research; Mario Negri Institute for Pharmacological Research; Agenzia Italiana del Farmaco
Recruiting - verified June 2011 - Conditions: Obesity; Gestational Diabetes; Type 2 Diabetes
Intervention: Behavioral: Exercise and dietary education
Sponsors: University of Manitoba; University of Manitoba; The Lawson Foundation
Recruiting - verified August 2011 - Conditions: Diabetes; Hyperglycemia
Interventions: Drug: Exendin-(9-39); 0.9% Saline; 20% Dextrose; Carnation Instant Breakfast; 95% Orleate; Drug: Exendin-(9-39); 20% Dextrose; 75g oral glucose; 0.9% Saline; Drug: Insulin Glargine; 20% Dextrose; 75g oral glucose; 0.9% Saline
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Type 1 Diabetes Mellitus
Interventions: Procedure: Islet transplant; Drug: Belatacept; Drug: Basiliximab; Drug: Mycophenolate Mofetil
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2011 - Condition: Type 1 Diabetes Mellitus
Intervention: Procedure: Islet transplant
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified December 2011 - Conditions: Type 2 Diabetes; Peripheral Vascular Disease
Interventions: Behavioral: Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive standard diabetes care by their admitting physician; Behavioral: Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive diabetes care under the direction of the Diabetes Action Team; Behavioral: Subjects without diabetes will have their blood glucose levels monitored while in the hospital
Sponsors: University of British Columbia; University of British Columbia; Novo Nordisk
Recruiting - verified December 2011 - Conditions: Insulin Resistance; Hypertriglyceridemia; Diabetes; Hepatic Steatosis
Intervention: Other: low-fat diet ( Still recruiting )
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; National Institutes of Health (NIH); Takeda Global Research & Development Center, Inc.; Amylin Pharmaceuticals, Inc.
Recruiting - verified August 2011 - Condition: Type 2 Diabetes
Interventions: Drug: glyburide; Drug: GlucoNorm
Sponsors: University of British Columbia; University of British Columbia; Novo Nordisk
Recruiting - verified February 2012 - Condition: Type 2 Diabetes
Intervention: Drug: Sitagliptin 100 mg
Sponsors: University of British Columbia; University of British Columbia; Merck Frosst Canada Ltd.
Recruiting - verified February 2012 - Conditions: Obesity; Insulin Resistance; Overweight; Diabetes Mellitus, Type 2
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified June 2011 - Conditions: Hypertension; Obesity; Type 2 Diabetes; Insulin Resistance
Interventions: Drug: Dietary Supplement: epigallocatechin 3-gallate (EGCG); Procedure: hyperinsulinemic isoglycemic glucose clamp; Procedure: insulin-stimulated brachial artery blood flow; Procedure: assess capillary recruitment in forearm skeletal muscle
Sponsors: University of Maryland; University of Maryland; Office of Dietary Supplements (ODS); National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified December 2011 - Condition: Type 2 Diabetes
Interventions: Procedure: laparoscopic gastric bypass surgery; Procedure: laparoscopic adjustable gastric banding; Procedure: Intensive Medical Management
Sponsors: McMaster University; Hamilton Health Sciences Corporation
Recruiting - verified May 2012 - Conditions: Morbid Obesity; Diabetes Mellitus Type 2; Insulin Resistance; Obstructive Sleep Apnea; Mood Disorders
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2012 - Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Oral Insulin
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Allergy and Infectious Diseases (NIAID); National Center for Research Resources (NCRR); American Diabetes Association; Juvenile Diabetes Research Foundation
Recruiting - verified February 2012 - Condition: Diabetes
Intervention: Behavioral: Resistance Exercise
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified May 2012 - Conditions: Cardiovascular; Diabetic
Interventions: Behavioral: Aerobic Exercise and Strength Exercise; Behavioral: Strength training
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting - verified December 2011 - Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Device: Pump therapy (CSII); Drug: Multiple daily injections (MDI) using insulin glargine + rapid acting analog
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic
Recruiting - verified April 2012 - Condition: Diabetes
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified August 2011 - Conditions: Nephropathy; Diabetes
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2012 - Condition: Non-Insulin Dependent Diabetes Mellitus
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified October 2011 - Conditions: Diabetes Mellitus; Glucose Intolerance
Interventions: Other: life-style intervention; Drug: Life style intervventions plus concomitant use of pitavastatin.
Sponsors: Tokyo University; Tokyo University
Recruiting - verified April 2012 - Condition: Type 1 Diabetes
Intervention: Drug: Thiazolidinedione
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified November 2011 - Conditions: Kidney Diseases; Heart Diseases; Diabetes Mellitus
Intervention: Procedure: The Combined Cardiac Kidney Diabetes Care Clinic
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified February 2012 - Condition: Diabetes
Interventions: Procedure: High Hemoglobin Concentration; Procedure: Low Hemoglobin Concentration
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified February 2012 - Condition: Diabetes Mellitus
Intervention:
Sponsors: University of Minnesota - Clinical and Translational Science Institute; Michael Mauer, MD; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes of Health (NIH)
Recruiting - verified April 2012 - Conditions: Renal Insufficiency; Diabetes Mellitus
Interventions: Drug: Iodixanol 320 mg I/mL (Visipaque™); Drug: iopamidol 300 mg I/mL (IsoVue)
Sponsors: GE Healthcare; GE Healthcare; ABX-CRO; EMSI; Covance; Quintiles Laboratories; Averion-Hesperion
Recruiting - verified July 2011 - Condition: Hypertension
Interventions: Drug: Thiazide diuretics; Drug: No diuretics
Sponsors: Kyoto University; Kyoto University; University of the Ryukyus
Recruiting - verified October 2011 - Condition: Diabetes Mellitus, Type 1
Intervention:
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Research Resources (NCRR); Juvenile Diabetes Research Foundation; American Diabetes Association
Recruiting - verified March 2012 - Conditions: Stroke; Myocardial Infarction; Diabetes
Interventions: Drug: pioglitazone; Drug: placebo
Sponsors: Yale University; Yale University; National Institute of Neurological Disorders and Stroke (NINDS); Takeda Pharmaceuticals North America, Inc.
Recruiting - verified August 2011 - Condition: Diabetes Mellitus
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2011 - Conditions: Diabetes Mellitus; Obesity
Intervention: Procedure: Oral glucose tolerance test
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Conditions: Endocrine Disease; Glucose Intolerance; Hyperinsulinemia; Impaired Glucose Tolerance; Non Insulin Dependent Diabetes Mellitus; Obesity; Type II Diabetes Mellitus
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified November 2011 - Conditions: Diabetes Mellitus; Insulin Resistance
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified April 2012 - Conditions: Coronary Disease; Obesity
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2011
 |
Join Clinical Trials That Study Diabetes |
